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Abstract 
Sensitised lanthanide complexes based on macrocyclic chelating ligands have been 
used extensively to study biological function at a cellular level, due to their very 
bright and long-lived emission, sharp emission bands and high stability to photo-
degradation. These photophysical properties, in addition to their excellent 
chiroptical behaviour, also make these complexes promising candidates for security 
labelling and as anti-counterfeiting tools. 
Novel highly emissive chiral europium(III) complexes based on macrocyclic ligands 
have been synthesised and their photophysical properties studied. They possess 
high molar extinction coefficients and are amenable to excitation using commonly 
available light sources. These complexes have been resolved by chiral HPLC and the 
circularly polarised luminescence (CPL) spectra of their enantiomers recorded. They 
exhibit strong circularly polarised emission in response to excitation using near 
ultra-violet light, and are stable to thermally-activated racemisation. 
A simple off-the-shelf camera set up has been developed which is capable of 
discriminating ‘real’ europium(III) emission from emission from a ‘fake’ marking, 
based on emission lifetime and wavelength. Additionally, chiroptical discrimination 
has been achieved using a custom built microscope incorporating a quarter-wave 
plate and linear polariser. 
The solvent dependent emission behaviour of a series of C3-symmetric 
lanthanide(III) complexes has been studied, demonstrating that the form of the 
total emission and CPL is extremely sensitive to minor changes in the outer 
solvation sphere of the complex. 
Finally, macropinocytosis has been identified as the mechanism of cell uptake of 
this family of complexes in NIH-3T3 cells, and the internalisation and subsequent 
sub-cellular localisation has been shown to be dependent on complex chirality.  
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CHAPTER ONE : INTRODUCTION 
1.1 Introduction to lanthanide luminescence 
1.1.1 Overview 
Luminescence is defined as the spontaneous emission of radiation from an 
electronically excited species. Luminescence can be categorised further depending 
on how the electronically excited species is formed, e.g. photoluminescence is the 
result of absorption of a photon, chemiluminescence is a result of a chemical 
reaction, triboluminescence arises from mechanical stress and electroluminescence 
occurs as a result of an electric current passing through a substance. 
Photoluminescence can be described using a Jabłońksi diagram which shows the 
processes that can occur (Fig. 1.1). 
Figure 1.1 A Jabłońksi diagram showing the primary processes involved in photoluminescence. 
Absorption of a photon excites the molecule from the singlet ground state (S0) to 
higher vibrational levels of a singlet excited state (S1). Very fast radiationless 
relaxation (timescale of 10-13 to 10-11 s) to the lowest vibrational level of S1 occurs 
by internal conversion (IC), following Kasha’s Rule.1 From here, there are three 
possible pathways: (i) non-radiative decay back to S0; (ii) decay to S0 accompanied 
by emission of a photon (fluorescence, 10-9 to 10-7 s); or (iii) intersystem crossing 
(ISC) to a triplet excited state, T1. From the T1 state, a molecule can return to the S0 
state either by non-radiative pathways or by emission of a photon 
(phosphorescence, 10-4 s to hours e.g. in ‘glow in the dark’ products). 
Absorption Fluorescence 
Phosphorescence 
ISC 
S1 
S0 
T1 
IC 
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Trivalent lanthanide cations display peculiar photoluminescent properties which 
can be attributed to their electronic structure. Lanthanide(III) ions have partially 
filled 4f orbitals, and the arrangement of the electrons in these ions can be 
described using the Russell-Saunders coupling scheme by term symbols in the form, 
2S+1LJ, where S denotes the spin quantum number of the ion and L is the total orbital 
angular momentum. Vector addition of L and S gives the possible values of J, the 
total angular momentum.  
Several lanthanide(III) ions exhibit radiative decay from electronic excited states. 
Thus, Sm3+, Eu3+, Tb3+ and Dy3+ emit light in the visible region of the spectrum, while 
Nd3+, Ho3+, Er3+ and Yb3+ emit near infrared light, and Gd3+ emits UV light. Normally, 
the larger the energy gap between the emissive state and the ground state, the less 
likely non-radiative pathways are to occur. This means that visible and UV emitters 
tend to be more efficient than IR emitters. Eu3+ and Tb3+ are the most commonly 
used lanthanide ions for luminescence studies in the visible region. In this work, the 
focus has been on emissive europium(III) species. 
The various electronic states of europium(III) can be characterised by their Russell-
Saunders term symbols, and the splitting of energy levels caused by various factors 
can be broken down as shown in Fig. 1.2. For europium(III) luminescence 
spectroscopy, emission from the 5D0 state is the most commonly studied. Emission 
from 5D1, 5D2 and higher levels is rarely observed, except in extended inorganic 
lattices.2  
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Figure 1.2 The contributions of various factors in the splitting of energy levels in Eu(III). 
For the 4f6 electron configuration of Eu(III), the ground state term is 7F. Spin-orbit 
coupling splits this term into 6 possible J levels (J = 0, 1, 2, 3, 4, 5, 6) which are 
separated from each other by energies of the order of 102-103 cm-1. Each of these J 
states can be split by crystal field effects into 2J+1 mJ or Stark states. In lanthanides, 
because the 4f orbitals are well shielded by the 5s and 5p orbitals, the effect of 
crystal field is small, meaning the separation of the mJ states is of the order of a few 
hundred wavenumbers. This small crystal field splitting (compared to the spin-orbit 
coupling) gives rise to transitions whose barycentres are largely independent of 
ligand environment. It is normally assumed that only the intensity and fine 
structure of transitions are affected by the environment. 
Transitions from the 5D0 excited state to various 7FJ levels are characterised by the 
dipolar nature of the transition. Intraconfigurational (s-s, p-p, d-d and f-f) transitions 
are formally forbidden by the Laporte selection rule as they do not involve a change 
in parity, so electric dipole (ED) transitions cannot occur. However, in non-
centrosymmetric environments, f-f transitions can occur via an induced electric 
                                                                                             CHAPTER ONE : INTRODUCTION 
 
4 
 
dipole mechanism. Magnetic dipole (MD) transitions are allowed by the Laporte 
selection rule but they are inherently weaker than electric dipole transitions. The 
selection rules for induced electric dipole and magnetic dipole transitions are 
summarised in Table 1.1. 
Table 1.1 Selection rules for intraconfigurational f-f transitions. 
 Selection rules 
Transition type S L J 
Induced electric dipole ΔS = 0 
|ΔL| ≤ 6; if L = 0 or 
L’ = 0, |ΔL| = 2, 4, 6 
|ΔJ| ≤ 6; if J = 0 or 
J’ = 0, |ΔJ| = 2, 4, 6 
Magnetic dipole ΔS = 0 ΔL = 0 
|ΔJ| ≤ 1 except 
0↔0 
 
These strict selection rules for ΔS, ΔL and ΔJ rely on S, L, and J being good quantum 
numbers. However, for the moderately heavy lanthanides, this assumption begins 
to break down, meaning these strict selection rules can be relaxed slightly. In 
particular, it should be noted that all transitions involving a change in spin are 
formally forbidden. Since most of the transitions involved in lanthanide 
luminescence involve changes in spin, it is clear that these selection rules do not 
always hold. The selection rules for the orbit quantum number, L, are also relaxed. 
The outcome of these rules in the instance of transitions from the 5D0 state of 
europium(III) is as follows. The 5D0 → 7F0 (ΔJ = 0) transition is an allowed induced ED 
transition, while 5D0 → 7F1 (ΔJ = 1) is forbidden by the selection rules for ΔJ for 
induced ED as J’ = 0 (therefore only |ΔJ| = 2, 4, 6 are allowed). It is, however, an 
allowed MD transition. The 5D0 → 7F2,4,6 (ΔJ = 2, 4, 6) transitions are induced ED 
allowed although ΔJ = 6 is rarely observed as it far into the red/near-IR region of the 
spectrum where conventional photomultiplier tube detectors are less sensitive. The 
5D0 → 7F3,5 (ΔJ = 3, 5) transitions are formally forbidden by all the selection rules. 
However, they can be very weakly allowed due to J-mixing, where wavefunctions of 
other J levels close in energy can mix, relaxing the ΔJ selection rules. 
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1.1.2 Emission lifetime 
Long luminescent lifetimes are often observed for lanthanides because f-f 
transitions are formally forbidden and usually involve a change of spin. For the 
commonly used emissive lanthanides, this leads to lifetimes of the order of 
microseconds for samarium and dysprosium and milliseconds for europium and 
terbium. These lifetimes are several orders of magnitude longer than the 
nanosecond lifetimes of organic fluorophores, which introduces the possibility of 
time-gated detection (see Fig. 1.3). This allows emission from long-lived species to 
be measured without competing interference from short-lived emitting 
compounds. Time-gated fluorescence microscopy, for example, has proved to be 
useful in live cell imaging using lanthanide stains, as background fluorescence from 
endogenous biomolecules can be eliminated from the measurement. 
 
Figure 1.3 Schematic representation of time-gated detection: long-lived lanthanide luminescence 
(red) is detected after a short delay, allowing the short-lived organic fluorescence (green) to decay. 
Emission from a single species decays following a first order rate profile such as in 
Eqn. 1.1. 
𝐼𝑡 = 𝐼0𝑒
−𝑡
𝜏  (1.1) 
where It and I0 are the emission intensities at time, t, and at t = 0, respectively, and τ 
is the measured emission lifetime, which is the inverse of the observed rate 
Em
is
si
o
n
 In
te
n
si
ty
Time
Detection window 
                                                                                             CHAPTER ONE : INTRODUCTION 
 
6 
 
constant, k, for depopulation of the emissive state. As such, lifetimes can be 
obtained by measuring emission intensity at various time points after excitation. A 
plot of ln(It) against t has a gradient of -1/τ. 
1.1.3 Excitation of lanthanides 
A further side-effect of forbidden f-f transitions is that transitions from lanthanide 
ground states to their excited states are very weakly absorbing, i.e. they have very 
low molar extinction coefficients (often <1 mol-1 dm3 cm-1). As a result, efficient 
direct excitation of lanthanide ions can only be achieved using lasers. This drawback 
can be overcome by the use of sensitising chromophores which excite the 
lanthanide via the antenna effect. The process involves absorption of incident 
photons by an antenna chromophore, followed by transfer of the energy onto the 
lanthanide ion. From the lanthanide excited state, photons can be emitted (see Fig. 
1.4). This can result in large pseudo-Stokes’ shifts compared to organic systems 
where absorption and emission bands often overlap. 
 
Figure 1.4 An illustration of the antenna effect in sensitised lanthanide photoluminescence. 
The energy transfer step is classically explained either by the Fӧrster or Dexter 
mechanisms. The Fӧrster mechanism is a highly distance-dependent (r-6) process 
involving non-radiative energy transfer through dipole-dipole coupling between the 
donor and acceptor,3 while the Dexter mechanism is a short range electron transfer 
between the donor and acceptor.4  
The Jabłońksi diagram in Fig. 1.1 can be extended to account for these processes 
(see Fig. 1.5). Here, the sensitising chromophore absorbs a photon before 
intersystem crossing to the triplet excited state T1. From here, energy transfer to 
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the excited state of the lanthanide ion occurs, before lanthanide-centred emission 
returns the system to its ground state. 
 
Figure 1.5 A Jabłońksi diagram showing the pathways involved in sensitised emission of lanthanides. 
There are several conditions that should be optimised to ensure efficient energy 
transfer to the lanthanide ion. The energy gap between S1 and T1 should be small to 
allow efficient intersystem crossing. If the energy gap is too large, chromophore 
fluorescence occurs more readily than intersystem crossing. Additionally, the T1 
state should be at least 1700 cm-1 higher in energy than the lanthanide excited 
state to minimise thermally-activated back energy transfer and chromophore 
phosphorescence.5 
An alternative mechanism for sensitisation has also been proposed, involving an 
internal charge transfer (ICT) excited state.6 This mechanism has been observed in 
systems where sensitising chromophores have large charge separation. Such ICT 
transitions often exhibit sensitivity to temperature and solvent polarity, and can 
occur in conjunction with the triplet-facilitated route described in Fig. 1.5. 
1.1.4 Quenching processes  
There are various pathways by which sensitised lanthanide emission can be 
quenched, the most important of which are summarised in Scheme 1.1. All of these 
processes will reduce the luminescence quantum yield of the species. After 
absorption of a photon, the chromophore singlet excited state can re-emit the 
Absorption 
Fluorescence 
Phosphorescence 
Intersystem 
crossing 
Energy Transfer 
Back Energy 
Transfer 
Excited State 
Ground State 
Ln3+ Emission 
S1 
S0 
T1 
Sensitising chromophore Ln3+ 
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photon as fluorescence, be quenched by electron transfer (eT) or by collisional 
quenching (by a quencher, Q). The chromophore triplet excited state can 
phosphoresce or be quenched by molecular oxygen (which has a triplet ground 
state). The lanthanide excited state can be quenched by electron transfer, energy 
transfer (ET) to another species, back energy transfer (BET) to the chromophore or 
by vibrational energy transfer to proximal X-H oscillators (where X = C, N, O). For 
Eu(III) and Tb(III), inner sphere water molecules and secondary amine groups are 
particularly efficient quenching species as the lanthanide excited states are of 
similar energy to higher vibrational levels of the O-H and N-H oscillators.  
 
Scheme 1.1 Various quenching processes possible during sensitised lanthanide emission. Redrawn 
from Ref. [7]. 
1.1.5 Photoluminescence quantum yield and brightness 
In order for a species to be useful in chiroptical or biological applications, it must 
possess a high photoluminescence quantum yield, Φ. In the case of sensitised 
lanthanide complexes, the quantum yield can be expressed as follows: 
𝛷 = 𝜂ISC𝜂ET𝛷
Ln (1.2) 
where ηISC is the efficiency of intersystem crossing from the chromophore singlet to 
the triplet excited state, ηET is the efficiency of energy transfer from the 
chromophore triplet state to the lanthanide excited state and ΦLn is the intrinsic 
quantum yield of the lanthanide ion. This parameter can be regarded as the ratio of 
the radiative rate constant, kr, to the sum of all possible rate constants for 
deactivation such that: 
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𝛷Ln =
𝑘𝑟
𝑘𝑟 + 𝑘𝑛𝑟
 (1.3) 
In addition to high quantum yields, complexes should also possess large molar 
extinction coefficients for absorption. The molar extinction coefficient, ε, is an 
intrinsic property of a molecule and describes how strongly a species absorbs light 
at a given wavelength. It can be related to concentration, c, and experimentally 
measured absorbance, A, by the Beer-Lambert Law, where l is the pathlength of the 
light travelling through the sample. 
𝐴(𝜆) = 𝜀(𝜆)𝑐𝑙 (1.4) 
The photoluminescence quantum yield and molar extinction coefficient of an 
emissive complex can be used to calculate a brightness parameter, B, as in equation 
1.5. 
𝐵(𝜆) = 𝜀(𝜆)𝜙 (1.5) 
Here, the brightness corresponds to the product of the molar extinction coefficient 
at the wavelength of the absorption maximum and the quantum yield when excited 
at this wavelength. From this equation, it can be seen that practical probes for 
fluorescence imaging require both high quantum yields and large molar extinction 
coefficients. 
1.1.6 Ligands for Ln(III) complexes 
As discussed previously, the highly contracted nature of the 4f orbitals means that 
interactions between Ln(III) ions and their ligands are mostly electrostatic in nature. 
Ln(III) ions usually prefer to be 8- or 9-coordinate in solution. In lanthanide 
coordination chemistry, the ligand can be used to control thermodynamic and 
kinetic stability, solubility, responsiveness to the environment and photophysical 
properties. 
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In most of the applications of lanthanide coordination chemistry, stability towards 
lanthanide ion dissociation is a key requirement. Much of the development of 
ligands for lanthanide(III) ions has stemmed from their use in Gd3+ contrast agents 
for Magnetic Resonance Imaging (MRI). All of the currently approved Gd3+ contrast 
agents use complexes with chelating or macrocyclic ligands such as DTPA 
(Magnevist), DOTA (Dotarem) and HP-DO3A (ProHance) (see Fig. 1.6).8 The nature 
of these ligands provides favourable binding due to the chelate effect and those 
with macrocycles further increase the stability by reducing the entropic penalty 
caused by ligand rearrangement upon metal binding. This can be observed by 
comparing the binding constants of [Gd(DTPA)]2- and [Gd(DOTA)]- (log K = 22.3 and 
24.7, respectively).9 
 
Figure 1.6 From left to right: H5DTPA, H4DOTA and H3-HP-DO3A ligands for Gd3+-based MRI contrast 
agents. 
Whilst the macrocyclic ligands above are based on a cyclen core (1,4,7,10-
tetraazacyclododecane, 12-N4), it also possible to use 1,4,7-triazacyclononane (9-
N3) as the central macrocycle. The simple 9-N3 analogue of DOTA (NOTA) is not a 
suitable ligand for lanthanide ion coordination as it only provides 6 donor atoms. 
However, NOTA has found use in other applications such as positron emission 
tomography (PET), where it has been used as a ligand in very stable C3 symmetric 
complexes (log K = 31) of Ga3+.10 The carboxylate donor arms have also been 
replaced with phosphinate groups (Fig. 1.7), which confer various advantages over 
the carboxylate analogues. Firstly, the lower pKa of the phosphinate groups (1.4 vs. 
3.1 for the carboxylates) render them more stable to metal dissociation under 
acidic conditions.11 Secondly, introduction of a pentavalent phosphorus(V) atom 
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allows for further functionalisation of the ligand and extra control of properties 
such as solubility.  
 
Figure 1.7 From left to right: 1,4,7- triazacyclononane-N,N',N"- triacetic acid (NOTA); the 
triphosphinic acid derivative of 9-N3; and the tris-picolinic acid derivative of 9-N3. 
In order to make these 9-N3 based ligands suitable for lanthanide coordination, 
extra donor atoms must be introduced. This can be achieved using the tris-picolinic 
acid derivative of 9-N3. Addition of the pyridine ring allows the ligand to be used as 
a sensitising group in addition to its coordination behaviour. It can also provide the 
basis for functionalisation of the complex. Another example of a ligand that 
provides both chelating coordination and sensitisation is the tris-bipyridine 
cryptand shown in Figure 1.8. This ligand provides a cage in which the metal ion 
sits, however these complexes suffer from low aqueous solubility and low quantum 
yields due to the presence of bound solvent molecules, despite having reasonably 
high molar extinction coefficients (in the region of 18 000 mol-1 dm3 cm-1).12  
 
Figure 1.8 The europium complex of the tris-bipyridine macrobicyclic cryptand ligand. 
A huge variety of chromophoric moieties has been used to sensitise lanthanide 
ions, although it ought to be noted that some chromophores cannot be used to 
sensitise multiple lanthanides. As discussed in Section 1.1.3, the chromophore 
excited state should lie at least 1700 cm-1 above the lanthanide emissive state in 
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order to efficiently sensitise the metal. In the cases of the most emissive 
lanthanides, the Eu(III) 5D0 state has an energy of around 17 200 cm-1, compared to 
20 500 cm-1 for the 5D4 state of Tb(III). As a result, some chromophores are better 
tuned to sensitise certain lanthanide ions.  
Examples of sensitising groups that have been utilised in lanthanide(III) complexes 
include pyrenes and 8-hydroxyquinolinates (for near-IR emitting Er(III), Nd(III) and 
Yb(III));13,14 1-hydroxypyridin-2-one (1,2-HOPO) for Eu(III);15 and 2-
hydroxyisophthalamide (IAM) for Eu(III), Tb(III), Dy(III) and Sm(III).16  
 
Figure 1.9 Clockwise from top left: DO3A appended with pyrene groups (Ln = Er(III), Nd(III) or Yb(III)); 
8-hydroxyquinolinate sensitisers attached to a tripodal chelating platform; a tripodal ligand bearing 
1,2-HOPO groups; and a similar ligand with 2-IAM sensitisers. 
Some further examples of complexes bearing pendant chromophore arms are 
shown in Figure 1.10. Each of these examples and their derivatives possess 
absorption maxima in the range 330-410 nm, making them suitable for in cellulo 
imaging (excitation at these wavelengths avoids co-excitation of endogenous 
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fluorescent biological molecules). Tetraazatriphenylene based chromophores (Fig. 
1.10, left) exhibit fast intersystem crossing and have suitable triplet excited energy 
(24 000 cm-1) for sensitisation of both terbium(III) and europium(III).17 Acridone 
groups (Fig. 1.10, centre) have also been investigated as pendant chromophores. 
They showed promising absorption characteristics (λmax 410 nm, εH2O 5300 mol-1 
dm3 cm-1),18,19 but the highly solvent-dependent π-π* singlet excited state is 
significantly lower in energy in polar solvents (such as water, alcohols) than in non-
polar media. As a result, in polar media the rate of ligand fluorescence is greatly 
increased compared to the rate of intersystem crossing, meaning this chromophore 
is not usually suitable for use in cellulo. Extensive use has been made of 
azaxanthones and their sulphur analogues, azathioxanthones (Fig. 1.10, right). 
These systems have triplet excited state energies between 23 500 and 25 000 cm-1, 
and a low ligand fluorescence quantum yield making them suitable for sensitising 
both europium(III) and terbium(III). Unlike the acridone group, the pyridine 
nitrogen binds to the metal centre. Substitution of oxygen for sulphur shifts the 
absorption maximum from 335 to 375 nm, although the sulphur analogue does 
have increased ligand fluorescence.20 Complexes bearing aza(thio)xanthone and 
tetraazatriphenylene sensitisers have been used in live cell stains for the 
mitochondria21 and lysosomes,22 as well as probes for bicarbonate,23 citrate,24 
lactate,24 and pH.25 The large size of these chromophores means that a maximum of 
two sensitisers can be appended to a 12-N4 macrocycle. 
 
Figure 1.10 A selection of europium(III) complexes bearing pendant chromophore arms. From left to 
right: tetraazatriphenylene, acridone, azaxanthone (X = O) or azathioxanthone (X = S). 
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The various chromophores discussed above are all believed to use excited states 
corresponding to n-π* or π-π* transitions to sensitise lanthanide luminescence, 
which limits their molar extinction coefficients, and hence the complex brightness. 
An alternative class of chromophores have been shown to utilise an internal charge 
transfer (ICT) excited state. These chromophores possess pyridylarylalkynyl 
structures with electron rich aryl groups and electron deficient pyridine groups, 
separated by a conjugated alkyne linker (see Fig. 1.11). This creates a large charge 
separation along the chromophore, resulting in a broad ICT absorption band. 
Chromophores of this type were first used in lanthanide coordination chemistry in 
the early 1990s, incorporated into chelating aminopolycarboxylate ligands,26 and 
have also been attached to 9-N3 as pendant chromophore arms (see Fig 1.11, 
right).27 The europium(III) complex of this macrocyclic ligand exhibited a molar 
extinction coefficient of 48 400 M-1 cm-1 and a luminescence quantum yield of 22% 
in aqueous solution.28 However, the absorption maximum of 315 nm is somewhat 
too short for biological application (as discussed above). The complex was not able 
to efficiently sensitise terbium(III). This can be attributed to the fact that the ligand 
excited state is too low-lying, facilitating back energy transfer from the terbium(III) 
ion. 
 
Figure 1.11 Early examples of pyridylarylalkynyl chromophores for europium(III) complexes.26,27 
The advantage of these systems is that the absorption maximum can be tuned by 
the addition of electron donating groups to the aryl group of the chromophore. The 
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more electron-rich the aryl group becomes, the more the absorption maximum is 
shifted to longer wavelengths. Some examples are shown in Fig. 1.12.  
 
Figure 1.12 Examples of various Eu(III) complexes, [Eu.Lcn], containing different aryl substituents on 
the pyridylarylalkynyl chromophores. The photophysical properties of the Eu(III) complexes are 
shown in Table 1.2.29  
Table 1.2 Photophysical properties for selected Eu(III) complexes bearing 
pyridylarylalkynyl chromophores. All measurements made in MeOH solution.29  
Complex λmax / nm ε / M-1 cm-1 Φ / % τ / ms 
[Eu.Lca] 339 58 000 42 0.99 
[Eu.Lcb] 345 60 000 55 0.97 
[Eu.Lcc] 351 60 000 45 0.90 
[Eu.Lcd] 339 60 000 41 1.01 
[Eu.Lce] 341 60 000 8 0.49 
[Eu.Lcf] 349 60 000 32 0.85 
n.b. the units given in Ref [29] for the extinction coefficient, ε, are incorrect. 
 
It is clear to see that addition of electron-donating groups in the conjugated ortho 
and para positions (relative to the alkyne group) causes a bathochromic shift in the 
absorption maxima but addition of alkoxy groups in the non-conjugated meta 
positions does little to affect the absorption properties (c.f. [Eu.Lca] and [Eu.Lce]). In 
every case, no ligand fluorescence was observed, suggesting highly efficient energy 
transfer to the lanthanide excited state. Each complex was highly emissive, with the 
exception of [Eu.Lce] which has a much lower quantum yield and shorter lifetime. It 
is possible that this is due to competition from alternative non-radiative 
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deactivation pathways that are present in this complex. It should be noted that the 
absorption bands for these derivatives are very broad and structureless, consistent 
with internal charge transfer character in the excited state. This behaviour is in 
contrast to the unsubstituted example in Fig. 1.11 which shows a structured 
absorption band corresponding to predominately π-π* character.29  
The carboxylate donor groups can also be exchanged for phosphinate groups. As 
discussed earlier in this section, substitution of carboxylates by phosphinates 
confers several advantages, such as better stability towards metal dissociation, 
better control of solubility and opportunity for further functionalisation of the 
ligand. The methyl and phenyl phosphinate analogues of [Eu.Lca] ([Eu.Lmpa] and 
[Eu.Lppa], respectively) have been studied to determine what effect the change in 
donor groups has on the photophysical properties of the complex. DFT-optimised 
structures for the three yttrium(III) analogues showed little change in the overall 
calculated structure on changing from carboxylate to phosphinate groups (see Fig. 
1.13),29 and the DFT structure for [Y.Lppa] was consistent with the experimental X-
ray structure for [Eu.Lppa].30 In the crystal structure, [Eu.Lppa] exists with a slightly 
distorted tri-capped trigonal prismatic coordination polyhedron with pseudo-C3 
symmetry. In solution, the complex exhibits only one 31P NMR resonance and the 1H 
NMR spectrum is consistent with time-averaged C3 symmetry. 
 
Figure 1.13 DFT-optimised structures of (top to bottom) [Y.Lca], [Y.Lmpa] and [Y.Lppa] showing 
increased shielding effect in the phosphinate complexes. Adapted with permission from Ref. [29]. 
Copyright (2014) Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. 
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The photophysical properties are displayed in Fig. 1.14 and Table 1.3. The red shift 
in the absorption maximum for [Eu.Lca] compared to the phosphinate complexes 
can be explained by the geometry of the complex. The tetrahedral geometry at the 
phosphorus atoms produced a more constrained chelate than the carboxylate. This, 
combined with the longer P-O bond compared to C-O, mean that the Npy-Ln bond 
length is slightly longer in the phosphinates than in the carboxylates. As a result, 
there is stronger coordination in the carboxylate complex with the Lewis acidic 
metal centre making the pyridine more electron deficient, and hence the 
chromophore has a larger charge separation leading to a longer wavelength 
absorption band. 
Table 1.3 Photophysical properties for the carboxylate complex [Eu.Lca] and its, methyl 
phosphinate and phenyl phosphinate analogues. All measurements made in MeOH solution.29  
Complex λmax / nm ε / M-1 cm-1 Φ / % τ / ms 
[Eu.Lca] 339 58 000 42 0.99 
[Eu.Lmpa] 331 58 000 43 1.18 
[Eu.Lppa] 332 58 000 52 1.30 
 
 
Figure 1.14 Absorption (top) and emission spectra (bottom) for [Eu.Lca] (black), [Eu.Lmpa] (dark 
grey) and [Eu.Lppa] (light grey). Spectra were recorded in methanol at room temperature. Reprinted 
with permission from Ref. [29]. Copyright (2014) Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. 
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On changing from the carboxylate donor groups to the methyl and phenyl 
phosphinate groups, the emission lifetime also increases. This behaviour can be 
attributed to the increased shielding effect of the phosphinate moieties (see Fig. 
1.13). The phosphinate substituents are positioned on the top face of the complex, 
thereby shielding it from solvent molecules.‡ The quenching of the europium(III) 
excited state caused by O-H oscillations in the solvent is therefore reduced. For 
[Eu.Lmpa], the high quantum yield is retained in water (39%) with only a small drop 
in emission lifetime (1.01 ms).29 
1.2 Introduction to circularly polarised luminescence 
Circularly polarised luminescence (CPL) is a phenomenon that was first observed in 
1948 by Samojlov whilst studying emission from single crystals of sodium uranyl 
acetate at low temperature.31 In the late 1960s and early 1970s, CPL was observed 
in solution by Emeis and Oosterhoff, from chiral organic molecules and from the Δ 
and Λ enantiomers of [Cr(en)3]3+.32,33 In 1974, the first results of CPL from 
lanthanide complexes were reported by Luk and Richardson.34 These experiments 
concerned emission from complexes of Tb(III) with malic and aspartic acid ligands. 
Luk and Richardson observed that the form of the CPL was very sensitive to the 
ligand structure and that the complex fine structure in the total emission spectra of 
the terbium ion could be resolved using the CPL spectra. Much of the theoretical 
background to CPL was developed by Riehl and Richardson during the 1970s and 
1980s.35,36 
1.2.1 Theoretical background 
Polarised light is classically described as an electromagnetic wave comprising a 
magnetic field vector and an electric field vector which are perpendicular to each 
other. Conventionally, the polarisation of the wave is determined by the direction 
of the electric field vector. 
                                                     
‡ It should be noted that in pre-2015 publications, the phosphinate substituents were drawn as 
dashed, i.e. below the plane, when the complex was viewed from the top face. This is incorrect, as 
the substituents are orientated above the open face of the complex (see Fig. 1.13). 
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The electric field vector can be regarded as the superposition of two perpendicular 
components with equal frequency. When these two perpendicular components 
have identical amplitude, but are exactly a quarter wavelength phase shifted from 
one another, it results in a wave where the total electric field vector describes a 
helical wave as a function of time (see Fig. 1.15). 
 
Figure 1.15 Left and right handed circularly polarised light; perpendicular components are in blue 
and green and the resulting electric field vector is shown in red.  
Transformation between linearly and circularly polarised light can be achieved by 
passing the light through a quarter-wave plate at an angle of 45° to the optical axis. 
When linearly polarised light passes through the quarter-wave plate, one 
component is retarded by a quarter wavelength due to the birefringence of the 
quarter-wave plate, resulting in circularly polarised light.  
Circularly polarised luminescence spectroscopy measures the differential emission 
of left- and right-handed circularly polarised light by a chiral species. It can be 
treated as a complementary tool to circular dichroism (CD) spectroscopy. In CD, it is 
the difference in absorption between left- and right-handed circularly polarised 
light that is measured, giving information about the ground state of the molecule. 
CPL spectroscopy measures the difference in emission intensity of left- and right-
handed circularly polarised light after excitation with unpolarised light, and so 
explores the properties of the molecular excited state (see Eqn. 1.6).  
                                                        ∆𝐼(𝜆) = 𝐼𝐿(𝜆) − 𝐼𝑅(𝜆)                                             (1.6) 
where IL and IR are the intensities of left- and right-handed CPL, respectively. 
Absolute measurements of emission intensity vary from instrument to instrument 
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and so can be difficult to compare. Instead, the magnitude of the CPL at a given 
wavelength can be calculated by comparison to the total emission (IL + IR), by 
defining an emission dissymmetry factor, gem:  
𝑔em(𝜆) =
2Δ𝐼(𝜆)
𝐼L(𝜆) + 𝐼R(𝜆)
 (1.7) 
It can be seen from this definition that the maximum possible value for glum is ± 2, 
i.e. all emission at a given wavelength is polarised in one direction.  
For a transition i → j, the emission dissymmetry factor, gem, can also be written as 
𝑔em =
4𝑅𝑖𝑗
𝐷𝑖𝑗
 (1.8) 
where Rij is the rotatory strength of the transition i → j, and Dij is the dipole 
strength of the transition i → j. These terms can also be expressed as functions of 
the magnetic transition dipole vector, mij, and the electric transition dipole vector, 
μij: 
𝑅𝑖𝑗 = |𝛍𝒊𝒋| ∙ |𝐦𝒊𝒋| cos 𝜃𝛍,𝐦 (1.9) 𝐷𝑖𝑗 = |𝛍𝒊𝒋|
2
+ |𝐦𝒊𝒋|
2
 (1.10) 
where θμ,m is the angle between the magnetic and electric transition dipole vectors. 
As a result, gem can be rewritten as: 
𝑔em = 4
|𝛍𝒊𝒋| ∙ |𝐦𝒊𝒋|
|𝛍𝒊𝒋|
2
+ |𝐦𝒊𝒋|
2 cos 𝜃𝛍,𝐦 (1.11) 
Typically the magnetic transition dipole is much smaller than the electric transition 
dipole, so equation 1.6 can be simplified to:  
𝑔em = 4
|𝐦𝒊𝒋|
|𝛍𝒊𝒋|
cos 𝜃𝛍,𝐦 (1.12) 
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From this expression, it follows that the largest gem values occur in magnetic dipole 
allowed transitions with small electric dipole character. It can also be seen that a 
value of zero is returned when the electric and magnetic dipole transition moments 
are orthogonal (i.e. θμ,m = 90°) and is a maximum when θμ,m = 0°, 180°. In the case 
of europium(III), it is the ΔJ = 1 transition that is magnetic dipole allowed, so it is in 
this emission manifold that we would normally expect to see the largest values for 
the emission dissymmetry factor.  
CPL can be considered as a complementary technique to circular dichroism (CD). 
Whilst CD examines the chirality of the absorbing state, CPL can probe the emitting 
state of a transition. However, CPL can be particularly useful in lanthanide 
spectroscopy as it can be used to probe excited states that are difficult to access via 
absorption spectroscopy.  
1.2.2 Instrumentation for the detection of CPL 
Until the first commercial CPL spectrometer entered the market in recent years, the 
majority of CPL spectrometers were ‘home-built’. In general, the spectrometer 
setup is modular (see Fig. 1.16), and home-built spectrometers tend to contain 
several common features. In several instances, spectra have been compared 
between different spectrometers and have been found to be broadly equivalent. 
Typically, excitation light is passed through a monochromator, allowing selection of 
the absorption maximum of the complex of interest. The sample is excited and the 
emitted light is collected at 90°. The emitted light first passes through a 
photoelastic modulator (PEM) and then a linear polariser. The PEM is made of an 
isotropically optically transparent material (e.g. quartz) which becomes birefringent 
on application of physical stress. It can behave as an oscillating quarter-wave plate 
at a frequency of 50 kHz when powered by an AC signal. In a cycle of the PEM, the 
left- and right-handed components of the circularly polarised light are alternately 
converted into the appropriate linearly polarised light which is selected by a linear 
polariser. The linearly polarised light is then passed through a scanning 
monochromator before detection. Two different methods of detection have been 
employed in home-built spectrometers. The first method (which is used in the 
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Durham spectrometer) was first reported by Steinberg and Gafni and comprises a 
photomultiplier tube (PMT) that collects the emitted photons. A lock-in amplifier 
operates in phase with the PEM cycle and extracts the left and right polarised 
components of the PMT output to an AC (CPL) and DC (total emission) signal.37 The 
second method employs a photon gate coupled to the PEM. By synchronising the 
gate with the PEM signal, photons are directed into two different photon counters 
for detection.38 The latter system was shown to be superior to the lock-in amplifier 
system for the detection of very small CPL signals. In the case of the Durham 
instrument, a red correction is embedded in the detection algorithm. A red 
correction is required because at longer wavelengths (such as in the red region of 
the visible spectrum), the photon energy is lower and therefore the probability of 
generating an electric current in the detector is reduced as it requires promotion of 
an electron across the band gap of the semiconducting material. 
 
Figure 1.16 A schematic diagram of the Durham CPL spectrometer.39 
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1.3 CPL-active organic and transition metal systems 
There are many examples of CPL-active systems in the literature, varying from 
single organic molecules to metal complexes and aggregated polymers. Each class 
of system has advantages and disadvantages for various applications, which will be 
discussed in the following sections.   
1.3.1 Single Organic Molecule (SOM) systems 
Examples of single organic molecules (SOMs) that emit circularly polarised 
luminescence have been observed from the early work of Emeis and Oosterhoff. 
They examined simple chiral ketones such as the bicyclic (+)-(S,S)-trans-β-
hydrindanone (Fig. 1.17, left), which exhibited CPL in the ultraviolet region upon UV 
excitation of the carbonyl (gem = 3.5 × 10-2 at 361 nm).32 It ought to be noted that 
the luminescent-active carbonyl is itself planar (and hence inherently achiral), but 
that the nature of its electronic transition is influenced by the chirality of the 
structure in which it resides.  
Since this observation, several other CPL-active ketones have been examined, 
mainly in molecules containing conformationally restricted polycyclic structures. 
Some examples based on norbornane and adamantane are shown in Fig. 1.17. All of 
these molecules exhibit gem values within the 10-3-10-2 range, but suffer from very 
low quantum yields (on the order of 10-5).40–42 Their small Stokes’ shifts and UV-
emission limits their practical use.  
 
Figure 1.17 A selection of CPL-active chiral ketones; from left to right: (+)-(S,S)-trans-β-
hydrindanone, (1R)-camphor, (1R)-fenchone, (1R)-camphorquinone and (1S, 3R)-4-
methyleneadamantan-2-one. 
In order to bring the emission wavelengths into the visible region of the spectrum, 
extended π-conjugated systems have also been developed. Among the most 
commonly used structures are BODIPY dyes (BODIPY = difluoroboron-
dipyrromethene). BODIPY-based dyes are already used extensively in cellular 
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imaging but are usually achiral in nature.43 Addition of chiral substituents to the 
BODIPY core has resulted in several examples of CPL-active BODIPY dyes. Addition 
of the dihydropyrrolone groups (Fig. 1.18, left) gave a BODIPY compound with a 
quantum yield of 48% and a gem value of 0.94 × 10-3 at 546 nm (CH2Cl2). 
Interestingly, the excitation is thought to be via the dihydropyrrolone moieties, 
implying that there is an energy transfer occurring between the dihydropyrrolone 
groups and the BODIPY core.44 Replacing the BF2 bridge of the BODIPY core with the 
two enantiomers of an axially chiral 1,1’-bi-2-naphthol (BINOL) group gives two 
enantiomeric complexes which exhibit mirror imaged CPL (Fig. 1.18, right). Here, as 
with the chiral ketones earlier, the achiral BODIPY core is the chromophore and the 
chiral BINOL group perturbs the otherwise achiral environment. This compound 
exhibited very similar photophysical properties to the dihydropyrrolone-appended 
BODIPY (gem = +0.7 × 10-3 (R), -0.8 × 10-3 (S) at 570 nm, Φ = 46%, CHCl3). It can be 
seen in Figure 1.18 that the CPL signal is very weak and there is substantial noise in 
the data. The solid lines through the data are acquired by using the lineshape of the 
total emission band, overlaid onto the CPL data, and are therefore not true fits of 
the data. Here the BODIPY is excited directly, resulting in a small Stokes’ shift (ca. 
20 nm).45  
 
Figure 1.18 Left: examples of chiral BODIPY dyes bearing dihydropyrrolone (top) and 1,1’-bi-2-
naphthol (BINOL) (bottom) substituents. Right: the total emission and CPL spectra for the S (blue) 
and R (red) enantiomers of the BINOL O-BODIPYs. Reproduced with permission from Ref. [45]. 
Copyright (2014) American Chemical Society. 
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In addition to the examples shown in Fig. 1.18, BODIPY monomers have been 
oxidatively coupled to produce dimers which contain an axis of chirality due to 
restricted rotation around a C-C single bond, in contrast to the previous examples 
where addition of a chiral substituent confers chirality to the BODIPY (see Fig. 1.19 
for one example).46 This compound exists as two enantiomers which can be 
assigned as aR and aS, and can be separated by chiral HPLC. The resolved 
enantiomers display mirror imaged CPL and CD spectra, with a Stokes’ shift of 95 
nm which is larger than most BODIPY dyes. The gem values are ±3.8 × 10-3 at 655 nm 
in dichloromethane,47 which is at the higher end of the range reported for single 
non-aggregated organic molecules. 
 
Figure 1.19 A pair of axially chiral BODIPY dimer enantiomers. 
Another class of organic compounds shown to exhibit CPL are helicenes and 
heterohelicenes. These molecules comprise ortho-fused aromatic rings which are 
sterically constrained to exist as helices, i.e. they are distorted from the expected 
planar conformation. As a result, they possess inherent chirality which is dependent 
on the direction of the helical twist. Recent examples of CPL-active helicenes 
include the work of the group of Tanaka in Tokyo (see Fig. 1.20). By following 
synthetic pathways involving achiral starting materials and the use of chiral metal 
complexes as catalysts, they have created enantioenriched helicenes (>90% ee) 
with a fluorene core, which exhibit CPL in the visible region of the spectrum. They 
possess gem values around -3 × 10-2 upon irradiation with UV light, and quantum 
yields around 30%.48  
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Figure 1.20 CPL-active helicenes with fluorene and spiro-fluorene cores. 
These gem values are an order of magnitude higher than have been reported for 
other helicenes that do not bear the fluorene core. However, the quantum yield is 
lower than has been observed for the BODIPY systems discussed previously, 
perhaps due to the distortion of the extended π-conjugation in the helicenes. 
Using further enantioselective synthetic routes, Tanaka’s group has also 
investigated ‘S-shaped’ double helicenes which showed enhanced CPL activity 
compared to the parent single helicenes. For example, the double azahelicene in 
Figure 1.21 has a gem value more than 10 times higher than its parent single 
helicene (-1.1 × 10-2 vs. < 1 × 10-3 (below the limit of detection)).49 
 
Figure 1.21 The M-double azahelicene (left) and its parent single helicene (right). 
A very recent example of a CPL-active azahelicene utilises rigid linkers between 
helicene monomers to create a figure-of-eight shaped azahelicene dimer (see Fig. 
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1.22). Rather than enantioselective synthesis, resolution of the diethynyl helicene 
monomer is achieved by chiral HPLC before oxidative ‘Eglinton type’ Cu(II)-
catalysed homocoupling forms the twisted dimer. The rigid structure limits non-
radiative decay pathways, resulting in the dimer having a quantum yield of 55% 
with a gem value of 8.5 × 10-3 at 588 nm. However, the extended π-conjugation 
shifts the absorption maximum to 536 nm, resulting in a small Stokes’ shift.50  
 
Figure 1.22 The structure of the figure-of-eight shaped azahelicene dimer. 
Other recent examples of CPL-active heterohelicenes include the use of silicon,51 
boron,52 and platinum53 in the structures.  
In summary, CPL-active single organic molecules offer high quantum yields which 
can, to some extent, make up for the low gem values they exhibit. Weak CPL can be 
attributed to the primarily electric dipole nature of the transitions involved, which 
is an inherent limitation in these systems. Their solubility in organic solvents means 
they can be handled easily and are less prone to aggregation, which is beneficial in 
applications such as display devices.  
1.3.2 Supramolecular aggregates 
Species which aggregate in solution have been explored as a method of increasing 
emission dissymmetry factors in organic systems. Since the photophysical 
properties of organic molecules can often be controlled by self-assembly, extended 
planar aromatic systems offer the potential for highly circularly polarised emission. 
Often, aggregated assemblies amplify the small emission dissymmetry observed in 
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the monomeric units. Excimer-like properties have been observed in π-stacked 
chromophores such as the perylene bisimide shown in Figure 1.23. The two 
perylene units are attached to a cyclohexane ring which confers chirality to the 
molecule. In dilute solutions (10-5 M in chloroform) emission from both the 
monomeric and excimer forms are visible. The observed CPL is an order of 
magnitude stronger from the excimer state and is of opposite handedness to the 
monomer.54 
            
Figure 1.23 The structure of the S-form of the perylene bisimide (left) and the CPL spectra of the two 
enantiomers at a concentration of 1 × 10-5 M in CHCl3 (right). Adapted with permission from Ref. [55] 
Copyright (2015) American Chemical Society. 
In methylcyclohexane solution, self-assembly of the molecules into extended helical 
fibres could be observed by SEM and AFM, the helicity of which depended on the 
chirality in the cyclohexane core. The CPL of the aggregated fibres was observed to 
possess much higher emission dissymmetry than the monomer or excimer CPL and 
showed a change of sign compared to the excimer (see Fig. 1.24). The fibres formed 
from the opposite enantiomer of the monomer exhibited mirror imaged CPL. 
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Figure 1.24 (a) An AFM image showing the network of fibres formed from aggregation of the chiral 
cyclohexyl perylene bisimides, (b) a glum vs wavelength plot for the aggregated fibres and (c) a 
schematic representation of the self-assembly process. Reprinted with permission from Ref. [55]. 
Copyright (2015) American Chemical Society.  
Whilst self-assembled structures may provide larger gem values, there are significant 
drawbacks to their use in CPL studies. It is often difficult to be certain of the 
speciation of these compounds as it is very dependent on solvent and 
concentration. Additionally, extended aggregated structures often suffer from low 
emission efficiency and can be very difficult to process, which limits their 
applicability in several applications, such as security printing, display devices and 
biosensing. 
1.3.3 Transition metal complexes 
In addition to the incorporation of a platinum ion into the backbone of the 
inherently chiral helicene discussed above, chiral transition metal complexes have 
also been investigated as CPL-emissive species. They have potential applications in 
3D display screens and optical storage devices. Synthesised by various methods 
including enantioselective synthesis, use of enantiopure ligands, and chiral 
resolution of racemic products, a number of CPL-active transition metal complexes 
have been studied. Many are based on the numerous examples of emissive 
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transition metal complexes of Ru(II), Os(II) and Ir(III) developed for use in display 
devices. Transition metal complexes have the advantage that emission wavelength 
can be tuned by systematic ligand design, and complexes often possess high 
phosphorescence efficiency. However, some chelate complexes of transition metals 
have exhibited photo-induced racemisation.56–60 Examples of complexes containing 
achiral ligands include the iridium(III) complexes shown in Figure 1.25. These 
complexes are synthesised as racemates and resolved by chiral supercritical fluid 
chromatography. The homoleptic fluorinated complex emits CPL in the blue-green 
region of the spectrum with a gem value of +1.99 × 10-3 at 495 nm for the Λ-
enantiomer while the heteroleptic acac complex has slightly less polarised emission 
(gem = +1.72 × 10-3 at 515 nm). Both complexes have quantum yields in the region of 
30%.61 Recently, similarly designed Ir(III) complexes with achiral ligands have been 
investigated in terms of their circularly polarised electroluminescence (CPEL), 
displaying similar profiles to CP photoluminescence spectra. Again, emission 
dissymmetry factors are of the order of 10-3.62  
                         
Figure 1.25 The structures of the Λ enantiomers of a homoleptic (left) and a heteroleptic (right) Ir(III) 
complex (R = fluorine). Adapted with permission from Ref. [61] Copyright (2008) American Chemical 
Society. 
Other examples have incorporated chiral ligands to create CPL-active transition 
metal complexes. Many of these examples feature pinene units in the ligand 
structure. Cage-like structures containing pinene-appended bipyridine ligands have 
been shown to form helical complexes with Ru(II) and Zn(II). The enantiomers of 
each complex emitted mirror imaged CPL, with gem values of ± 5.4 × 10-4 and ± 2.4 × 
10-3 for the Ru(II) and Zn(II) complexes, respectively (see Fig. 1.26).63 Interestingly, 
since Zn(II) has a d10 electron configuration, the emission in this complex is assumed 
not to involve metal orbitals and is purely a triplet ligand centred emissive state, in 
contrast to the Ru(II) analogue. 
                                                                                             CHAPTER ONE : INTRODUCTION 
 
31 
 
 
 
Figure 1.26 The (-)-pinene substituted bipyridine ligand which forms the Δ-helical Ru(II) and Zn(II) 
cage complexes (top); and the CPL and gem spectra for the two enantiomers of the Zn(II) cage 
complex (bottom). Reprinted with permission from Ref. [63]. Copyright (2007) American Chemical 
Society.  
Recently, a pinene-based cyclometallated platinum complex has been shown to 
reversibly switch on CPL signal in response to temperature. In methanol solution, 
the complex exhibits no CPL, but in aqueous solution a CPL signal is observed at 
room temperature. On heating to 353 K, the CPL signal is lost, but recovers on 
cooling.64 It has been proposed that in aqueous solution helical aggregation occurs, 
controlled by the remote chirality of the pinene. At increased temperatures, the 
aggregates decompose, returning to CPL-inactive monomers. 
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In summary, whilst the photophysical properties of transition metal complexes can 
be tuned by rational ligand design, their small emission dissymmetry factors still 
make their practical use a challenge. 
1.4 Chiral lanthanide complexes 
As described in Section 1.2.1, large gem values are expected to occur in transitions 
with large magnetic dipole character and only small electric dipole contribution. 
Compared to the organic and transition metal complexes discussed previously, 
lanthanide complexes can offer unparalleled access to large emission dissymmetry 
factors, due to their magnetic dipole allowed transitions. This section will discuss 
various approaches to CPL-active lanthanide complexes with reference to the 
molecular design, before describing some examples of the use of CPL to probe 
various biological analytes. 
1.4.1 Design and control of chirality 
There are several approaches that have been utilised to synthesise chiral lanthanide 
complexes. They can be broadly categorised as follows: (a) complexes that use 
enantiopure ligands to favourably form one enantiomer of complex over the other; 
(b) dynamically racemic complexes; (c) complexes that are formed as racemic 
mixtures and are separated into their enantiomers by methods such as chiral HPLC 
or co-crystallisation. 
Arguably the easiest method of creating a chiral complex is to use chiral ligands. 
Examples of this strategy have already been discussed for transition metal complex 
in Section 1.3.3. In addition to the use of chelating and macrocyclic ligands, 
discussed in Section 1.1.6, β-diketonates have been shown to be effective ligands 
for lanthanide(III) ions due to the oxophilic nature of the metal ions and the ease of 
control of absorption characteristics, with relatively simple structural 
modifications.65 Typical lanthanide(III) complexes of β-diketonate ligands can either 
possess three β-diketonate ligands, forming a neutral 6-coordinate complex, leaving 
the remaining coordination sites for solvent molecules, or can comprise or four 
ligands creating an anionic 8-coordinate complex. Examples of β-diketonates used 
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in lanthanide(III) complexes include hexafluoroacetylacetonate (hfac), 
thenoyltrifluoroacetonate (TTA), and trifluoromethylcamphorate (facam) (see Fig. 
1.27). In fact, commercially available [Eu(facam)3] in DMSO solution has been used 
as a standard for CPL spectrometers,36 although its sensitivity to water has led to 
suggestions it should be replaced by alternatives. Furthermore, combining chiral 
ancillary ligands with achiral and chiral β-diketonates can modify the CPL of the 
complexes in solution. Examples include axially chiral BINAP-type ligands, and point 
chiral ‘PyBox’ ligands where chiral oxazoline groups are attached to a pyridine, 
making a tridentate neutral donor.66–68  
 
Figure 1.27 Top: examples of β-diketonate ligands used in Ln(III) coordination chemistry; bottom: 
chiral ancillary ligands used in CPL-active lanthanide complexes. 
The largest reported emission dissymmetry factor has been from a complex 
containing chiral β-diketonate ligands. The Cs[Eu((+)-hfbc)4] complex (where hfbc = 
heptafluorobutyrylcamphorate) showed a gem value of +1.38 at 595 nm (see Fig. 
1.28).69 This ligand was also successful in producing highly circularly polarised 
emission from the samarium(III) complex (gem values as large as -1.15 at 553 nm).70 
The analogous complexes with other Group 1 metals did not reveal such 
extraordinary emission dissymmetry and demonstrated multiple species in solution, 
whereas only one species was observed for the Cs+ analogue.71  
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Figure 1.28 The structure of Cs[Ln((+)-hfbc)4] (left) and the CPL spectra of Cs[Sm((+)-hfbc)4] in the 
4G4/2→6H5/2 and 4G4/2→6H7/2 transitions (right, CHCl3, 295 K, λexc 338 nm) Reprinted with permission 
from Ref. [70]. Copyright (2011) American Chemical Society.  
To rationalise the extraordinarily large emission dissymmetry observed in 
Cs[Eu((+)-hfbc)4], it is necessary to consider the factors affecting the strength of CPL 
signals. As discussed in Section 1.2.1, the gem value is dependent on the relative 
strength of the magnetic and electric dipole transition vectors, and the angle 
between them. In 8- or 9-coordinate C4-symmetric environments (i.e. square 
prismatic and (twisted) square antiprismatic), the angle between the electric and 
magnetic dipole transitions is dependent on the twist angle between the two ligand 
planes, i.e. the atoms of the first coordination sphere.72 If this angle, α, is 0° or 45° 
(corresponding to cubic or perfect square antiprismatic environments, 
respectively), then the first coordination environment is locally achiral. In these 
systems, CPL strength should follow a sin2αcos2α relationship. As a result, largest 
CPL strengths are expected where the twist angle is ±22.5°.  In the case of Cs[Yb((+)-
hfbc)4], which adopts a similar axially symmetric twisted square antiprismatic 
structure in solution, the twist angle was found to be -41.4° meaning the first 
coordination sphere is almost perfectly achiral (see Fig. 1.29).71 Clearly, this so-
called static coupling mechanism cannot account for the large gem values observed 
in this system. Instead, a dynamic coupling mechanism must be considered, 
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involving the metal-centred magnetic dipole transition and the nearby electric 
dipole transitions in the diketonate ligands. In this system, the electric quadrupole 
generated by the metal-centred transition induces electric dipoles centred on the 
ligands. If the angle of the ligand-centred electric dipoles is skewed compared to 
the molecular symmetry axis, this can break the symmetry of the inner coordination 
environment. In the case of Cs[Yb((+)-hfbc)4], the ligand-centred electric dipole is 
along the line between the two oxygen atoms of the diketonate which is tilted at an 
angle of -27.5° with respect to the symmetry axis. When the magnetic dipole 
transition of ΔJ = 1 is active, the induced electric dipoles couple constructively to 
add rotational strength to the transition, making its emission highly circularly 
polarised.65 
 
Figure 1.29 Solution state (CHCl3) structure of Cs[Yb((+)-hfbc)4] along (left) and perpendicular (right) 
to the C4 symmetry axis. The angle, α, denotes the twist angle of the twisted square antiprism 
geometry while ψ denotes the tilt angle of the ligand-centred electric dipole relative to the 
symmetry axis. For ease of calculation, CF3 groups were used in place of C3H7 chains. Reprinted with 
permission from Ref. [71]. Copyright (2012) American Chemical Society. 
As discussed in Section 1.1.6, picolinate-based ligands are suitable for 
lanthanide(III) coordination. Examples of chiral dipicolinate derivatives have been 
used to form helical complexes of the form [ML3]. This approach is exemplified by 
the work of Muller et al. who have used chiral dipicolinamides to form 
enantiomeric complexes with strong CPL activity. The two enantiomers of N,N’-
bis(1-phenylethyl)-2,6-pyridinedicarboxamide were observed to self-assemble with 
Eu3+ ions with the (R,R) and (S,S) enantiomers forming the Λ and Δ complexes, 
respectively (see Fig. 1.30). Unfortunately, the complexes exhibit low luminescence 
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quantum yields, but their simple synthesis and strong CPL has led to the suggestion 
of their use as CPL calibration standards in the place of [Eu(facam)3].73 
 
Figure 1.30 The structure of the N,N’-bis(1-phenylethyl)-2,6-pyridinedicarboxamide ligand (left) and 
schematic structures of the Λ-(centre) and Δ-(right) ML3 helical complexes formed from (R,R) and 
(S,S) chiral dipicolinamides, respectively. Adapted with permission from Ref. [74]. Copyright (2011) 
American Chemical Society.  
Combining the chiral aspects of these examples with the proven stability of the 
macrocyclic and chelating structures discussed earlier, offers the potential to create 
extremely stable chiral lanthanide(III) complexes. The increased rigidity of these 
complexes can also enhance their chiroptical behaviour. Numerous examples exist 
of macrocyclic ligands with remote chiral centres that are able to control the 
chirality of the resulting complexes. For example, amide donor groups with remote 
chiral centres have been shown to favour the formation of one complex helicity 
(either Δ or Λ) both in 9-N3,75 and 12-N4 systems76 (see Fig. 1.31). Briefly, helicity of 
the arms of a chelating complex can be described as either Δ or Λ, corresponding to 
a clockwise or anticlockwise arrangement, respectively. The torsion angle in the 
macrocyclic ring can be described by δ or λ depending on whether the angle is 
positive or negative. A more detailed explanation of the chirality in these aza-
macrocyclic complexes is included in Chapter 2. In the case of the 
triazacyclononane example, the ratio of isomers was 15:1 for the europium(III) 
complex.75 A similar approach has also been demonstrated where α-substituents on 
the carboxylate donor arms of DOTA type ligands can lock the conformation of the 
complex by providing a steric barrier to arm rotation.77  
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Figure 1.31 Representative examples of lanthanide(III) complexes where the inclusion of a chiral 
centre on a donor arm can control the helicity of the complexes. 
Alternatively, C-substituted macrocycles such as those shown in Fig. 1.32 have also 
demonstrated the ability to preferentially induce the formation of one complex 
stereoisomer. Addition of chiral centres to the macrocyclic framework can provide 
an insurmountable barrier to the ring inversion process which is required for 
interconversion. Addition of four methyl substituents onto a DOTA framework 
yields a ligand whose ytterbium(III) complex ((SSSS)-[Yb[Me4DOTA]-) exists as two 
isomers in solution. These were identified to be the Λ-(λλλλ) and Δ-(λλλλ) isomers 
which are present in a 1:0.095 ratio, with the methyl substituents occupying 
equatorial positions.78,79 This clearly demonstrates that the addition of the methyl 
groups locks the macrocyclic ring into one conformation (S-methyl group gives λ-
macrocycle) and that this, in turn, favours one orientation of the acetate arms. In 
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triazacyclononane systems, addition of single substituents to the macrocycle has 
been shown to favour formation of one enantiomer of complex in high 
enantiomeric excess. Recently, the addition of an isopropyl substituent to the core 
of a tris-pyridylphosphinate ligand produced a single enantiomer of complex in 
>96% ee. By studying the CPL sign and form of the complexes and comparing to 
similar systems of known configuration it was found that an S-configuration at the 
chiral centre gave the Λ-complex while the R-configuration gave the corresponding 
Δ-complex.39 A similar example using an (S)-lysine derived macrocycle has 
permitted conjugation of the complex to biomolecules known to bind to cell 
membrane receptors. This, in combination with the anionic nature of the complex 
due to the phenylsulfonate groups, has allowed this complex to be used in time-
resolved FRET bioassays.80,81  
 
Figure 1.32 Examples of complexes where C-substitution of the macrocycle leads to preferential 
formation of one stereoisomer in the complex. 
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This approach requires that the chirality in the macrocycle is introduced early in the 
synthesis, often through the use of amino acid precursors. One such synthetic 
example is shown in Scheme 1.2.80,81 Care must be taken throughout the synthesis 
to avoid the possibility of racemisation of the chiral centre, which can limit the 
conditions used. This method is obviously extremely labour intensive, as each 
macrocycle must be synthesised from acyclic precursors. 
Scheme 1.2 A synthetic route to a C-substituted macrocycle. 
The examples described so far all utilise chirality in the ligands to direct the 
formation of their corresponding complexes. However, it is also possible to form 
chiral complexes from achiral ligands that rapidly interconvert between 
stereoisomers. These are known as dynamically racemic complexes. Since they exist 
as a racemic mixture, they show no chiroptical properties such as CPL and CD. On 
interaction with another chiral species, CPL can be induced either by affecting the 
position of the equilibrium between the two enantiomers, or by changing the 
coordination environment.  
Early examples of dynamically racemic lanthanide complexes focussed on D3 
symmetric complexes such as [Eu(dpa)3]3-, which exist as a rapidly interconverting 
mixture of Δ and Λ enantiomers (see Scheme 1.3). On addition of chiral additives, 
the equilibrium shifts in favour of one enantiomer which is stabilised due to more 
favourable diastereomeric interactions with the chiral additive. This phenomenon is 
termed the Pfeiffer effect, named after Paul Pfeiffer who observed this effect on 
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the induced optical rotation of dynamically racemic [Zn(phen)3]2+ complexes, on 
addition of camphorsulfonic acid.82 Examples of CPL chiral additives studied include 
amino acids,83 sugars,84 and carboxylic acids.85 It is important to note that this effect 
must be distinguished from the similar response that might be generated by 
displacing one of the achiral ligands with the chiral additive i.e. a constitutional 
change in the complex. When analysing the effect of adding a chiral species to a 
dynamically racemic complex, it is important to consider all the non-covalent 
interactions that are taking place (Coulombic, π-stacking, hydrophobic etc.), not just 
the configuration of the chiral additive. Recent work has shown that the effect is 
primarily caused by interaction of the complex with the outer-sphere hydrogen 
bonding network.86 Further examples of dynamically racemic complexes will be 
discussed in the context of sensing biological analytes in Section 1.4.2, along with 
examples of achiral complexes which become chiral on the binding of a chiral 
analyte. 
 
Scheme 1.3 The equilibrium between the Δ and Λ enantiomers of [Ln(dpa)3]3+ complexes; 
interconversion involves a dissociative ligand exchange mechanism. 
1.4.2 Ln(III) complexes as CPL probes for biological analytes 
Chiral lanthanide(III) complexes have been used as probes for various biological 
analytes such as proteins, DNA and oxyanions. Structurally well-defined chiral 
lanthanide complexes are practical probes in solution for a number of reasons. 
Binding events can be monitored by changes in emission, chiroptical behaviour and 
also by NMR. Specifically, changes in the coordination environment upon binding 
can lead to changes in total emission or CPL spectral form, and displacement of 
bound water molecules can bring about changes in emission lifetime by removing 
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proximal O-H oscillators. The ratio of changes between the hypersensitive ΔJ = 2 
transition and other transitions (often ΔJ = 1) can be used as a ratiometric reporting 
mechanism, which removes the requirement to have a known concentration of 
probe complex.  
A notable example of the modulation of a CPL signal on binding a chiral analyte can 
be seen in the work of Parker et al. Terbium(III) and europium(III) complexes based 
on 12-N4 and bearing a tetraazatriphenylene chromophore were shown to bind to 
bovine serum albumin (BSA) with a significant change in the form of the CPL (see 
Fig. 1.33).87 The (SSS)-Δ-isomers of the complexes were observed to bind to BSA 
with an apparent 1:1 binding constant of log K = 5.1. However, the enantiomeric 
(RRR)-Λ complex was shown to behave differently, with various low affinity adducts 
forming at different concentrations. This difference in response was confirmed by 
CPL spectroscopy which showed negligible change in form for the (RRR)-Λ 
enantiomer, but a significant reduction in CPL intensity, accompanied by a change 
in CPL sign and form, was observed for the (SSS)-Δ enantiomer.87 This change in CPL 
sign signifies a change in complex helicity in the protein-bound form of the 
complex.88  
 
Figure 1.33 The (SSS)-Δ enantiomer (left) and its CPL spectrum in the absence (blue) and presence 
(pink) of 2 equivalents of bovine serum albumin (295 K, D2O, λexc 348 nm). Reproduced from Ref. 
[87] with permission from The Royal Society of Chemistry. 
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Similarly, changes in CPL form have been used to measure bicarbonate (HCO3-) 
concentration.89 A europium(III) 12-N4 complex with chiral amide arms and an 
azaxanthone sensitising group showed significant changes in CPL form on binding 
bicarbonate (see Fig. 1.34). In contrast to the previous example, it is not likely that a 
change in complex helicity is responsible for this modulation, but that displacement 
of the bound water molecules changes the form of the CPL in the ΔJ = 1 and ΔJ = 2 
transitions. Further evidence for this is a change in form of ΔJ = 1 in the total 
emission spectrum, and a large increase in intensity in ΔJ = 2, consistent with a 
change in axial ligand polarisability.  
 
Figure 1.34 The CPL spectra of the europium(III) complex in the absence (red) and presence (blue) of 
30 mM sodium bicarbonate (295 K, pH 7.40, 0.1 M NaCl). Reprinted with permission from Ref. [89]. 
Copyright (2012) Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. 
Addition of a weakly bound sulfonamide arm to this complex renders it sensitive to 
pH.90 At low pH, the sulfonamide nitrogen is protonated and is not bound to the 
metal centre. As pH increases, the nitrogen is deprotonated and binds to the metal, 
displacing a water molecule (see Fig. 1.35). The response can be monitored by 
observing changes in total emission, lifetime and also by CPL. When the 
sulfonamide binds to the metal, the complex becomes more rigid which in turn 
increases the magnitude of the emission dissymmetry. From the gem data, a pKa for 
the complex was found to be 5.65 ± 0.04. After calibration in vitro, the complex was 
then used to measure pH in cellulo where it localised to the lysosomes of NIH-3T3 
(mouse skin fibroblast) cells. 
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Figure 1.35 The mechanism of sulfonamide pH-responsiveness and the resulting variation in gem 
value at 632 nm for the Eu(III) complex (295, K, 0.1 M NaCl). Reproduced from Ref. [90] with 
permission from The Royal Society of Chemistry. 
A final example of the use of chiral lanthanide complexes for biological sensing 
involves the detection of phosphorus(V) oxyanions. These anions are an important 
class of biological molecule. Phosphorylated peptides and proteins are involved in 
cell signalling, proliferation and development, while phosphorylated sugars such as 
ATP, ADP and AMP are crucial in cellular respiration and signalling. As such, the 
ability to observe them with high spatial resolution in real time is highly desirable. 
CPL signals characteristic of the type of phosphate could be observed upon binding 
to a chiral europium(III) complex (see Fig. 1.36). Different forms of CPL were 
observed in ΔJ = 1 for HPO4-, glucose-6-phosphate (Glc-6-P)2- and O-
phosphotyrosine (O-P-Tyr)2-.91 
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Figure 1.36 Left: the structures of the (RRR)-Λ enantiomer (top) and the (SSS)-Δ enantiomer 
(bottom). Right: the CPL (top) and total emission (bottom) of the complexes in the presence of 10 
equivalents of phosphate anion (293 K, 0.1 M MOPS, pH 7.4). Adapted from Ref. [91] with 
permission from John Wiley and Sons. Copyright 2005.  
There are several recent examples of dynamically racemic complexes that are 
capable of sensing biological molecules. One example uses a C2-symmetric 12-N4 
complex which reversibly binds to α1-acid glycoprotein (α1-AGP), an acute phase 
protein involved in inflammatory response. The complex has two identical pendant 
azaxanthone chromophores and exists in solution as rapidly converting Δ and Λ 
enantiomers. As expected, no CPL or CD signal was observed for the complex in 
aqueous solution. However, on the addition of α1-AGP, significant modulation of 
the total emission spectrum and a large induced CPL signal were observed with gem 
= -0.23 at 598 nm (see Fig. 1.37). The ratio of the total emission intensities of ΔJ = 1 
and ΔJ = 2, and the gem values in these bands could be plotted as a function of 
added protein, allowing a calibration curve to be established.92  
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Figure 1.37 The total emission spectrum before (blue) and after (red) the addition of 50 μM α1-AGP. 
Inset: the induced CPL spectrum after the addition of 50 μM α1-AGP (20 μM complex, 295 K, 0.1 M 
NaCl, pH 7.4). Adapted from Ref. [92] with permission from The Royal Society of Chemistry. 
The changes in photophysical properties were studied in detail in an attempt to 
elucidate the mode of binding between the complex and α1-AGP. Firstly, on binding 
to the protein, measurement of the hydration state showed the bound water 
molecule was lost in the protein-bound form. The large increase in intensity of the 
ΔJ = 2 manifold suggests a change in axial ligand polarisability, consistent with 
displacement of the water by a proximal amino acid carboxylate side chain. The CD 
spectrum of the protein-bound complex showed two partially resolved bands, 
consistent with the two azaxanthone chromophores occupying different 
environments. As such, a binding mode was proposed (see Scheme 1.4) where one 
azaxanthone becomes uncoordinated and sits within the hydrophobic drug binding 
pocket of the protein, and the bound axial water is displaced by the carboxylate 
side chain of a proximal glutamate residue. Indeed, incremental addition of 
chlorpromazine (a drug known to bind in the hydrophobic pocket of α1-AGP) led to 
a gradual decrease in the magnitude of the induced CD signal, suggesting the 
complex and chlorpromazine were competing for the binding site. The same 
complex was also shown to bind to α1-antitrypsin (AAT) albeit with a lower binding 
constant.  
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Scheme 1.4 The proposed binding mode to α1-AGP with one azaxanthone chromophore situated in 
the hydrophobic binding pocket and the proximal glutamate carboxylic acid occupying an axial 
coordination site. 
Recently, dynamically racemic complexes bearing pyridylarylalkynyl chromophores 
have exhibited induced CPL signals on binding to various phosphorylated amino 
acids,93 and to sialic acid,94 an amino sugar overexpressed in tumours. The 
complexes are based on 9-N3 and have two identical chromophore arms. The third 
ring nitrogen is substituted with aromatic groups chosen to aid the binding of 
specific target biomolecules (see Fig. 1.38). Despite the complexes only being seven 
coordinate, there is no bound solvent molecule, most likely due to the steric bulk of 
the N-benzyl group. Sialic acid contains a 1,2-diol functional group which has been 
shown to reversibly form five-membered cyclic boronate esters with aromatic 
boronic acids. This motif has been used extensively in the design of various sensors 
for sugars.95–97 Therefore, it was envisaged that the addition of an aromatic boronic 
acid would elicit binding to sialic acid, which in turn would establish a chiral 
environment around the complex, thereby inducing CPL. A similar principle was 
employed for the detection of phosphorylated amino acids. Addition of an N-
methylammonium group on the benzyl substituent would provide a hydrogen bond 
donor which could stabilise the binding of an anionic phosphate to the metal 
centre.  
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Figure 1.38 Dynamically racemic complexes for the detection of sialic acid (left) and phosphorylated 
amino acids (right). 
On addition of sialic acid to the boronic acid complex in methanol solution, induced 
CPL was observed (Fig. 1.39), accompanied by a change in the total emission 
spectrum, indicating binding of sialic acid. Interestingly, a higher affinity was 
observed for this complex than for the analogous complex without the 
benzylboronic acid. This indicates that the boronic acid does indeed aid in the 
binding. However, no binding could be observed in water, likely due to the much 
higher hydration energy of sialic acid in water.  
 
Figure 1.39 The induced CPL spectrum following addition of 10 equivalents of sialic acid (inset) (5 μM 
complex, λexc 356 nm, MeOH).94 
In the case of sensing phosphorylated amino acids, addition of O-phosphoserine 
and O-phosphothreonine induced a CPL signal from the dynamically racemic probe 
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(see Fig. 1.40). Whilst the form of the induced CPL spectra were very similar, the 
gem values differed, with the threonine adduct exhibiting larger emission 
dissymmetry factors than with serine. It was hypothesised that this was due to the 
extra methyl group in the side chain of threonine generating a more rigid adduct 
with the complex. Addition of O-phosphotyrosine did not elicit a CPL response, 
which was attributed to its chiral centre being more remote.93 Hexapeptides 
incorporating these phosphorylated residues were also studied, and compared to 
the non-phosphorylated versions. No binding was observed with the non-
phosphorylated peptides, confirming that the interaction is via the phosphate 
group. Interestingly, the forms of the induced CPL spectra were not the same as in 
the spectra after the addition of the single amino acids. This suggests that the chiral 
environment of the whole peptide is contributing to the form of the induced CPL. 
 
 
Figure 1.40 Top: the structures of phosphorylated serine, threonine and tyrosine. Bottom: the 
induced CPL spectrum after addition of 10 equivalents of natural O-P-Ser and an expansion of the ΔJ 
= 1 region after addition of both enantiomers of O-P-Ser (λexc 352 nm, 1:1 MeOH:H2O, 10 mM HEPES, 
5 μM complex, pH 7.4).93  
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In addition to dynamically racemic complexes, inherently achiral complexes can also 
be used as induced CPL sensors. The work of Iwamura involves the use of achiral 8-
coordinate Eu(III) complexes based on 2,2’-bipyridine-6,6’-dicarboxylate (bda) to 
sense chiral amino acids by induced CPL.98 The complex [Eu(bda)2]- displays intense 
emission from europium under UV irradiation, but no CPL signal, as expected for an 
achiral complex. On addition of both enantiomers of 2-pyrrolidone-5-carboxylic 
acid, equal and opposite induced CPL was observed (see Fig. 1.41). The binding 
mode was proposed to involve direct coordination of the deprotonated carboxylate 
to the metal centre without displacement of a chromophore. A 10% drop in the 
emission intensity of the ΔJ = 2 transition also suggests a change in coordination 
environment occurs on binding. The appearance of the induced CPL could be 
plotted as a function of concentration of added amino acid to plot a calibration 
curve. However, it ought to be noted that these titrations are using approximately 
10000-fold excess of amino acid relative to Eu(III) complex, which makes their 
practical utility somewhat limited. 
 
Figure 1.41 Top: the structures of [Eu(bda)2]- and 2-pyrrolidone-5-carboxylic acid, and the induced 
CPL signal in the ΔJ = 1 transition on addition of R- and S-pyrrolidone-5-carboxylic acid (0.1 mM 
complex, 1 M amino acid). Bottom: the gem value at 592 nm, CPL signal and total emission in ΔJ = 1   
as a function of added S-2-pyrrolidone-5-carboxylic acid. Adapted with permission from Ref. [98]. 
Copyright (2012) American Chemical Society. 
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This work was then developed for other amino acids using 1,10-phenanthroline-2,9-
dicarboxylic acid (pda) as the ligand.99 Unlike for [Eu(bda)2]-, [Eu(pda)2]- was found 
to exist as several species in aqueous solution, as shown by multiple ΔJ = 0 
transitions in the total emission spectrum, although a single exponential decay in 
the lifetime measurement suggests these structures are in fast equilibrium on the 
timescale of the lifetime measurement (ca. 1 ms). Relatively strong induced CPL 
was observed on the addition of histidine and arginine, whilst little or no induced 
CPL was observed for ornithine, alanine, isoleucine, threonine, phenylalanine, 
proline, lysine, glutamine or leucine under the same conditions. Interestingly, the 
induced CPL was similar in form for histidine and arginine but was found to be pH 
dependent. The induced CPL could only be observed for histidine in acidic solution 
and arginine in neutral solution, implying that the binding of these amino acids is 
dependent on their protonation state. The concentration dependence of the 
induced CPL in response to arginine and histidine was studied (see Fig. 1.42). The 
data for arginine binding showed a sigmoidal profile and did not fit a 1:1 binding 
model, but the data did fit a 1:2 binding model (2 amino acids per metal centre). In 
contrast, the data for histidine binding was significantly more complex. 1:1 and 1:2 
binding models failed to represent the data well, although a 1:3 model did seem 
more successful. In the context of coordination at the lanthanide centre, a 1:3 
binding mode without loss of a pda ligand would make the metal centre 11-
coordinate, which is not possible. If the 1:3 binding mode is indeed the case, partial 
dissociation of a pda ligand must occur, to satisfy the coordination requirements of 
the metal. Another important observation is that as the concentration of added 
histidine is increased, the CPL signal changes sign. This indicates that different 
adducts are present at different concentrations, and have significantly different 
chiral coordination environments. The complexity of the speciation behaviour and 
the weakness of amino acid binding limits considerably the impact and significance 
of this work. 
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Figure 1.42 The variation of gem as a function of added amino acid concentration for arginine at pH 7 
(left) and histidine at pH 3 (right) (λexc 310 nm, λem 592 nm, 0.1 mM complex). The red, blue and 
black lines correspond to 1:1, 1:2 and 1:3 binding models, respectively. Adapted with permission 
from Ref. [99]. Copyright (2014) American Chemical Society. 
 
1.5 Cell imaging with lanthanide complexes 
Lanthanide complexes have extensively been shown to be of use as cellular stains 
for live cell imaging. The design considerations for emissive cellular stains will be 
discussed, followed by some examples of localisation profiles for various classes of 
complex. Finally, efforts to understand the cell uptake mechanisms of these 
complexes will be discussed.  
1.5.1 Design considerations 
For lanthanide complexes to be useful as emissive cellular stains for living cells, they 
must possess a number of properties. Firstly, the complexes must be capable of 
crossing the phospholipid cell membrane quickly and preferably irreversibly 
(although egress over time periods much longer than the period of measurement is 
acceptable). Secondly, the presence of the complex must not perturb cell 
homeostasis, otherwise it becomes impossible to probe normal cellular processes.  
Following on from this requirement, the stain must be non-toxic at the 
concentration required for imaging (i.e. cell viability or division must not be 
compromised). The toxicity of a compound is often described by an IC50 value which 
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is the concentration of substance at which 50% of the cell sample is non-viable. The 
complexes should be stable both to chemical reaction and metal dissociation in 
cellulo, and should also be resistant to photobleaching and photofading to allow 
repeated measurements over a long period of time.  
The photophysical properties of a complex must also be suitable for in cellulo 
imaging. Excitation should be possible using accessible wavelengths using lasers or 
LEDs. Commonly used light sources include nitrogen lasers (337 nm), Nd:YAG lasers 
(third harmonic at 355 nm), UV-LEDs (365 nm) and violet laser diodes based on GaN 
(405 nm). The advantage of using these long UV wavelength sources is two-fold. 
Firstly, most endogenous biological molecules are not excited in this region of the 
spectrum which reduces background interference. Secondly, these wavelengths are 
less harmful to the biological sample than shorter wavelength UV light (such as 254 
nm from mercury lamps) which causes DNA and RNA damage. 
Complexes should be highly absorbing (i.e. large extinction coefficients) and have 
large photoluminescence quantum yields, which maximises the brightness of the 
complex (see Section 1.1.5). Highly absorbing complexes allow the excitation 
sources to be used at lower power and in pulsed mode, which limits 
photodegradation and cell damage. Higher brightness also means smaller doses can 
be used, which minimises the possibility of disrupting cell homeostasis. Finally, long 
emission lifetimes permit time-resolved image acquisition, thereby increasing the 
signal to noise ratio (see Section 1.1.2). 
1.5.2 Examples of sub-cellular localisation profiles 
Broadly, 4 main sub-cellular localisation profiles have been observed for emissive 
europium(III) and terbium(III) complexes. These can be described by predominant 
localisation in the lysosomes, mitochondria, endoplasmic reticulum and nucleoli. 
Efforts to understand the structure-localisation correlation require various 
examples of structural modifications to be made and the localisation profiles 
compared.  
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Examples of complexes exhibiting lysosomal localisation are shown in Figure 1.43. 
These comprise 12-N4 complexes bearing azaxanthone and tetraazatriphenylene 
chromophores,22 as well as 9-N3 complexes with pyridylarylalkynyl 
chromophores.100 Complexes that enter cells via endocytotic pathways often show 
lysosomal staining, as endosomes mature into lysosomes over time. Additionally, 
complexes which the cell identifies as ‘foreign’ are often transported to the 
lysosomes.  
Lysosomes are acidic vesicles used by the cell to degrade unwanted substances. The 
lysosomally-localised complexes have a wide variation in structure with no obvious 
common features. The selection comprises different chromophores, different donor 
groups (carboxylates, amides and phosphinates), different linkers between the 
macrocycle and chromophore (simple methylene bridges and pyrazole ring) and 
different charges (cationic, neutral and anionic). Among the triazacyclononane-
based complexes, attempts to direct nuclear localisation by the addition of a Cys-
Gly-Pro-(Lys)3-Arg-Lys-Val nuclear localisation peptide were not successful, with the 
complex still localising to the lysosomes. Indeed, this complex was shown to be 
toxic with an IC50 of 1 μM compared to >100 μM for the other 9-N3 complexes 
studied.100 
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Figure 1.43 Examples of complexes exhibiting lysosomal localisation.22,100 
The second class of complexes localises in the mitochondria. The mitochondria are 
the centre of aerobic respiration within the cell, and generate ATP which is an 
essential compound in many cellular processes. Again, large structural variation is 
observed among the mitochondrial-localising complexes (see Fig. 1.44). Fast uptake 
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of the glucamide-appended complex was observed in NIH-3T3 (mouse skin 
fibroblast) and CHO (Chinese hamster ovary) cells and mitochondrial localisation 
was confirmed by co-staining with MitoTracker Green. The cells could be imaged 
periodically over 48 hours with no reduction in cell proliferation. The localisation 
profile has been attributed to the amphipathic nature of the complex and the 
peripheral glucamides may inhibit degradation by normal cellular processes. 
Phosphorylation of the hydroxyl groups has been tentatively suggested to aid the 
mitochondrial localisation. In the anionic complex with one peripheral carboxylate 
group (see Fig. 1.44), mitochondrial localisation was also observed, in contrast to 
the analogous complex with three identical peripheral carboxylates which localised 
in the lysosomes. This result rules out the possibility that simply the nature of the 
head group controls the localisation of these triazacyclononane complexes. This 
complex was observed to move to the endoplasmic reticulum after approximately 8 
hours. Addition of a peripheral poly-arginine peptide also directs localisation to the 
mitochondria followed by the endoplasmic reticulum after extended time 
periods.100  
                                                                                             CHAPTER ONE : INTRODUCTION 
 
56 
 
 
Figure 1.44 Top: examples of mitochondrial localising complexes. Bottom: LSCM images showing (a) 
mitochondrial localisation of the tris-glucamide complex in NIH-3T3 cells (1 h, 18 μM, λexc 355 nm, 
λem 605-720 nm); (b) MitoTracker Green (λexc 488 nm, λem 500-530 nm); and (c) RGB merged image 
showing co-localisation (P = 0.95). Reproduced from Ref. [100] with permission from The Royal 
Society of Chemistry. 
Nucleolar staining has been observed from complexes based on 12-N4 macrocycles. 
All the examples in Figure 1.45 contain the azathioxanthone chromophore but vary 
in the donor arm structure and linker group. The nucleolus is a sub-nuclear 
organelle involved in ribosome assembly. Cell uptake studies at various 
concentrations of complex and a range of incubation times have suggested that 
trafficking to the nucleolus occurs when the cell is under stress, which is linked to 
increased membrane permeability.22 Indeed, by deliberately increasing membrane 
permeability by the addition of surfactants, several complexes which previously 
A B C 
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localised in the mitochondria or lysosomes were observed to accumulate in the 
nucleoli.  
 
Figure 1.45 Examples of complexes that have been observed to localise in the nucleoli.22 
1.5.3 Cell uptake mechanisms 
A comprehensive understanding of the cell uptake mechanism of a probe is 
required if it is to be used in cellulo. It allows the rational design of probes and can 
provide insight into the causes of certain sub-cellular localisation profiles. Broadly, 
cell uptake mechanisms can be classified as either active or passive. Passive 
transport occurs along concentration gradients and includes osmosis and diffusion, 
while active transport requires an energy input. Active transport can further be 
categorised as primary, secondary or vesicular. Primary and secondary active 
transport are used to move small molecules and ions across membranes. However, 
lanthanide complexes for in cellulo imaging are too large to be taken up by primary 
or secondary active transport, and hence are taken in via vesicular pathways. 
Vesicular transport utilises fluid-filled vesicles formed from phospholipid 
membranes to transport species into (endocytosis) and out of (exocytosis) the cells.  
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There are a number of different types of vesicular endocytosis, which vary in the 
formation mechanism for the vesicle. Phagocytosis involves the cell membrane 
extending to engulf a solid particle before taking it into the cell to be digested. This 
process occurs in the destruction of dead cells and in the immune response for the 
removal of pathogens, for example. A second class of endocytotic pathways involve 
the invagination of the cell membrane in response to a substrate binding to a cell 
surface receptor to form a vesicle containing extracellular fluid (and any solute) 
which subsequently buds off the membrane.101 This process is known receptor-
mediated endocytosis, and is characterised by the way in which the invaginations 
form. Clathrin- and caveolae-mediated endocytosis are the two most common 
forms. In receptor-rich regions of the membrane, pits develop that are coated with 
protein (clathrin or caveolin). These proteins transform the pit into a vesicle by 
closing the top of the pit and inducing fission to form a clathrin- or caveolin-coated 
vesicle. Once separated from the inside of the cell membrane the coating is 
removed and the vesicle fuses with the appropriate organelle to release its 
contents.  
In contrast to these receptor-mediated mechanisms, macropinocytosis does not 
involve the formation of coated vesicles. In macropinocytosis, the cell membrane 
responds to stimulation by forming ruffles which can close to form large, irregularly 
shaped vesicles called macropinosomes.102 These membrane-bound vesicles can 
then fuse with other organelles to transport their contents. Macropinosomes are 
also thought to be leaky compared to other endocytotic vesicles, meaning that their 
contents can reach the cytoplasm before transport to various sub-cellular 
organelles.  
Extensive studies have been carried out on 12-N4 complexes of Eu(III) and Tb(III) to 
elucidate the mechanisms of cell uptake.22 By incubating cells with complex in the 
presence of various known promoters and inhibitors of different endocytotic 
pathways, and subsequently measuring the intracellular complex concentration by 
ICP-MS, it is possible to find out which pathways are responsible for uptake. The 
promoters and inhibitors studied included sucrose and chlorpromazine (inhibitors 
of clathrin-mediated endocytosis),103,104 filipin (inhibitor of caveolar 
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formation),105,106 wortmannin and amiloride (inhibitors of macropinocytosis),107–109 
fatty acid glycerols and phorbol esters (stimulators of macropinocytosis),110,111 and 
monensin and chloroquine (inhibitors of maturation and acidification of endosomes 
to form lysosomes).112,113 Additionally, experiments were carried out at low 
temperature (4 °C) which inhibits all energy-dependent processes,114 and with poly-
L-lysine which disrupts the association of cell membranes.115 A summary of the cell 
uptake mechanisms and their promoters and inhibitors is shown in Figure 1.46. 
 
Figure 1.46 A schematic illustration of three possible endocytotic pathways for the uptake of 
lanthanide complexes, and the maturation of endosome to lysosomes. In red are known activators 
(denoted with a +) and inhibitors (-) of each process. Reprinted from Ref. [116] Copyright (2009) with 
permission from Elsevier.  
Cell uptake experiments were conducted with a range of complexes which all have 
different localisation profiles, bearing various chromophores (tetraazatriphenylene, 
azaxanthone, azathioxanthone), various charges (neutral and cationic), various 
linker groups between the macrocycle and chromophore, and different 
counteranions (chloride, nitrate, acetate and triflate).22,117 In every case, the 
observed uptake was consistent with macropinocytosis being the mechanism of cell 
uptake. The results are summarised graphically in Figure 1.47. Internalised cell 
concentration was reduced in the presence of wortmannin and amiloride, the 
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macropinocytosis inhibitors, and enhanced with the addition of a fatty acid glycerol 
and a phorbol ester which are known activators of macropinocytosis. None of the 
other treatments caused a significant effect on the cell uptake, except the low 
temperature study which confirmed that the uptake is energy-driven. The 
identification of macropinocytosis as the mechanism of uptake was supported by a 
co-localisation study which showed that a fluorescein-labelled dextran conjugate 
known to stain the macropinosomes. At early time points (up to 20 minutes), this 
stain was observed to co-localise with the Tb(III) and Eu(III) complexes.  
 
Figure 1.47 Relative uptake of various 12-N4 complexes of Eu(III) and Tb(III) in the presence of 
inhibitors and activators of macropinocytosis, clathrin-mediated and caveolar-mediated endocytosis. 
Statistically significant results (p < 0.05 *, p < 0.01 **) were calculated using a two-tailed paired 
Student’s t-test. Reproduced from Ref [22] with permission from The Royal Society of Chemistry. 
More recently, similar preliminary experiments have been carried out on complexes 
based on 9-N3 with pyridylarylalkynyl chromophores. Early indications are that 
these complexes are also internalised by macropinocytosis but no other 
mechanisms were studied in this work. Notably, a complex derivatised with a biotin 
tag was internalised independently of any promoters or inhibitors, which is 
indicative of a biotin-specific pathway.100  
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1.6 Lanthanides in security labelling 
Lanthanides have been used in anti-counterfeiting for a number of years, with the 
most well-known application being the incorporation of various species containing 
Eu(III) and Eu(II) as luminescent security features in Euro bank notes (see Fig. 1.48). 
Due to the nature of the application, much of the information about these features 
is not in the public domain and several examples are protected by patents. Polymer 
banknotes have been used in Australia since 1988,118 and are now in circulation in 
more than 30 countries across the world.119 Polymer £5 notes were introduced to 
circulation in the UK in 2016, with polymer £10 notes released in September 2017. 
Polymer £20 notes are due to be released in 2020. This rapidly advancing field 
presents an interesting possibility as a target for new-anti-counterfeiting features.  
In 2002, C2W (the magazine of the Royal Dutch Chemical Society) published an 
article by Suyver and Meijerink in which they had attempted to identify the red, 
green and blue phosphors in a €5 note.120 Based on studies of the emission, 
excitation and lifetimes of the phosphors they suggested that the red emission is 
from a Eu(III) β-diketonate complex, the broad emission band of the green dye is 
due to a d-f transition in SrGa2S4 doped with Eu(II), and the blue emission is from 
(BaO)x·6Al2O3 doped with Eu(II). They contacted De Nederlandse Bank (the central 
bank of the Netherlands) who, unsurprisingly, refused to confirm their findings.  
 
Figure 1.48 A €50 note irradiated at 366 nm and the resulting emission spectrum from area 
indicated by the arrow. The red-emitting europium species is probably a tris (β-diketonate) complex. 
Reproduced from Ref. [121] with permission of The Royal Society of Chemistry.  
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The use of Eu(III) and Eu(II) in banknotes is an example of UV-excited species 
emitting in the visible region (downconversion). A recent example of 
downconverting sensitised europium complexes for anti-counterfeiting has used 
[Eu(dpa)3]3- and [Tb(dpa)3]3- (see Fig. 1.49) as water-soluble inks for full colour inkjet 
printing with a standard household printer. Using europium and terbium for red 
and green, respectively, combined with a commercially-available blue fluorescent 
ink (CyanFirefly™), images were printed that are invisible to the naked eye but are 
full colour luminescent images when irradiated with UV light. A full gamut of 
colours could be achieved by various combinations of the three inks, calculated 
using extensive colour-matching algorithms.122 Comparisons of the colours printed 
using the luminescent inks with the computer predictions showed an average ΔE94 
value of 0.9.§ This represents a colour match that is close enough that the human 
eye cannot distinguish the difference. In image printing tests, the inks produced 
vivid full colour luminescent images that reproduced skin tones, natural colours of 
fruit and ‘man-made’ colours of plastics in high quality. The applications in the 
security industry rely on the unique software developed for the colour matching. 
The inks themselves are easily copied but without the software it would be very 
difficult to produce an identical image. 
 
Figure 1.49 The structure of [Ln(dpa)3]3- complexes and examples of full colour images that are 
invisible to the naked eye.122  
There are, however, some challenges that may need to be overcome for this 
method to become a commercially useful method of anti-counterfeiting. Firstly, the 
pictures have to be printed on paper that does not contain artificial brighteners, as 
                                                     
§ ΔE94 parameter is a measure of how different the predicted and actual colours appear. Lower 
values mean a better colour match. A value of 1.0 is the limit of human colour perception. 
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they are fluorescent and would therefore interfere with the colour reproduction. 
Also, the quality of the printed images is highly dependent on the paper they are 
printed on. In the study, several different types of paper were used and each 
showed different properties with respect to ink spreading, light scattering and 
colour reproduction. The cost of printing may also be an issue. No indication is 
given of the quantity of the ink required to print the images but the paper costs 
approximately 1000 times more than standard printer paper. Finally, the chemical 
composition of the blue fluorescent ink is unknown. It could be envisaged that an 
extra unique feature could be incorporated that takes advantage of the long 
luminescent lifetimes of the lanthanides. With the present system, only the red and 
green components of the image possess long-lived emission. Replacing the blue 
fluorescent ink with a lanthanide-based blue emitter could allow all three colour 
components to be phosphorescent. However, lanthanide blue emission is extremely 
difficult to produce. Thulium has been used to provide a blue component in white 
light emission,123 but efficient sensitised emission from thulium is challenging, due 
to competitive vibrational deactivation of the thulium excited state.124 Alternative 
options include the use of ligand-centred blue emission, though this would not 
overcome the problem of short lived emission. 
Very recently, work by Gupta et al. has used lanthanide(III) doped Y2O3 nanorods to 
produce multicoloured luminescent security codes which are ‘unclonable’.125 In this 
example, Eu(III), Tb(III) and Ce(III) were used for red, green and blue emission, 
respectively.  An optimised concentration of 15 mol% Ln3+ was used giving nanorods 
of the formula Y1.7O3:Ln0.33+, and synthesis was carried out by a hydrothermal 
method where aqueous solutions of the reagents are heated to 185 °C under 
pressure. The nanorods precipitated from solution and were separated and dried. 
Scanning electron microscopy showed that the rods were uniform in size with a 
diameter of 80-120 nm and a length of 2-5 μm. The photophysical properties of the 
nanorods are shown in Figure 1.50. The Eu3+-doped nanorods displayed a broad 
excitation band around 254 nm attributed to O2- - Eu3+ charge transfer, along with 
small bands between 300 and 500 nm assigned to f-f transitions. Specifically, the 
peaks at 395 nm and 465 nm are due to 7F0 → 5L6 and 7F0 → 5D2 transitions, 
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respectively. The Tb3+-doped nanorods have a similar broad charge transfer 
excitation band around 300 nm, and for the Ce3+-doped nanorods, maximal 
excitation was around 380 nm. The Eu3+- and Tb3+-doped nanorods displayed 
characteristic emission spectra ascribed to 5D0,1 → 7FJ (J = 0-5) and 5D4 → 7FJ (J = 3-
6) respectively. Meanwhile, the Ce3+-doped nanorods display a broad emission 
band centred around 440 nm. The only f-f transition which exists for Ce(III) is in the 
infra-red (approx. 2000 cm-1) whereas this blue emission arises from a 4f0 5d1 → 4f1 
5d0 transition.126  
 
Figure 1.50 Excitation (left) and emission spectra (right) of Eu3+- (top), Tb3+- (middle) and Ce3+-doped 
(bottom) Y2O3 nanorods. CIE colour coordinates are shown in the insets. Wavelengths of excitation 
and emission are displayed on the spectra. Reprinted with permission from Ref. [125]. Copyright 
(2017) American Chemical Society. 
                                                                                             CHAPTER ONE : INTRODUCTION 
 
65 
 
The nanorods were then dispersed in a PVC medium which is used for commercial 
screen printing and the logo of the Council of Scientific and Industrial Research - 
National Physical Laboratory of India (CSIR-NPL) was printed onto black paper. The 
printed logos are not visible under normal light but appear brightly under UV light. 
Confocal microscopy showed that the printed nanorods had a uniform distribution 
on the paper. The authors claim that the common host material makes synthesis 
simpler, and that this collection of three species of nanorod opens the door to 
simple multicolour anti-counterfeiting features. However, each coloured nanorod 
requires different excitation wavelengths so designs featuring different doped 
nanorods would not necessarily emit in the red, green and blue regions 
simultaneously. It could be envisaged, however, that each coloured ink could be 
used to print a different image and that the anti-counterfeiting feature was based 
on different images becoming visible under different excitation sources.  
 
Figure 1.51 The CSIR-NPL logo printed with Eu3+-, Tb3+- and Ce3+-doped Y2O3 nanorods, visualised 
under UV excitation. Adapted with permission from Ref. [125]. Copyright (2017) American Chemical 
Society. 
Other examples of downconverting systems patented for use in security coatings 
include a DuPont patent for lanthanide complexes containing chelating amide 
ligands where comparison of an emission spectrum to that of a known standard can 
be used to distinguish forgeries from genuine items.127 The complexes are dissolved 
in toluene and printed as inks onto the surface of interest. Amide ligands can 
contain alkyl, aryl or heteroaryl groups and can be combined with other non-amide 
ligands to form the complexes. The structures proposed in the patent are shown in 
Fig. 1.52. However, both structures include amide groups binding through both the 
nitrogen and oxygen atoms, forming a 4-membered chelate. This arrangement is 
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unlikely due to the very tight chelating angle, and it is certain that the amides bind 
only through the carbonyl oxygen. This would leave further vacant coordination 
sites that might be occupied by further equivalents of amide or non-amide ligands. 
 
Figure 1.52 Putative structures of complexes based on amide ligands that have been printed in 
toluene-based inks; R1 and R2 are alkyl, aryl or heteroaryl, R3 is an alkyl chain C1-C8. 
Another example in a patent owned by Samsung Electronics Co., used 
phenanthroline-based complexes containing an acetylacetonate ligand which can 
be excited both in the UV range and using X-rays (see Fig. 1.53). In this proposed 
structure, the lanthanide ion is 10-coordinate. As lanthanide complexes are usually 
8- or 9-coordinate, this is unlikely to be a true representation of the structure. It is 
more likely that the nitrate anions are unidentate. The complexes contain mixed 
lanthanides where Ln is TbxEr1-x. Excitation with UV or X-rays leads to green 
emission that can be compared to a known standard.128  
 
Figure 1.53 The proposed structure of a lanthanide complex capable of luminescence when excited 
by UV or X-ray radiation; Ln = TbxEr1-x). 
A second use of lanthanides in security applications is based on inks containing 
upconverting lanthanide-doped nanoparticles. Upconversion refers to emission that 
is at shorter wavelengths than the excitation light. In the case of lanthanide-doped 
nanoparticles, visible emission is produced as a result of near-infrared excitation.129 
There are several benefits to this class of compounds in the security printing field. 
Firstly, patterns can be printed and detected on fluorescent surfaces (such as 
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papers containing brighteners) as the near-IR excitation will not excite the 
interfering fluorescent species. Secondly, the nanoparticles themselves are very 
difficult to copy and excitation sources in the near-IR range are also hard to 
duplicate. Recent work by Meruga et al. has used inks composed of NaYF4 
nanoparticles doped with Yb3+, Er3+ and Tm3+ to produce green and blue 
upconverting inks that are invisible to the naked eye.130 Within the nanoparticles, 
Yb3+ acts as a sensitiser for the visible-emitting Er3+ and Tm3+. The Yb3+ is excited 
from its 2F7/2 ground state to the 2F5/2 state upon absorption of light at 980 nm. 
Consecutive non-radiative energy transfer from the 2F5/2 state of Yb3+ to the 
emitting states of Er3+ and Tm3+ results in various emissive transitions in the visible 
region of the spectrum (see Fig. 1.54). Emission from Er(III) is perceived by the eye 
as green, while emission from Tm(III) is perceived as blue. 
 
Figure 1.54 An energy level diagram showing the IR to visible upconversion processes in NaYF4 
doped with Yb3+/Er3+ and Yb3+/Tm3+. Only emissive transitions in the visible region are shown here. 
Reprinted from Ref. [129], Copyright (2005), with permission from Elsevier B. V. 
The nanoparticles themselves are capped with oleic acid and are then dissolved in a 
90:10 mixture of toluene and methyl benzoate with poly(methyl methacrylate) 
(PMMA) beads. The PMMA acts as a binding agent after printing and solvent 
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evaporation. The inks contain 2 wt% of nanoparticles and were used to print quick 
response (QR) codes, two-dimensional barcodes that are capable of holding more 
than 100 times more information than a traditional barcode, and can be quickly 
read by scanning applications on smart phones (see Fig. 1.55).131 The process of 
printing the QR codes begins with the code generation online. The code is then 
converted to an AutoCAD file which is used to print the invisible code. The printed 
code was then excited at 980 nm using an infrared diode laser, and a photograph 
taken using a Nikon DSLR camera (15 s exposure). This photo was then successfully 
scanned using a QR reader on a smart phone.130 
 
Figure 1.55 (a) A standard black and white QR code and (b) the same QR code printed using the 
invisible Er(III) doped upconverting nanoparticle ink, irradiated at 980 nm. Reproduced with 
permission from Ref. [130]. Copyright 2012 IOP. 
These codes have been printed on paper and glass and can be read in both cases. 
Despite some spreading of the ink giving a less well-defined pattern, the scanner is 
still able to recognise the code. Approximately 0.3-0.4 mL of ink is required to print 
each code. The codes were also shown to be mechanically stable and could still be 
read electronically after the paper was folded 50 times. Additionally, codes could be 
overprinted with a second ink to add an extra level of security. Printing with the 
Tm(III)-doped blue-emitting ink over the green-emitting Er(III) ink gave three 
discernible coloured regions – one each for the two inks on their own and a third 
colour where both inks were present on top of each other. The perceived colour 
could also be altered by the power density used in the excitation. The upconversion 
transitions to excite Tm(III) are three- and four-photon processes, whereas for Er(III) 
it is only a two-photon process. As a result, the Tm(III)-doped ink is more sensitive 
to changes in excitation power. This effect can be seen by comparing the emission 
spectra from mixtures of the two inks at various levels of excitation power density 
(see Fig. 1.56). As excitation power is increased, the emission intensity from Tm(III) 
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transitions (1D2 → 3F4 and 1G4 → 3H6) in the blue region of the spectrum increased 
proportionally more than the Er(III) transitions in the green region of the spectrum, 
meaning the eye perceives a bluer colour from the ink.  
 
Figure 1.56 Visible upconversion luminescence spectra as a function of excitation power density of a 
region of the QR code with blue ink and green ink printed together (λexc = 980 nm). Reproduced with 
permission from Ref. [130]. Copyright 2012 IOP. 
1.7 Project Aims and Outline 
The first aim of the project relates to the use of highly emissive chiral europium(III) 
complexes as security labels. Several examples are known of the use of lanthanide 
emission in anti-counterfeiting applications, but none has utilised the possibility of 
chiroptical discrimination. Lanthanide complexes possessing strongly absorbing 
ligands and efficient sensitised emission provide the ideal target for such a system. 
To this end, the following specific aims are envisaged: 
i) The synthesis of novel emissive, water insoluble europium(III) complexes 
with high quantum yields that can be processed in organic solvents and 
are amenable to excitation by commonly available light sources at 355 
and 365 nm. 
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ii) The chiral resolution of the europium(III) complexes and a study of their 
thermal stability to racemisation. 
iii) Study of the chiroptical properties of the resulting enantiopure 
complexes, with particular attention to identifying a suitable complex for 
use in a CPL-based anti-counterfeiting feature. 
iv) Development of a simple system capable of distinguishing emission from 
a chiral europium(III) complex from a ‘fake’ emitter. Ideally, the system 
should be relatively cheap and simple to operate.  
v) Use of this system to demonstrate chiroptical, wavelength and lifetime 
discrimination in europium(III) complexes, both in solution and the solid 
state. 
The synthesis of several novel europium(III) complexes is described, together with 
analysis of their photophysical properties and rates of racemisation. The 
development of a new detection method for these complexes as security labels is 
also reported. 
The solvent dependent emission behaviour of the rare earth complexes is 
described. In particular, studies into the effects of varying solvent on the total 
emission and CPL of europium(III) complexes are defined and a combined emission 
and NMR study is given, examining the unusual properties of a series of simple C3-
symmetric lanthanide(III) complexes.  
In addition to their use in security labelling, the behaviour of chiral complexes in a 
biological environment is explored. Whilst racemic lanthanide(III) complexes have 
been used extensively as probes and stains in cellulo, the effect of chirality on cell 
uptake and sub-cellular localisation has not been studied before. Preliminary 
experiments into the mechanism of cell uptake of 9-N3 complexes with 
pyridylarylalkynyl chromophores are given, identifying the mechanism of 
internalisation of this class of complexes. Moreover, the effect of complex chirality 
on the extent and nature of cellular localisation has been studied. 
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CHAPTER TWO : CHIRAL Eu(III) COMPLEXES FOR SECURITY 
LABELLING  
2.1 Requirements for a security label 
In order for an emissive species to be suitable for use as a security label, it must 
possess several key properties. Primarily, it must contain at least one unique 
feature that can be used to distinguish it from ‘counterfeit’ labels. This feature may 
take the form of wavelength selection in either absorption or emission, emission 
lifetime, or various chiroptical properties. Ideally, multiple unique features should 
be incorporated, in order to make imitation of the label unfeasible. Secondly, the 
method of detection should be simple and relatively inexpensive. In the various 
applications of emissive security labels, detection without the use of specialist 
spectroscopic equipment is required. Therefore, systems using readily-available 
components that do not require specialist training in operation are desirable. 
Finally, the compounds must be simple to process and apply to the target substrate 
and must then be durable. The necessity for durability is both with respect to 
physical processes as may be expected to occur during the lifetime of a labelled 
item, and in chemical degradation that could occur over time. In the context of 
documents and banknotes, stability with respect to long term exposure to daylight, 
repeated exposure to UV light, folding, heating, handling by humans and processing 
by machines needs to be considered. For anti-counterfeiting labels in clothing or 
similar items, resistance to repeated washing would also be required. For example, 
the lifetime of a passport or driving licence in the UK is 10 years, while a cotton £20 
note is estimated to circulate for 113 months and change hands over 2000 times 
before being withdrawn.132 Any emissive label would need to be stable over such 
an extended time period.  
Emissive lanthanide(III) complexes possess several properties that make them near 
ideal candidates for security labels. These include their relatively long luminescent 
lifetimes (compared to organic emitters) which allow time-resolved measurements, 
the ability to tune their excitation wavelength by alterations to the organic antenna 
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groups, and their favourable chiroptical properties. The line-like appearance of their 
emission spectra also facilitates wavelength selection of specific transitions using 
optical filters.  
2.2 Synthesis of target systems 
The synthetic targets for the investigation are the complexes [EuL1] and [EuL2] (see 
Fig. 2.1). Based on previous work, their absorption maxima were expected to be 
around 360 and 340 nm respectively, making them ideal for excitation with 
commonly available light sources as discussed in Section 1.5.1. They contain 
pyridylarylalkynyl chromophores which have been shown to have very high molar 
extinction coefficients (55 000-60 000 M-1 cm-1).29 Phenyl substituted phosphinate 
donors have been chosen to reduce the water solubility, in anticipation that this 
may increase the durability of the complexes. The phenyl groups were also 
expected to increase the rigidity (and therefore stability to racemisation) and the 
emission lifetimes of the complexes. Once resolved by chiral HPLC, the complexes 
were expected to have strong CPL signals, following UV excitation. 
 
Figure 2.1 The structures of target complexes [EuL1] and [EuL2]. 
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The choice of [EuL1] and [EuL2] also allows their properties to be compared to the 
more hydrophilic methyl phosphinate analogues, [EuL3] and [EuL4] (see Fig. 2.2), 
which have been prepared previously.29  
 
Figure 2.2 The structures of the methyl phosphinate analogues [EuL3] and [EuL4]. 
2.2.1 Synthesis of [EuL1] 
The synthesis of [EuL1] was carried out using modified literature procedures for 
structurally similar complexes. Various synthetic routes have been explored for 
such complexes. The two primary routes are to synthesise each ligand separately, 
before complexation with a europium(III) salt as the final step, or to prepare them 
by a divergent route involving the synthesis of a common intermediate, which could 
then be functionalised further under mild reaction conditions (see Scheme 2.1). In 
the case of the pyridylarylalkynyl complexes, a tris-(4-bromopyridyl) europium 
complex can be identified as the common intermediate.133 The complex contains a 
C-Br bond which allows functionalisation by palladium-catalysed C-C bond forming 
reactions, such as a Sonogashira coupling reaction. In another example, the 
bromine atom was displaced by an azide group, before Cu(I)-catalysed ‘click’ 
chemistry was used to form a triazole ring.133  
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Scheme 2.1 A retrosynthetic analysis showing the common tris (4-bromopyridyl) europium complex 
which can be used in a divergent synthetic pathway. 
Although the divergent route appears to be more economical, purification of the 
final complexes proved challenging, as multiple chromatographic separations under 
both normal and reverse phase conditions were required to separate the 
complexes from palladium catalyst residues, which led to rather low isolated yields 
of complex. Therefore, for the synthesis of [EuL1] and [EuL2], it was decided to 
synthesise the complete ligand before complexation of the metal as the final 
step.134 Retrosynthetic analysis of [EuL1] identifies the required fragments, as 
shown in Scheme 2.2. 
 
Scheme 2.2 An alternative retrosynthetic analysis for [EuL1]. 
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The chromophore head group was synthesised via a two-step Corey-Fuchs reaction 
from 2,4,6-trimethoxybenzaldehyde 1. In the first step, the aldehyde 1 was 
converted to the dibromoalkene 2, which was then transformed to the terminal 
alkyne 3 (see Scheme 2.3). 
 
Scheme 2.3 The Corey-Fuchs method of terminal alkyne formation. 
The conversion of the aldehyde 1 to the dibromoalkene 2 was very slow (28 hours), 
compared to Corey and Fuchs’ original example where benzaldehyde was 
converted to the corresponding dibromoalkene in 5 mins at 0 °C.135 There are two 
possible explanations for this. The reaction involves attack at the aldehyde by a 
phosphorus ylid. An electron rich aromatic ring such as in aldehyde 1 reduces the 
electrophilicity of the aldehyde group. Also, the aldehyde is sterically hindered by 
two ortho-methoxy groups, making the approach of the bulky ylid (Br2C=PPh3) more 
challenging. Subsequent conversion of the dibromoalkene 2 to the alkyne 3 was 
successful using n-butyllithium, and resulted in a high yield of product. In this step, 
the dibromoalkene undergoes an elimination reaction to give a bromoalkyne, 
followed by a lithium-halogen exchange which yields the terminal alkyne upon 
aqueous work up.  
The synthesis of the phenyl-phosphinate pyridine platform 4 has been reported 
previously,30 and began from 2-bromo-6-methylpyridine 5, which was oxidised with 
meta-chloroperbenzoic acid to form the N-oxide 6, allowing addition of a nitro 
group in the pyridine 4-position to form 7. The N-oxide was reduced using PBr3 to 
give 2-bromo-6-methyl-4-nitropyridine, 8 (see Scheme 2.4).  
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Scheme 2.4 Activation of the pyridine to allow nitration by SNAr.  
The next step was to introduce the phenyl phosphinate group, which was achieved 
by a palladium-catalysed C-P bond forming reaction with ethyl phenylphosphinate. 
Subsequent conversion of the nitro group of 9 to a bromine atom was carried out 
using acetyl bromide. Unfortunately, this step simultaneously hydrolyses the ethyl 
phosphinate ester which had to be restored by refluxing the phosphinic acid in 
triethylorthoformate to yield the phosphinate ester 10. In order to introduce the 
alcohol functionality, it was necessary to re-oxidise the pyridine nitrogen to form 
the N-oxide 11, before a Boekelheide rearrangement using trifluoroacetic 
anhydride furnished the ester 12. Room temperature solvolysis of this ester yielded 
the final pyridine platform 4. 
 
Scheme 2.5 Palladium-catalysed coupling of the phenyl phosphinate group followed by a 
Boekelheide rearrangement to introduce the alcohol functional group. 
The mechanism of the Boekelheide rearrangement (see Scheme 2.6) has been 
proposed to proceed via either a concerted [3.3]-sigmatropic rearrangement or an 
ion pair mechanism. Experiments using 18O- labelled acetic anhydride suggest that 
the ion pair mechanism is the more likely.136  
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Scheme 2.6 Two possible mechanisms of the Boekelheide rearrangement. 
The Boekelheide rearrangement reaction was difficult to monitor by mass 
spectrometry as the trifluoroacetate ester is susceptible to hydrolysis at room 
temperature which presents a problem for reverse phase liquid chromatography. 
Additionally, the N-oxide 11 and alcohol 4 have identical molecular masses. Instead, 
it was possible to monitor the reaction by 1H NMR. The 6-methyl pyridine 
substituent of 11 has a 1H resonance at 2.47 ppm (3 H, s, CDCl3). As the Boekelheide 
rearrangement occurred, this peak disappeared whilst a new peak appeared at 5.44 
ppm (2 H, s, CDCl3), corresponding to the –CH2OCOCF3 protons in 12. The 
trifluoroacetate ester hydrolysis can also be monitored by 1H NMR as the chemical 
shift of the aforementioned CH2 group moves from 5.44 ppm to 4.75 ppm. 
With both fragments of the chromophore now synthesised, a Sonogashira reaction 
was used to couple them together (see Scheme 2.7). This reaction forms a carbon-
carbon bond between a terminal alkyne and an aryl halide and is catalysed by 
palladium(0) and a copper(I) co-catalyst. The reaction is useful due to its relatively 
mild conditions. The reaction is sensitive to oxygen and so must be carried out in 
degassed solvents. Typically a palladium(II) pre-catalyst is used which is more stable 
for long term storage. This is reduced in situ to provide the palladium(0) species 
required to catalyse the coupling. Prior work in the group had established that 
Pd(dppf)Cl2 ([1,1’-bis(diphenylphosphino)ferrocene]dichloropalladium(II)) was a 
suitable catalyst for this coupling reaction. 
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Scheme 2.7 The Sonogashira coupling reaction of alkyne 3 to ethyl [4-bromo-6-
(hydroxymethyl)pyridine-2-yl](phenyl) phosphinate 4. 
The reaction was complete after 4 hours. Initial purification of 13 by column 
chromatography using dichloromethane and methanol as eluent (very gradual 
increase from neat dichloromethane to 3% methanol) did result in separation of 
some of the catalyst by-products. However, the product co-eluted with other by-
products. Various solvent systems were tested to see whether the product could be 
separated from the by-products. Reasonable separation was achieved in neat ethyl 
acetate. Therefore, a second purification by column chromatography was carried 
out using an ethyl acetate/hexane eluent system. This time, the product could be 
isolated from the remaining catalyst in a reasonable yield.  
Mesylation of 13 with methanesulfonyl chloride and triethylamine led to the 
mesylate 14 in quantitative yield. The mesylates are reactive and must be used in 
the alkylation step without further purification (see Scheme 2.8). Alkylation of 
1,4,7-triazacyclononane was carried out in acetonitrile using potassium carbonate 
as the base. After stirring at 60 °C overnight, the suspension was centrifuged to 
remove inorganic salts and the solution was decanted. The solid was then washed 
repeatedly with acetonitrile and centrifuged again. The crude ligand was purified by 
column chromatography and gave the product in a rather low isolated yield.  
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Scheme 2.8 The mesylation of alcohol 13 and the subsequent alkylation of triazacyclononane with 
mesylate 14 to give the tri-ethyl ester of L1. 
Finally, phosphinate ester hydrolysis and complexation were required to reach the 
final complex. Phosphinate ester hydrolysis was carried out in a CD3OD/D2O mixture 
with potassium hydroxide at 60 °C (see Scheme 2.9). The use of deuterated solvents 
allows the reaction to be monitored by NMR. Disappearance of the proton 
resonances for the ethyl esters can be observed but more useful is the change in 
the shift of the phosphorus resonance in the 31P NMR spectrum, from 
approximately +25 ppm for the ethyl ester to +16 ppm for the free phosphinate. 
This method of reaction monitoring is favoured as the hydrolysed ligands are 
difficult to observe by mass spectrometry. After 8 days, 31P NMR showed the 
hydrolysis to be complete. This reaction was significantly slower than has been 
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reported for the methyl phosphinate analogues,29 which could be attributed to a 
more hindered approach of the solvated OH- nucleophile to the phosphorus atom 
due to the large phenyl substituent. In earlier work on these systems, phenyl 
phosphinate ester hydrolysis was achieved using 6 M HCl. However, this method is 
not compatible with the extended chromophores as the alkyne bond is hydrated in 
similar complexes under acidic conditions.137 Evidence for this process was 
obtained by mass spectrometry (increase of 54 Da, consistent with addition of 
three water molecules), by significant changes in the absorption spectra, and by 
loss of observable emission after exposure to acidic solution. A possible mechanism 
for this process is shown in Scheme 2.10. 
 
Scheme 2.10 Proposed mechanism of acid-catalysed addition of water to a pyridylarylalkynyl 
chromophore.137  
Once the ester hydrolysis was complete, europium(III) chloride hexahydrate was 
added. The reaction was stirred overnight at 60 °C, after which time the mass 
spectrum of the reaction mixture showed formation of the complex. The reaction 
was neutralised with dilute aqueous acid and concentrated, before the crude 
complex was purified by reverse phase HPLC. Due to the reduced solubility of these 
complexes in water, the crude complexes were purified in multiple small injections 
to limit precipitation of the complex in the HPLC instrument.  
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Scheme 2.10 Phosphinate ester hydrolysis and complexation to form [EuL1]. 
2.2.2 Synthesis of [EuL2] 
Due to the commercial availability of the starting material 4-bromo-3-methylanisole 
15, the synthesis of the chromophore head group of [EuL2] follows a different 
route. An alkyne group was introduced by a Sonogashira coupling of 15 to 
ethynyltrimethylsilane to form the silane 16. The trimethylsilyl protecting group 
was removed with triethylamine trihydrofluoride to give the terminal alkyne 17 in 
good yield (see Scheme 2.11). The deprotection reaction was slow, taking 6 days for 
complete deprotection. An alternative method for the deprotection has been 
tested in the group using tetrabutylammonium fluoride (TBAF) instead. This 
reaction was much quicker but the product could not be easily isolated from the 
reaction mixture.  
 
Scheme 2.11 The synthetic route to 1-ethynyl-4-methoxy-2-methylbenzene 17. 
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This terminal alkyne 17 could then be coupled to the p-bromopyridyl moiety 4 using 
a Sonogashira coupling reaction to give the extended pendant chromophore arm 18 
(see Scheme 2.12). As with the purification of 13, the crude product was subjected 
to two column chromatography purifications in order to remove all the catalyst 
residues.  
 
Scheme 2.12 The Sonogashira coupling of alkyne 17 to ethyl [4-bromo-6-(hydroxymethyl)pyridine-2-
yl](phenyl) phosphinate 4. 
Following the same route as for complex [EuL1], fragment 18 was converted to the 
mesylate 19 in quantitative yield and was then used to alkylate triazacyclononane 
(see Scheme 2.13). When TLC conditions were tested for purification of the crude 
alkylation product, no separation could be achieved. It was therefore decided to 
complex the unpurified ligand, rather than risk losing a large quantity of the 
material on a silica column. Identification of the desired product in the crude 
mixture was achieved by NMR spectroscopy and mass spectrometry (see Chapter 
5).  
Consequently, phosphinate ester hydrolysis was carried out with potassium 
hydroxide in a CH3OH/H2O mixture and addition of europium(III) chloride 
hexahydrate led to the desired complex [EuL2] which was purified by RP-HPLC. 
Solubility of the crude product in the HPLC solvent was again a problem. The 
solutions to be injected were filtered to avoid any solid particles being injected onto 
the columns. 
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Scheme 2.13 The synthesis of the tri-ethyl ester of L2 and the complexation reaction to form [EuL2]. 
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2.3 Photophysical properties of [EuL1] and [EuL2] 
The photophysical properties of the novel europium(III) complexes, [EuL1] and 
[EuL2], were measured in methanol. As predicted, the absorption spectra of [EuL1] 
and [EuL2] show broad absorption bands that closely resembled those of the 
methyl-phosphinate analogues, [EuL3] and [EuL4] (see Fig. 2.3). 
 
 
Figure 2.3 Absorption spectra of [EuL1-4] (MeOH, 295 K), showing broad, featureless absorption 
bands assigned to an internal charge transfer transition. 
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Excitation spectra (example shown in Fig. 2.4) also confirmed that sensitisation of 
the europium(III) ion did indeed occur via this broad absorptive transition, 
attributed to an internal charge transfer state. These broad bands mean that the 
complexes bearing trimethoxy-substituted chromophores ([EuL1] and [EuL3]), 
absorb almost the same amount of light at 365 nm (the wavelength of a UV-LED) as 
they do at their absorption maxima (356 and 355 nm, respectively). For [EuL2] and 
[EuL4], bearing the p-methoxy-o-methyl substituted chromophores, there is still 
40% efficiency in absorption at 365 nm, despite their absorption maxima being over 
20 nm away. At 355 nm (3rd harmonic of Nd:YAG lasers), there is approximately 
70% absorption efficiency, demonstrating the potential utility of these complexes in 
security applications using 355 or 365 nm excitation. 
 
Figure 2.4 Overlaid absorption (blue) and excitation (grey) spectra for [EuL2] confirming 
europium(III) excitation via the internal charge transfer absorption band (MeOH, 295 K, λem 614 nm). 
The emission spectra of [EuL1] and [EuL2] also closely resemble their methyl 
phosphinate analogues (see Fig. 2.5). Given that the N6O3 coordination cage is the 
same in both instances, this is perhaps unsurprising. However, small differences can 
be observed in the relative intensities of the transitions in the ΔJ = 4 manifold (680-
710 nm), and also between the major band and the smaller doublet in the ΔJ = 2 
manifold (610-630 nm). These differences are conserved on changing the 
chromophore group. Since the ΔJ = 2 and 4 transitions are sensitive to ligand to 
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ligand environment (indeed ΔJ = 2 is hypersensitive), it is possible that these minor 
differences are due to a small change in geometry or Eu-O bond distance upon 
changing from a methyl phosphinate to a phenyl phosphinate donor group. 
 
 
Figure 2.5 The normalised emission spectra of [EuL1-4] (MeOH, 295 K, 5 μM complex, excited at the 
absorption maximum for each complex). 
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Emission lifetimes were also recorded for [EuL1] and [EuL2] and were found to be 
longer than for the methyl phosphinate analogues, and consistent with related 
similar phenyl phosphinate complexes. The molar extinction coefficients for [EuL1-4] 
are all in the range 57 000 – 65 000 M-1 cm-1, consistent with other complexes of 
this type.29 The key photophysical properties of [EuL1-4] are summarised in Table 
2.1. Absorbance values at 365 nm are also quoted as a percentage of the 
absorbance at λmax as this is a common LED excitation wavelength, as used in these 
experiments. The complexes possess brightness values in the range 16.8 – 
30.2 mM-1 cm-1, compared to the red fluorescent protein mCherry, with a 
brightness of 19 mM-1 cm-1 (mCherry has an emission maximum at 612 nm, 
corresponding to the emission maximum in the ΔJ = 2 manifold of [EuL1-4]).138 
Due to their broad absorption bands, the complexes possess brightness parameters 
up to 23 mM-1 cm-1 at the common excitation wavelengths of 355 and 365 nm. 
Quantum yields were measured by an absolute method using an integrating sphere 
rather than by comparison to a standard.139 The phenyl phosphinate complexes 
have higher quantum yields than the analogous methyl phosphinate complexes, 
consistent with more effective shielding of the metal centre by the bulkier phenyl 
groups. However, it is clear to see that the complexes bearing the more electron 
rich trimethoxy-substituted chromophore ([EuL1] and [EuL3]) have lower quantum 
yields than the p-methoxy-o-methyl-substituted complexes, [EuL2] and [EuL4]. The 
more electron rich trimethoxy-substituted chromophore is more easily oxidisable 
which, in combination with the reducibility of Eu(III) to Eu(II), could lead to the 
ligand excited state being quenched by electron transfer to the metal centre.5 Such 
a process would lower the quantum yield of the complexes bearing these 
chromophores. 
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Table 2.1 Key photophysical properties of the europium(III) complexes [EuL1-4] 
(295 K, MeOH). 
Complex λmax
a/ 
nm 
Normalised absorbance 
at 365 nm / % 
Φem / 
% 
τEu/ 
ms 
Brightness, B, at 
365 nmb / mM-1 
cm-1 
[EuL1] 356 98 39 1.18 22.9 
[EuL2] 343 40 50 1.22 12.0 
[EuL3] 355 100 28 1.10 16.8 
[EuL4] 342 37 42 1.14 9.3 
a  Extinction coefficients for these complexes are 60 000 (±5 000) M-1 cm-1.  
b  These brightness calculations assume that the quantum yields are constant across the 
excitation band. 
 
2.4 Complex chirality and resolution by chiral HPLC 
In complexes of this type based on 9-N3, three different forms of chirality arise (see 
Fig. 2.6). The first is the configuration around the tetrahedral phosphorus atoms in 
the phosphinate groups, which can be described as R or S in the same way as for 
point chirality at a carbon atom, following Cahn-Ingold-Prelog rules (green in Fig. 
2.6). In this instance, the oxygen coordinated to the metal takes the highest 
priority, followed by the second oxygen atom, then the pyridine carbon, with the P-
methyl or P-phenyl substituent in lowest priority. Secondly, the NCCNpyr torsion 
angle (viewed along the C-C bond indicated by the blue arrow) can be described as 
either positive or negative, which confers Δ or Λ helicity, respectively, on the 
complex. Thirdly, the torsion angle of the NCCN link in the macrocycle (viewed 
along the C-C bond indicated by the red arrow) can either have a positive or 
negative sign, which define a δ or λ conformation, respectively. 
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Figure 2.6 Schematic diagrams showing the definitions of the chirality at phosphorus (green), 
complex helicity (blue) and macrocycle conformation (red) in 9-N3 based pyridylphosphinate 
complexes. 
Such complexes could theoretically exist in any combination of R/S configuration, 
Δ/Λ helicity and δ/λ conformation. However, the steric bulk of the pyridine groups 
and the phosphinate substituents impose conditions on the structure. It is 
necessary that all three pyridine arms possess the same helicity to avoid a steric 
clash of the phosphinate groups. The methyl and phenyl substituents of the 
phosphinate groups are also required to point away from the macrocyclic ring. 
Taking into account these restrictions, four possible stereoisomers exist as shown in 
Figure 2.7.  
In systems where X-ray crystal structure determination has been possible, only the 
SSS–Δ(λλλ) and RRR-Λ(δδδ) isomers have been observed.140 Interconversion 
between stereoisomers requires cooperative ring inversion, arm rotation and 
inversion of the configuration at the phosphorus atom. The same arguments can be 
used to assign the chirality of complexes with carboxylate donors rather than 
phosphinates, and similar analyses are possible for complexes based on 12-N4 
macrocycles. 
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Figure 2.7 The four possible stereoisomers of a pyridylphosphinate 9-N3 complex. 
In order for europium complexes of this type to be used as CPL-emitting security 
labels, it was necessary to separate the racemic mixtures to obtain enantiopure 
complexes. The separation was achieved by chiral HPLC. Briefly, chiral HPLC differs 
from conventional HPLC in the use of a chiral stationary phase (CSP), leading to 
diastereomeric interactions between the CSP and the compound to be separated. 
The strength of these transient diastereomeric complexes can be different for 
different enantiomers of the same molecule, allowing the separation of the 
enantiomers. There is a very wide range of CSPs available, varying from synthetic 
and natural polymers (methacrylates, cellulose, amylose, proteins) to small 
molecules (crown ethers, cyclodextrins and macrocyclic glycopeptides). For the 
purposes of this work, chiral columns based on cellulose and amylose have been 
used (see Fig. 2.8). The structures of the chiral stationary phases imply that they are 
fully derivatised with the phenylcarbamate groups, but in reality it is rather difficult 
to measure the precise degree of derivatisation. 
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Figure 2.8 The chiral stationary phases used in Daicel CHIRALPAK-IC and ID columns. 
Chiral HPLC separation has been investigated for both of the complexes [EuL1] and 
[EuL2], as well as their methyl phosphinate analogues [EuL3] and [EuL4]. In each 
case, resolution of the enantiomers was achieved at room temperature using 
isocratic methanol as the eluent.134 For complexes [EuL2], [EuL3] and [EuL4], the 
best separation was achieved on the CHIRALPAK-ID columns. However, for complex 
[EuL1], poor separation was observed using the CHIRALPAK-ID column but good 
separation was achieved with the CHIRALPAK-IC column (see Fig. 2.9). Interestingly, 
the order of the enantiomer elution was the same for [EuL2-4] (using CHIRALPAK-ID) 
whereas the enantiomers of [EuL1] eluted in the reverse order. Such behaviour 
suggests that the difference in chirality at the anomeric carbon in the cellulose and 
amylose stationary phases contributes to the separation of the enantiomers. 
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Figure 2.9 Analytical chiral HPLC traces for crude [EuL1] on CHIRALPAK-ID (top) and CHIRALPAK-IC 
(bottom) (295 K, MeOH, 1 mL/min, UV detector λ = 356 nm). 
The longer the retention time of the compound, the broader the peak and the 
longer the tail. Such features can be seen very clearly for the analytical trace of 
[EuL4] (see Fig. 2.10). Therefore, the ideal conditions must strike a balance between 
a relatively short retention time and good separation. One variable that can be 
controlled is the flow rate. However, the range over which this can be changed is 
limited by the maximum pressure at which the columns can be used. Operating the 
columns at high pressure for extended periods of time can result in the stationary 
phase being damaged. 
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Figure 2.10 The analytical HPLC trace for the racemate of [EuL4] showing how longer retention times 
result in broad peaks with long tails (CHIRALPAK-ID, 295 K, MeOH, 1 mL/min, UV detection λ = 342 
nm). 
Once it had been determined that all four complexes could be resolved by chiral 
HPLC on an analytical scale, preparative separations were carried out. In order to 
replicate the conditions as closely as possible on moving from the analytical to 
semi-preparative columns, a flow rate of 4.4 mL/min was used. Such conditions 
represent a compromise between retention time and back pressure to prolong the 
lifetime of the columns. Thus, in preparative LC traces were observed with similar 
profiles to the analytical traces but slightly longer retention times. An example of 
this behaviour for [EuL3] can be seen in Fig. 2.11. In each case, removal of solvent 
from the collected fractions was carried out at room temperature to minimise the 
possibility of racemisation. 
                          CHAPTER TWO : CHIRAL Eu(III) COMPLEXES FOR SECURITY LABELLING 
 
94 
 
 
Figure 2.11 Analytical (top) and preparative (bottom) traces for [EuL3] (CHIRALPAK-ID, 295 K, MeOH, 
1.0 mL/min for analytical, 4.4 mL/min for preparative, UV detector λ = 356 nm) 
 
2.5 CPL characterisation 
CPL spectra have been recorded for each enantiomer of the complexes [EuL1-4] (see 
Figs. 2.12-2.15).134 In every case, mirror imaged CPL spectra were observed for 
enantiomers of the same complex. Comparison of the profiles of [EuL1-4] to the 
parent complexes [EuL5] and [EuL6] (see Figs. 2.16 and 2.17) allowed the absolute 
configuration of the enantiomers to be identified, due to the fingerprint-like profile 
in the ΔJ = 4 manifold (680-710 nm). The absolute configuration of the enantiopure 
parent complexes [EuL5] and [EuL6] has been established previously from X-ray 
crystal structure analysis.39,140  
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Figure 2.12 CPL spectra of the Δ- (red) and Λ- (blue) enantiomers of [EuL1] (MeOH, 295 K, 5 μM 
complex, λexc 356 nm, 5 scans averaged). 
 
Figure 2.13 CPL spectra of the Δ- (red) and Λ- (blue) enantiomers of [EuL2] (MeOH, 295 K, 5 μM 
complex, λexc 343 nm, 5 scans averaged). 
Comparing the CPL spectra of the two phenyl phosphinate complexes [EuL1] and 
[EuL2], very few differences can be observed. Both complexes exhibit similar 
profiles in all transitions. Of particular importance is the fact that in the ΔJ = 1 
transition (590-600 nm) all transitions for a particular enantiomer have the same 
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handedness. Similarly, for the methyl phosphinate complexes [EuL3] and [EuL4], 
almost identical profiles were observed. These results suggest that the nature of 
the chromophore does not have a significant effect on the form of the CPL 
spectrum. 
 
Figure 2.14 CPL spectra of the Δ- (red) and Λ- (blue) enantiomers of [EuL3] (MeOH, 295 K, 5 μM 
complex, λexc 355 nm, 5 scans averaged). 
 
Figure 2.15 CPL spectra of the Δ- (red) and Λ- (blue) enantiomers of [EuL4] (MeOH, 295 K, 5 μM 
complex, λexc 342nm, 5 scans averaged). 
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When compared to the parent complexes [EuL5] and [EuL6], the CPL spectra for 
[EuL1-4] show that, in general, the spectral form is conserved on addition of the 
extended chromophores. There are differences in the relative intensities of some of 
the transitions but the ordering and handedness of each transition is the same.  
 
 
 
Figure 2.16 The CPL spectra of the Δ- (red) and Λ- (blue) enantiomers of the phenyl phosphinate 
parent complex [EuL5] (1:1 MeOH:H2O, 295 K). Data replotted from Ref. [141]. 
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Figure 2.17 CPL spectra of the Δ- (red) and Λ- (blue) enantiomers of the methyl phosphinate parent 
complex [EuL6] (H2O, 295 K). Data replotted from Ref. [39]. 
Interestingly, differences are observed when CPL spectra of phenyl and methyl 
phosphinates are compared. For example, in the ΔJ = 1 region (590-600 nm), the 
phenyl phosphinates ([EuL1] and [EuL2]) appear to show three transitions, centred 
at 590, 594, and 597 nm, all with the same sign. In contrast, the methyl 
phosphinates ([EuL3] and [EuL4]), exhibit three distinct transitions at 592, 594 and 
599 nm, with the first of opposite sign to the remaining two. Additionally, in the ΔJ 
= 4 manifold (680-710 nm), the transition at 690 nm is proportionally larger in the 
phenyl phosphinates than in the methyl phosphinates, a difference that is mirrored 
in the total emission spectra (see Fig. 2.18).  
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Figure 2.18 The total emission and CPL spectra for Δ-[EuL2] (left) and Δ-[EuL3] (right) showing the 
difference in relative intensity of the transition at 690 nm. 
It is worth noting that the ΔJ = 1 manifolds in the CPL spectra of all four complexes 
appear to contain at least 3 distinct transitions. In C3 symmetry, only two bands are 
expected, as the 2J + 1 states are split into a singlet A level and a doubly degenerate 
E level.142 The appearance of 3 bands suggests that perhaps the complexes are not 
perfectly C3 symmetric in solution. There is evidence for this in DFT calculations 
carried out on analogous complexes, where the coordination polyhedron is slightly 
distorted from the C3-symmetrical tricapped trigonal prism structure.29 Additionally, 
X-ray crystal structure analysis of an analogous complex showed slightly distorted 
C3-symmetry in the solid state.30 It is clear to see from these spectra that the CPL 
spectra provide increased resolution when compared to the total emission spectra 
in all observed transitions, as a result of some transitions being of opposite 
handedness to neighbouring bands. 
Initially, only scans between 570 and 720 nm were taken in order to record the 
emission from the 5D0 → 7F0-4 transitions (although circularly polarised emission is 
forbidden in the 5D0 → 7F0 transition). In the spectra presented thus far, it is evident 
that additional transitions are visible in regions outside the 5D0 → 7F0-4 manifolds. 
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For example, weak transitions are visible around 580 nm and between 625 and 640 
nm. It was hypothesised that these belonged to transitions from the Eu(III) 5D1 
excited state, as the wavelength ranges concerned correspond closely to those in 
systems where 5D1 → 7FJ transitions have been observed previously.2  
CPL and total emission spectra of [EuL1-4] were recorded across a wider wavelength 
range in an attempt to observe further transitions. In every case, bands attributed 
to transitions from 5D1 to 7F2 (550-560 nm), 7F3 (575-585 nm), and 7F4 (625-640 nm) 
were observed in the CPL spectra, along with the weak 5D0 → 7F5 manifold around 
750 nm (see Fig. 2.19).134 Most reports of Eu(III) emission do not include the 5D0 → 
7F5 transition because it is much weaker than the 5D0 → 7F0-4 transitions, making it 
difficult to measure with standard photomultiplier tubes, which are inherently less 
sensitive at longer wavelengths. Even with specialist red-sensitive photomultiplier 
tubes, the 5D0 → 7F5 transition is only usually observed in crystalline matrices and 
frozen solution. Transitions from 5D1 are rarely observed in molecular systems at 
room temperature due to the stronger radiationless deactivation of this excited 
state, although emission from this level and higher excited states are often 
observed from Eu(III) in inorganic host lattices. 
 
Figure 2.19 Expanded CPL spectra of the Δ-(red) and Λ-(blue) enantiomers of [EuL2] showing less 
commonly observed transitions (MeOH, 295 K, 5 μM complex, λexc 343 nm, 5 scans averaged). Note 
cut x-axis. 
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In the total emission spectrum of [EuL2] (see Fig. 2.20), the 5D1 → 7F2 and 5D0 → 7F5 
transitions are visible along with the 5D1 → 7F1 transition at 537 nm, although 
perhaps surprisingly no corresponding CPL is observed in this region. According to 
the selection rules developed by Richardson,143 the 5D1 → 7F1 transition is a 
magnetic dipole allowed transition. As such, one might expect to observe strong 
CPL from this transition. However, recent work has suggested that the 5D1 → 7F1 
possesses significant electric dipole character.144 Such transitions are expected to 
be weak in CPL, which could explain the absence of a CPL signal corresponding to 
this transition. The 5D1 → 7F3 and 5D1 → 7F4 transitions in the total emission 
spectrum are obscured by the much stronger transitions from 5D0 in the similar 
wavelength regions. Addition of a 60 μs time-gate to the total emission spectrum 
acquisition renders the peaks corresponding to the 5D1 → 7F1 and 5D1 → 7F2 
transitions indistinguishable from the baseline noise. Lifetimes of the order of a few 
microseconds for the 5D1 excited state have been reported previously.145–147  
 
Figure 2.20 Expanded total emission spectrum for [EuL2] showing some transitions rarely observed 
in solution for molecular systems (MeOH, 295 K, 5 μM complex, λexc 343 nm, 5 scans averaged). 
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Selected gem values for [EuL1-4] of various emissive transitions are shown in Table 
2.2. The gem values are broadly similar for all complexes at each wavelength, with 
the exception of the 5D1 → 7F2 transition which displays larger CPL signals for the 
methyl phosphinates than for the phenyl phosphinates. All the emission 
dissymmetry values are within the expected range for lanthanide complexes of this 
type. 
 
Table 2.2 Selected gem values for [EuL1-4] (MeOH, 295 K) 
 gem / arb 
λ / nm 554 557 599 655 708 757 
[EuL1] 
Δ +0.14 -0.18 +0.11 -0.13 -0.23 -0.06 
Λ -0.15 +0.20 -0.13 +0.15 +0.26 +0.09 
[EuL2] 
Δ +0.11 -0.22 +0.14 -0.18 -0.30 -0.14 
Λ -0.13 +0.19 -0.14 +0.18 +0.29 +0.12 
[EuL3] 
Δ +0.17 -0.33 +0.12 -0.19 -0.31 -0.12 
Λ -0.17 +0.32 -0.13 +0.19 +0.31 +0.11 
[EuL4] 
Δ +0.18 -0.33 +0.12 -0.18 -0.30 -0.13 
Λ -0.18 +0.33 -0.11 +0.17 +0.29 +0.12 
 
In order to examine whether any spectra-structure correlation could be observed 
for these C3-symmetric 9-N3 complexes, the CPL spectra of [EuL1-4] were compared 
to similar complexes, where the phosphinate donors are replaced with amide and 
carboxylate groups. Initial comparisons to the carboxylate parent system [EuL7] (see 
Fig. 2.21) and a complex with extended chromophore arms and amide donor 
groups [EuL8] (see Fig. 2.22) were made. The CPL spectra of the enantiomers of 
[EuL7] show similar profiles in the ΔJ = 1 manifold to the phenyl phosphinate 
complexes [EuL1] and [EuL2] with every transition of the same sign. Additionally, the 
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fingerprint-like pattern observed in [EuL1-4] in the ΔJ = 4 manifold is common to 
[EuL7]. However, the ΔJ = 2 manifold is significantly different in [EuL7], comprising 
one strong transition at 615 nm accompanied by several weaker transitions of 
varying sign at higher and lower energy. In the phosphinate systems, the ΔJ = 2 
manifold is made up of several transitions of approximately equal intensity. In the 
amide system, two strong transitions of opposite sign are observed in the ΔJ = 1 
manifold (similar to the methyl phosphinates), but the patterns of the ΔJ = 3 and ΔJ 
= 4 manifolds are distinctly different from both the phosphinate and carboxylate 
complexes.  
 
 
Figure 2.21 The CPL spectra of the Δ- (left) and Λ- (right) enantiomers of [EuL7] (H2O, 295 K, λexc 272 
nm). Adapted from Ref. [39] with permission from The Royal Society of Chemistry. 
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Figure 2.22 The CPL spectra of the S-Δ (green) and R-Λ (blue) enantiomers of [EuL8]3+ (H2O, 295 K, 
λexc  348 nm). Reproduced from Ref. [75] with permission from The Royal Society of Chemistry. 
These initial observations suggest that within a series of complexes containing the 
same donor groups, similar CPL profiles are observed. However, these similarities 
do not extend to complexes of different donor groups, even those containing the 
same donor atom set. Importantly, subsequent work has shown that the CPL and 
total emission profiles are strongly dependent on the solvent, so comparisons of 
spectra in different solvents may inhibit conclusive comparisons being drawn. 
Further discussion on solvent effects in the photophysical properties of these 
complexes can be found in Chapter 3. 
The complex [EuL9] (synthesised by Dr. Matthieu Starck) is structurally similar to 
[EuL4], possessing two methyl phosphinate donor groups and one carboxylate 
group. The complex exhibits similar photophysical properties to [EuL4] (λmax = 340 
nm, τEu (MeOH) = 1.12 ms) and can be resolved by chiral HPLC using the same 
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method as for [EuL4].148 Comparison of the CPL form of [EuL4] to [EuL9] shows that 
the ΔJ = 3 and 4 manifolds are very similar to those in [EuL1-4] and [EuL7], which is 
not surprising given the donor groups are the same. However, the ΔJ = 1 and 2 
manifolds differ considerably from both the symmetric phosphinate and 
carboxylate complexes. This is perhaps as result of the C3 symmetry being broken in 
[EuL9], resulting in these transitions resembling neither the symmetric carboxylate 
nor methyl phosphinate complexes. Indeed, in the ΔJ = 1 manifold, the transitions 
differ in both energy and sign between [EuL9] and [EuL4]. 
 
 
Figure 2.23 The CPL spectra of the Δ-(red) and Λ-(blue) enantiomers of [EuL9] (MeOH, 295 K, λexc 340 
nm). 
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In order to further investigate the possible differences in the CPL spectra of 
complexes containing phosphinate and carboxylate donors, it was also decided to 
attempt separation of complex [EuL10], which also has extended arylalkynyl 
chromophores. The chromophore on this complex contains a second ortho-methyl 
group, which shifts the absorption maximum to slightly longer wavelengths than for 
[EuL2] and [EuL4]. 
 
Extensive attempts were made to resolve [EuL10] by chiral HPLC using both 
CHIRALPAK-IC and ID columns including using alternative solvent systems. No 
analytical scale injections showed any indication of chiral resolution. Therefore, it 
was decided to synthesise an analogous carboxylate complex via an alternative 
route.  
2.6 An alternative strategy for the synthesis of enantiopure 
carboxylate complexes 
Since direct chiral resolution of [EuL10] could not be achieved, an alternative 
strategy for the synthesis of enantiopure carboxylate complexes with extended 
arylalkynyl chromophores was required.  It has already been demonstrated that the 
pyridine carboxylate parent complex [EuL7], and the 4-bromo substituted 
methylphosphinate parent complex [EuL6] could be resolved using CHIRALPAK-IC 
and ID columns, respectively, using isocratic methanol as the mobile phase. 
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Therefore, it was envisaged that 4-substituted carboxylate parent complexes could 
be resolved under similar conditions. As such, a divergent synthetic route was 
proposed (see Scheme 2.14), featuring initial synthesis of the racemic 4-iodo 
substituted carboxylate complex [EuL11], followed by resolution using chiral HPLC. 
Then, coupling of the enantiomers of this intermediate complex with an alkyne-
bearing head group under mild Sonogashira conditions would lead to the 
enantiopure complex. The utility of this divergent route has been demonstrated 
previously.133  
Rather than the 4-bromo substituted intermediate complex used in that study, the 
4-iodo analogue was chosen in this case, as more facile Sonogashira coupling is 
observed for aryl iodides than aryl bromides.149 The use of milder reaction 
conditions was expected to reduce the possibility of racemisation of the complex 
during the reaction. It also worth noting that the electron-poor nature of the 
pyridine (due to metal coordination) is expected to increase the reaction rate, 
compared to an uncoordinated pyridine ligand. 
 
Scheme 2.14 Proposed strategy for the synthesis of enantiopure carboxylate complexes. 
The synthesis of the ligand was carried out using established methods,150 starting 
from chelidamic acid 20 (see Scheme 2.15). Treatment with thionyl chloride 
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replaced the 4-hydroxy substituent with a chlorine atom and converted the 
carboxylic acid groups to acid chlorides. The reaction was quenched by dropwise 
addition of methanol, converting the acid chloride groups to methyl esters. 
Subsequent displacement of the 4-chloro substituent of diester 21 using sodium 
iodide and acetyl chloride with sonication yielded 4-iodo diester 22. Careful mono-
reduction of 22 using sodium borohydride in CH2Cl2/CH3OH gave the alcohol 23. A 
compromise must be achieved between consumption of the starting material and 
over reduction to the diol. Consequently, reduction of 22 was carried out in ice and 
monitored regularly by TLC until the reaction was quenched with aqueous HCl. The 
crude mixture of starting material, desired product and a small amount of diol side 
product was separated by column chromatography to give the mono-reduced 
product 23 in good yield. Unreacted starting material was recovered from the 
purification and reused. Mesylation of the hydroxyl group to give 24 provided the 
required pyridine moiety for alkylation of triazacyclononane. 
 
Scheme 2.15 Synthesis of the 4-iodopyridine derivative, 24, from chelidamic acid. 
Alkylation of triazacyclononane was carried out in acetonitrile with potassium 
carbonate as the base, and the reaction was monitored by LCMS. Previous work in 
the group had identified the occurrence of ester hydrolysis during column 
chromatography of similar compounds. As a result, the crude ligand was directly 
hydrolysed under basic conditions before complexation using europium(III) chloride 
(see Scheme 2.16). The complexation reaction was carried out in aqueous solution 
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and after stirring at 70 °C, a white precipitate had formed. This solid exhibited 
bright red emission by visual inspection using a TLC reader lamp, but was insoluble 
in all common laboratory solvents, with the exception of DMSO.  
Scheme 2.16 Formation of the trimethyl ester of ligand L11, and complexation to form [EuL11]. 
Stirring the white solid in warm DMSO for 48 hours yielded a solution from which 
some photophysical properties of [EuL11] could be obtained (see Fig. 2.23). The 
absorption spectrum was consistent with the expected product, with an absorption 
maximum of 277 nm. The complex also exhibited weak sensitised europium(III) 
emission with an emission lifetime of 1.18 ms in DMSO. Unfortunately, due to the 
limited solubility of the complex, reliable NMR spectra could not be recorded. Due 
to the incompatibility of DMSO with LCMS, no mass spectral data could be obtained 
either. 
 
Figure 2.23 Absorption and emission spectra for crude [EuL11] after heating precipitate in DMSO for 
48 hours (DMSO, 295 K, λexc 277 nm). 
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Since the complex was insoluble in everything except DMSO, chiral HPLC could not 
be carried out. A Sonogashira coupling of the racemic complex with 2-ethynyl-1,3,5-
trimethoxybenzene was attempted in DMSO, to compare the photophysical 
properties of the resulting complex with [EuL1] and [EuL3] which bear the same 
chromophore. Previous Sonogashira couplings on complexes were carried out in 
DMF/THF mixtures to ensure solubility of all reagents and catalysts.133 In this 
instance, the starting material is poorly soluble in DMSO, but the product was 
expected to be soluble. Due to the presence of DMSO, the reaction could not be 
monitored by LCMS, so TLC and absorbance spectra were used to monitor the 
progress of the coupling, by observing the appearance of the internal charge 
transfer absorption band of the extended chromophore around 360 nm. After 
completion, the reaction mixture was added dropwise with stirring to 400 mL of 
cold diethyl ether, causing the product to precipitate. The solution was decanted 
and the precipitate recovered. LCMS analysis of the crude product showed that the 
expected C3 symmetric complex [EuL12] with extended arylalkynyl chromophores 
was indeed the major product. The complex [EuL13] with two extended 
chromophores and one 4-chloropyridine arm was identified as the minor product 
(see Fig. 2.24). 
 
Figure 2.24 The structures of [EuL12] and [EuL13] formed from the Sonogashira coupling of an 
arylalkynyl chromophore onto [EuL11] in DMSO. 
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Purification of the crude mixture of the two complexes was initially attempted using 
flash chromatography on alumina, which was successful in removing catalyst 
residues from the crude mixture but did not result in separation of [EuL12] and 
[EuL13]. Therefore, reverse phase HPLC was used to separate the two complexes 
(see Fig. 2.25). 
 
Figure 2.25 The RP-HPLC trace for the mixture of complexes [EuL12] and [EuL13]. (H2O/MeOH mobile 
phase, XBridge C18 OBD column (19 x 100 mm, 5 µm), flow rate 17 mL/min, 295 K). 
Photophysical properties of [EuL12] and [EuL13] were recorded in methanol solution 
(see Fig. 2.26). Both complexes exhibit broad absorption bands around 360 nm, as 
expected, due to the electron-rich chromophore. The complexes also demonstrate 
emission spectra consistent with previously synthesised carboxylate complexes.29 
The similarity in photophysical properties between [EuL12] and [EuL13] is hardly 
surprising, as they possess the same donor atom set and the absorption spectral 
behaviour will be dominated by the presence of the extended chromophores.  
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Figure 2.26 Absorption (blue), excitation (purple) and emission (red) for [EuL12] (top, MeOH, 295 K, 
λexc 363 nm, λem 614 nm) and [EuL13] (bottom, MeOH, 295 K, λexc 362 nm, λem 614 nm). 
Although the use of 4-iodopyridine groups had been intended to make subsequent 
Sonogashira couplings easier, it clearly had a major effect on the solubility of the 
complex. Therefore, it was decided that the 4-bromopyridine analogue [EuL14] 
would be used instead, despite this potentially sacrificing some of the enantiopurity 
of the final products as the Sonogashira couplings may have to be carried out at 
higher temperatures with longer reaction times. The synthesis followed a very 
similar pathway to [EuL11], except that the initial step was to convert chelidamic 
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acid 20 to the 4-bromo substituted acid bromide with molten PBr5, followed by 
methanolic work up to introduce the two methyl esters (see Scheme 2.17). 
Carefully controlled mono-reduction of 25 with sodium borohydride yielded alcohol 
26, before transformation to the mesylate 27. Alkylation of triazacyclononane with 
mesylate 27 followed by base-catalysed ester hydrolysis and complexation with 
europium(III) chloride afforded the desired complex [EuL14]. 
 
Scheme 2.17 Synthetic route to [EuL14]. 
Again, the complex [EuL14] was isolated as the precipitate from the aqueous 
solution of the complexation reaction. The solid was isolated by centrifugation and, 
like [EuL11], was found to be insoluble in all common solvents, except warm DMSO. 
After heating overnight in DMSO, photophysical properties of [EuL14] were 
recorded (see Fig. 2.27). The broad absorption band around 275 nm contains 
multiple local maxima, which may indicate that there are several absorbing species 
present in the solution. The emission lifetime of 1.19 ms in DMSO was similar to 
that measured for the 4-iodo complex [EuL11].  
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Figure 2.27 Absorption and emission spectra of [EuL14] (DMSO, 295 K, λexc 272 nm). 
From these investigations, it is evident that the solubility of these complexes is 
strongly influenced by structure. The unsubstituted tris-pyridine parent complex 
[EuL7] is soluble in a variety of solvents, including water and methanol. However, 
addition of a 4-halo substituent makes them virtually insoluble. The analogous 
methyl phosphinate complex [EuL6] is also soluble in a variety of solvents, 
highlighting the importance of the phosphinate group in controlling complex 
solubility. 
2.7 Racemisation kinetics 
In order for this class of complex to have utility in security labelling, they must be 
kinetically stable with respect to racemisation. For an enantiopure complex to emit 
CPL as an anti-counterfeiting feature, it must be stable to racemisation for the 
lifetime of the item in which it is embedded.  
The experiment to assess racemisation kinetics involved heating a solution of the 
enantiopure complex and taking small aliquots at regular intervals for analytical 
chiral HPLC analysis. As racemisation occurs, the ratio of the area of the peaks for 
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the two enantiomers approaches 1:1. A kinetic relationship can be derived to 
describe the racemisation process as follows, and here it assumes the racemisation 
begins with enantiopure Δ-complex. 
From the equilibrium, 
 
(2.1) 
and assuming k1 = k-1 = k, the rate constant for enantiomeric interconversion, the 
following expressions for the rate of interconversion of enantiomers can be written. 
−d[Δ]
d𝑡
= 𝑘[𝛥] − 𝑘[𝛬] 
 
(2.2) 
1
[𝛥] − [𝛬]
 d[𝛥] = −𝑘 d𝑡 
 
(2.3) 
Since [Λ] = [Δ]0 –[Δ], an integrated rate law can be derived as follows: 
∫
1
2[Δ] − [Δ]0
[𝛥]
[𝛥]0
 d[𝛥] = ∫ −𝑘
𝑡
𝑡0
d𝑡 (2.4) 
1
2
ln(2[𝛥] − [𝛥]0) −
1
2
ln(2[𝛥]0 − [𝛥]0) = −𝑘𝑡 (2.5) 
ln
2[𝛥] − [𝛥]0
[𝛥]0
= −2𝑘𝑡 (2.6) 
ln
[𝛥]0
2[𝛥] − [𝛥]0
= 2𝑘𝑡 (2.7) 
Therefore, a plot of ln
[𝛥]0
2[𝛥]−[𝛥]0
 against t will have a gradient of 2k. A half-life for 
racemisation can also be defined as the time required to reach an enantiomeric 
excess (ee) of 50%. 
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𝑡1
2⁄
=
ln 2
2𝑘
 
(2.8) 
Previous work had measured the racemisation kinetics for the parent complexes 
[EuL6] and [EuL7] (see Fig. 2.28).39 Using the mathematical treatment described 
above, the half lives for racemisation are found to be 74 ± 8 h for [EuL6] and 99 ± 1 
h for [EuL7] in aqueous solution at 60 °C. 
       
 
Figure 2.28 Kinetic plot of the rate of interconversion of enantiomers for [EuL6] and [EuL7] (60 °C, 
H2O). 
Similar experiments were carried out for the phenyl phosphinate complex [EuL2] 
and methyl phosphinate complex [EuL4]. Due to the limited aqueous solubility of 
these complexes, these experiments were performed in methanol. For [EuL4], 
racemisation from the enantiopure Λ-complex (tR ~ 25 min) could be observed over 
the course of a week (see Fig. 2.29), with the appearance of the peak corresponding 
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to the Δ-enantiomer (tR ~ 11 min). Over the same time period, no racemisation was 
observed for Λ-[EuL2] (see Fig. 2.30). Even after 3 weeks, no peak for the Δ-
enantiomer (tR ~ 13 min) could be distinguished from the baseline. 
 
 
Figure 2.29 Stacked chiral HPLC traces monitoring the racemisation of [EuL4] showing the 
appearance of the peak corresponding to the Δ-enantiomer (tR = 10.6 min) as a function of time 
(racemisation in MeOH at 60 °C; CHIRALPAK ID, isocratic MeOH, 1.0 mL/min, 295 K). 
t = 0 h 
t = 24 h 
t = 48 h 
t = 72 h 
t = 96 h 
t = 120 h 
t = 143 h 
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Figure 2.30 Stacked chiral HPLC traces monitoring the racemisation of [EuL2] as a function of time, 
showing only the peak corresponding to the Λ-enantiomer (tR ~ 24 min) (racemisation in MeOH at 60 
°C; CHIRALPAK ID, isocratic MeOH, 1.0 mL/min, 295 K). 
Plotting the proportions of each enantiomer according to Eqn. 2.7 (see Fig. 2.31) 
allows the half life for racemisation for [EuL4] to be found. The result of 180 ± 10 h 
is a factor of two longer than was observed for the parent complexes [EuL6] and 
[EuL7]. Due to the absence of any observable racemisation, no half life could be 
calculated for [EuL2]. 
t = 24 h 
t = 66.5 h 
t = 73 h 
t = 96 h 
t = 144 h 
t = 430 h 
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Figure 2.31 Kinetic plot of the rate of interconversion of enantiomers for [EuL4] (60 °C, MeOH). 
As shown in Section 2.4, interconversion between enantiomers requires 
cooperative arm rotation, inversion of the macrocycle ring, and in the case of 
complexes with phosphinate donor groups, inversion of the configuration at 
phosphorus. The difference in rates of racemisation between [EuL4] and [EuL6] 
could be attributed to the presence of the extended chromophore arms. When 
these extended chromophores are present, the push-pull system creates a larger 
dipole along the chromophore. As a result, the pyridine nitrogen is more 
polarisable, creating a stronger Eu-Npy bond, which would limit the rate of arm 
rotation and inhibit Eu-Npy dissociation. In the case of the phenyl phosphinate 
[EuL2], which exhibits no discernable racemisation over 3 weeks, the stability could 
be attributed to the increased overall rigidity of the complex and the more 
demanding steric nature of the phosphinate group making epimerisation at the 
phosphorus centres less favourable. 
In order to attempt to quantify the activation energy of the racemisation of [EuL4], 
the experiment was repeated at different temperatures. In order to access higher 
temperatures, ethylene glycol was chosen as the solvent. Initial experiments on Δ-
[EuL4] in ethylene glycol at 80 °C showed no appearance of a peak for the Λ-
enantiomer after 120 hours. To rule out that possibility that injecting the complex 
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onto the chiral HPLC column in ethylene glycol was affecting the resolution, a 
sample of racemic complex in ethylene glycol was analysed. Both enantiomers were 
observed, eluting at the same time as when injected in methanol, confirming that 
the appearance of only one peak was due to no racemisation having occurred. 
Therefore, the temperature was increased to 130 °C. Monitoring the racemisation 
for 240 hours showed gradual interconversion of the enantiomers. However, 
plotting the data according to Eqn. 2.7 did not appear to yield a linear relationship 
(see Fig. 2.32). Unfortunately, at later time points, the appearance of other 
overlapping peaks in the chiral HPLC trace suggested that decomposition of the 
complex was occurring. 
 
Figure 2.32 Kinetic plot of the rate of interconversion of enantiomers for [EuL4] (130 °C, ethylene 
glycol). 
These data clearly show that the racemisation of [EuL4] is solvent dependent. These 
well-shielded 9-coordinate complexes are presumed to racemise via a dissociative 
mechanism, rather than a solvent molecule displacing a donor group initiating 
racemisation. Therefore, the slightly increased size of ethylene glycol compared to 
methanol is unlikely to be the reason for the difference in rate. One tentative 
explanation for the slower racemisation is that ethylene glycol is more viscous than 
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methanol. At a molecular level, the energy required to move the chromophore 
arms through the solvent would be higher, making the process slower. 
The stability to racemisation observed for [EuL2] and [EuL4] makes these complexes 
promising candidates for use in a security labelling system. It is unlikely that in a 
‘real world’ setting the complex would ever reach 60 °C. Based on the rule of thumb 
that a reaction rate halves for every 10 °C decrease in temperature, the half-life for 
racemisation of [EuL4] at 20 °C would be of the order of 6600 hours ( = 9 months) in 
methanol solution. As a security label, the complex would be printed onto or 
embedded into a material rather than existing in solution. Moreover, in the solid 
state the rate of racemisation is expected to be much slower than in solution.  
 
2.8 Development of time-gated photography in security labelling 
The aim of the project is to develop a system where a solution-processible chiral 
europium(III) complex can be used to mark a region of interest for use as an 
emissive label. The emissive label should be detectable using a simple assembly 
comprising off-the-shelf components, which could distinguish an enantiopure Eu(III) 
complex from a ‘fake’ emissive label perhaps incorporating organic or transition 
metal red emitting species. It was envisaged that the unique combination of 
excitation wavelength, emission wavelength, lifetime and circular polarisation of 
emission of the Eu(III) complex would be sufficient to distinguish it from a 
counterfeit label.  
As such, the following detection setup was proposed. A digital single-lens reflex 
camera (DSLR) equipped with a xenon flash lamp would form the basis of the 
equipment. Band pass filters could be mounted onto both the flash lamp and 
camera to select the excitation and emission spectral regions of interest. Addition 
of a quarter-wave plate and linear polariser would allow selection of a particular 
circular polarisation of the emission, and a distance-controlled time gate could 
introduce a time-dependence to the measurement. Therefore, a ‘genuine’ 
europium(III) complex possessing a long lifetime, excitation in the correct spectral 
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region and CPL of the correct sign at the selected detection wavelength would be 
observed, while a ‘fake’ which does not possess the same combination of 
properties would not be observed. 
 
Figure 2.33 Off-the-shelf DSLR camera setup allowing wavelength selection and time gated 
photography (A and B), demonstrated with rhodamine B and a 9-N3 based europium complex: (C) 
Standard photograph showing cuvette arrangement; (D) Standard photograph with UV excitation; 
(E) Photograph with the addition of a 600 ± 25 nm band pass filter to the camera and (F) with the 
addition of a time delay before detection. 
Initial testing of the setup described above was carried out using a solution of a 
9-N3 based Eu(III) complex and a solution of the red-emitting organic dye 
rhodamine B (see Fig. 2.33). A 365 ± 25 nm band pass filter was fitted to the flash 
lamp to select for long wavelength UV excitation. With no emission wavelength 
A B 
C D 
E F 
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selection and no time-gating, red emission from both cuvettes was observed, with 
some blue light scattering from the excitation (Fig. 2.33D). Addition of a 600 ± 25 
nm band pass filter to the camera removed this scattered blue light (Fig. 2.33E). 
Finally, addition of the time-gating resulted in selective imaging of the long-lived 
europium(III) emission (Fig. 2.33F).134 
The combination of multiple emissive species with various emission wavelengths 
and lifetimes was expected to allow more complicated security labels to be 
developed. Such an approach could include marking of mixed compounds 
appearing as different colours depending on the use of time gating, or multiple 
spots which appear the same colour but disappear with the introduction of a time-
gate. Obviously, any compound to be used in conjunction with [EuL1-4] would need 
to be excited in the same wavelength range. A variety of complexes was explored 
(see Fig. 2.34) including fluorescent organic molecules, an aluminium 
phthalocyanine dye (kindly donated by Prof. A. Beeby) and three transition metal 
complexes (kindly donated by Prof. J. A. G. Williams), to find a suitable candidate 
for combination with a europium(III) complex in a multi-component security 
marking. 
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Figure 2.34 A range of compounds studied as possible ingredients of a two-component anti-
counterfeiting label. The photophysical properties of fac-Ir(ppy)3, Ir(F2dpyb)(dfppy)Cl and Pt2(2,3-
diphenylpyrazine)(acac)2 are described in detail elsewhere.151–153 
Each transition metal complex is reported to have an emission lifetime of the order 
of a few microseconds and can be excited in the long wavelength UV region. 
Ir(ppy)3 and Ir(F2dpyb)(dfppy)Cl display broad emission bands in the green and 
yellow regions of the spectrum, respectively (see Fig. 2.35). This region corresponds 
to emission observed by the naked eye. Such emission profiles would allow the 
iridium complexes to be used in a two-component security marking based on a 
colour. The complex Pt2(2,3-diphenylpyrazine)(acac)2 emits red light with an 
emission maximum exactly corresponding to the maximum of the ΔJ = 2 transition 
of [EuL1]. Such an overlap would preclude the use of this platinum complex in a 
multi-coloured marking, but the similar overall appearance of the emission to the 
naked eye would still allow its use in markings where differentiation of the 
components was based on lifetime or polarisation of emission.  
 
Figure 2.35 Normalised emission spectra of fac-Ir(ppy)3 (green), Ir(F2dpyb)(dfppy)Cl (orange), Pt2(2,3-
diphenylpyrazine)(acac)2 (brown) and [EuL1] (red), excited at a common wavelength of 356 nm (295 
K, CH2Cl2 except [EuL1] in MeOH). 
A mixture (in appropriate ratios) of a green emitter and a red-emitting europium 
complex would appear yellow to the naked eye, assuming no time-gating. However, 
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on introduction of a time gate, green emission would be lost, leaving just the red 
emission from europium. It might be envisaged that a camera system such as that 
described above could take two images, one without time gating and the other with 
time gating. Comparison of the two images should show two different coloured 
spots for the same region of interest.  
The time-gating method employed in the images in Fig. 2.33 uses the distance 
between the sample and the camera to distinguish between nanosecond 
rhodamine fluorescence and millisecond europium luminescence. Since light travels 
at 0.3 m ns-1, a 5 ns time gate can be introduced with a 1.5 m separation between 
sample and camera. This distance is more than sufficient to gate out rhodamine 
emission. However, transition metal complexes such as those shown in Fig. 2.34 
have lifetimes of the order of a microsecond in degassed dichloromethane. Time-
gating of this magnitude would not be possible using a distance-based method. 
These transition metal complexes could still be used in colour-based security 
markings that do not rely on differentiation of their emission lifetimes from those 
of europium(III) complexes.  However, using this system, it would be possible to 
distinguish microsecond iridium emission from nanosecond fluorescence. 
The sulfonated aluminium phthalocyanine was also investigated as a possible co-
spotting compound. Generally, unsubstituted phthalocyanines are very insoluble, 
but addition of sulfonate groups in this example makes the complex water soluble. 
Phthalocyanines have many modern uses such as in the textiles and paper 
industries as well as their use as dyes in the manufacture of compact discs (CDs). 
This particular phthalocyanine exhibits a broad absorption band centred at 350 nm 
which would allow co-excitation with a pyridylarylalkynyl-based europium complex 
and deep red emission from 660 to 760 nm (see Fig. 2.36). However, it also displays 
absorption bands between 600 and 700 nm, which corresponds to the region in 
which europium emission occurs leading to reabsorption of europium emission by 
the phthalocyanine, thereby reducing emission. Additionally, the region in which 
the phthalocyanine emits is close to the europium emission, meaning 
differentiation of its emission colour by eye might be difficult. Finally, due to its 
strong absorption profile in the red region, the aluminium phthalocyanine appears 
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deep blue to the naked eye. This means that any security label containing it would 
not be invisible in daylight. As a result of these properties, it was ruled out as a 
possible component of the proposed security markings. 
 
Figure 2.36 Absorption (blue) and emission (brown) of the sulfonated aluminium phthalocyanine dye 
(H2O, λexc 350 nm, 295 K) and the emission of [EuL1] (red, MeOH, λexc 356 nm, 295 K). 
With a time-gated multi-coloured security marking still in mind, fluorescent organic 
molecules with emission in the green/yellow region of the spectrum were studied. 
While the major absorption bands for both fluorescein and rhodamine 6G fall in the 
visible region, both can be excited around 350 nm. The broad emission band of 
fluorescein has a maximum at 520 nm (green) with a long tail into the red region of 
the spectrum whilst rhodamine 6G emits around 560 nm (yellow-orange) (see Fig. 
2.37). The absorption bands of both fluorophores are well separated from the 
emission of europium(III), meaning re-absorption of europium(III) emission would 
not occur. Emission from a mixture of rhodamine 6G and europium complex 
appears orange to the naked eye, which may be difficult to distinguish from the 
red-orange emission from europium alone. Therefore, further studies were carried 
out using fluorescein. 
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Figure 2.37 Normalised emission spectra of fluorescein (green, MeOH, λexc 354 nm, 295 K), 
rhodamine 6G (orange, MeOH, λexc 348 nm, 295 K) and [EuL1] (red, MeOH, λexc 356 nm, 295 K). 
Another important factor in the use of a two-component mixture is whether 
europium emission is affected by the addition of a second species. In order to study 
this issue, a titration of fluorescein and [EuL1] was carried out. The internal charge 
transfer absorption band, emission spectrum and emission lifetime of [EuL1] were 
recorded as a function of up to 10 equivalents of added fluorescein. No change was 
observed in the absorption spectrum of the complex. After addition of 10 
equivalents of fluorescein, the emission lifetime of [EuL1] was reduced by 
approximately 15%. However, this effect would not stop this mixture functioning as 
a two-component label as the europium emission lifetime of [EuL1] (1.18 ms in 
MeOH) is still over 200 000 times longer than that of fluorescein (5.49 ns in 
MeOH).154 The emission intensity of [EuL1] at 614 nm was also monitored as a 
function of added fluorescein. A small drop in emission intensity (30%) was 
observed until approximately two equivalents of fluorescein had been added. As 
more fluorescein was added, the emission intensity of [EuL1] began to recover. 
These changes in emission intensity were not accompanied by a change in spectral 
form, which suggests that the inner coordination environment is not affected. Since 
no changes were observed in the absorption spectra of [EuL1] on addition of 
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fluorescein, it is unlikely that fluorescein is interacting significantly with the 
extended chromophores of the complex by a π-stacking interaction, for example. It 
is possible that some other long range interaction is responsible for this quenching 
behaviour. In any case, the quenching behaviour in solution cannot be used to 
accurately predict the effect of a mixture of fluorescein and europium complex on a 
surface in the solid state. Based on these results, it does not appear that emission is 
quenched to such an extent that the mixture could not be used as a two 
component system. 
In order to test the applicability of fluorescein and a europium(III) complex in a two 
component multi-coloured time dependent security marking, a proof of concept 
test paper was designed (see Fig. 2.38). Non-brightened paper (Canson Infinity Rag 
Photographique 2010 g/m2) was used to ensure that fluorescence interference 
from brightening agents used in standard printer paper would not affect the 
measurements. The test paper possessed three spots. The left-hand spot contained 
[EuL1], the right-hand spot contained fluorescein, while the central spot was a co-
spot of [EuL1] and fluorescein. Each spot was deposited onto the paper as a solution 
in methanol using a TLC capillary spotter, before being allowed to dry in air. It was 
envisaged that images recorded without a time delay would show three spots (red, 
yellow and green), while images recorded with the time gating would show only 
two red spots.  
 
Figure 2.38 Left: proposed layout of test paper for a two-component security marking using time-
gated photography, comprising [EuL1], fluorescein and a co-spot. Right: the expected appearance of 
the test paper using time-gated photography. 
Initial tests confirmed that the addition of a 600 ± 25 nm band pass filter to the 
camera was not sufficient to remove the fluorescein emission from the image. This 
result was expected, based on the emission spectral profile of fluorescein (see Fig. 
2.37) as it exhibits a long tail into the red region of the spectrum, despite the overall 
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fluorescence appearing green. As expected, on introduction of the distance-based 
time gate, the fluorescein spot disappeared fully (see Fig. 2.39).134 
 
Figure 2.39 Left: photograph of the two-component test paper under UV excitation with no 
wavelength selection or time gating. Right: the same test paper after introduction of a time gate and 
a 600 ± 25 nm band pass filter. 
Spectral imaging of the central spot of the paper with and without a time gate 
confirmed that the fluorescein emission could be removed from the spectral profile 
(see Fig. 2.40). The lifetime of the [EuL1] emission was also measured and found to 
be 1.02 ms, similar to that observed in methanol solution. 
 
Figure 2.40 Spectral imaging of the central test paper spot before (yellow) and after (red) addition of 
a time gate. Introduction of the time gate removes the broad fluorescein emission band. 
To confirm the applicability of these complexes as chiroptical labels in the solid 
state, total emission and CPL spectra were recorded of spots of enantiopure [EuL2] 
deposited onto paper (see Fig. 2.41). The total emission and CPL spectra of [EuL2] 
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on the paper show very similar profiles to the spectra acquired in methanol 
solution. The only difference is the relative intensity of the CPL transition at 614 nm 
which is stronger in the solid state than in solution. 
 
 
Figure 2.41 Total emission (top) and CPL spectra (bottom) of the Δ- (red) and Λ- (blue) enantiomers 
of [EuL2] deposited on non-optically brightened paper (295 K, λexc 342 nm, 3 scans averaged). 
In addition to the test paper, the enantiomers of the complex [EuL2] were doped 
into poly(methyl methacrylate) (PMMA) and deposited as thin films on quartz discs 
(for details of the preparation of these films, see Chapter 5). In these preliminary 
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experiments, controlling the homogeneity of the film was challenging, although 
films suitable for CPL spectral acquisition were produced. The appearance of the 
excitation, total emission (Fig. 2.42) and CPL spectra (Fig. 2.43) in these films was 
very similar to that observed in solution, and the emission dissymmetry values were 
consistent with those observed in methanol solution. As in methanol solution, the 
5D0 → 7F5 manifold and various manifolds corresponding to emission from the 5D1 
state were visible (Fig. 2.42). An emission lifetime of 1.15 ms was observed from 
the immobilised complex, consistent with that observed in solution. 
 
Figure 2.42 Total emission spectrum (top) of 1% [EuL2]-doped PMMA film, deposited on a quartz 
disc, with circled regions expanded (bottom) (295 K, λexc 342 nm). 
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Figure 2.43 The CPL spectra of the Δ- (red) and Λ- (blue) enantiomers of [EuL2] in a PMMA film 
deposited on a quartz disc (295 K, λexc 342 nm). Selected gem values for Δ-[EuL2]: -0.45 (557 nm); 
+0.18 (599 nm); -0.18 (655 nm); -0.38 (708 nm).  
A second test paper was designed for the purpose of incorporating chiroptical 
selection into the photographic detection method (see Fig. 2.44). The 
phenylphosphinate complexes [EuL1] and [EuL2] show strong CPL signals in the ΔJ = 
1 manifold. Importantly, in this region all the transitions show CPL signals of the 
same sign, i.e. all positive or all negative. Such a feature presents a useful target for 
CPL detection using the camera. Using a band pass filter to select the ΔJ = 1 region, 
in combination with a quarter-wave plate and linear polariser to select for CPL sign, 
it was predicted that spots of enantiopure Eu(III) complex could be distinguished 
from each other by their emission polarisation. As such, a series of three spots, 
comprising enantiopure Λ- and Δ-enantiomers along with racemic complex, would 
appear differently under different chiroptical selection properties. For example, in 
both [EuL1] and [EuL2], positive CPL is emitted in the ΔJ = 1 transition of the Δ-
enantiomer, while negative CPL is emitted by the Λ-enantiomer. Therefore, 
orientating the linear polariser such that left-handed CPL is collected by the camera, 
should allow the spot containing the Δ-enantiomer to be selectively imaged, and 
vice versa. The racemic complex would be observed in both images. 
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Figure 2.44 Left: a test paper for chiroptical contrast photography comprising two spots of 
enantiopure complex and a central spot of racemic complex. Centre and right: the expected 
appearance of the test paper while selecting for positive or negative CPL, respectively. 
Unfortunately, addition of the quarter-wave plate and linear polariser reduced the 
light reaching the camera CCD to such an extent that the spots were too dim for 
chiroptical discrimination to occur. It is possible that more concentrated spots of 
complex could allow successful chiroptical discrimination using this setup, but lack 
of light due to additional filters being used will always be a limiting factor in these 
measurements.  
2.9 Time-gated chiral contrast microscopy 
After the difficulties encountered in chiroptical discrimination using an off-the-shelf 
camera setup, it was decided to attempt to observe chiral contrast imaging by 
microscopy. Modification of a time-resolved Zeiss Axiovert 200M epifluorescence 
microscope to allow chiroptical contrast detection was achieved by careful 
consideration of the components in the pathway of the emitted light. The 
microscope is equipped with a variable pulse sequence generator, permitting 
control of the excitation pulse and emission collection, which allows both 
continuous and time-gated imaging. Emitted light is guided to the detectors, which 
consist of separate CCDs for imaging and spectral measurement, as well as a 
photomultiplier tube for measuring emission lifetime. Since the microscope was 
originally set up for measurements of biological samples, it contains a de 
Sénarmont compensator. Normally, this component is used to account for 
elliptically polarised light generated when linearly polarised incident light is 
transmitted through a biological sample. It contains a rotatable quarter-wave plate 
and linear polariser combination to convert elliptically polarised light back to 
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linearly polarised light for imaging. Obviously, such a component would significantly 
affect the ability for chiroptical selection, making its removal a vital requirement in 
this setup.134 
Addition of a band pass filter in the path of the emitted light allows wavelength 
selection, before the emitted light is guided through a broad wavelength (400-800 
nm) quarter-wave plate, allowing translation of circularly polarised light into 
linearly polarised light. Left-handed CPL is translated to vertical linearly polarised 
light, while right-handed CPL is translated to horizontal linearly polarised light. 
Unfortunately, the small size (10 mm) of the commercially available quarter-wave 
plate restricts the size of the aperture. To overcome the potential loss of signal, a 
beam expander lens and a pair of variable irises were inserted to compensate for 
the small size of the aperture. The final element in the optical setup is a pair of 
linear polarisers, orientated at 90° to each other, and mounted in a sliding holder, 
allowing simple swapping between detection of either the horizontal or vertical 
linear polarised light generated by the quarter-wave plate. The selected linearly 
polarised light is then focused onto the CCD for image acquisition.134 
 
Figure 2.45 Schematic diagram of chiroptical microscopy setup, showing various optical components 
required for the discrimination of circularly polarised light. In this diagram, circularly polarised 
emitted light (represented by the orange and blue lines) is converted to perpendicular linearly 
polarised light (represented by red and green lines). The sliding linear polarisers allow only one 
perpendicular component to reach the CCD detector. 
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Image acquisition using this optical setup was achieved using pulsed excitation from 
a 365 nm UV-LED, followed by time gating (typically 6-10 μs) with images collected 
for 7.2 ms per frame. Images were collected using an accumulation sequence, 
allowing frames to be averaged using a saturation limiting algorithm. Using this 
algorithm, images were accumulated until a predefined maximum contrast value of 
255 was reached for a cluster of 20 pixels. Any difference in polarised emission (as 
defined by the gem value at a particular wavelength) is amplified, as the total 
contrast in the accumulated image is proportional to the number of images 
acquired. The total number of images acquired was governed by the maximum 
single image brightness; this was set automatically to be a minimum of five times 
the signal to noise ratio. 
Various microscopy images were recorded using this system, demonstrating both 
time-gating and chiroptical selection (see Fig. 2.46). In each case, the samples were 
deposited onto non-optically brightened paper as solutions in methanol and 
allowed to dry in air. Areas of similar brightness were selected and well-defined 
rectangular pieces were cut using a dye punch. These pieces were mounted onto a 
microscope slide and covered with a coverslip. Microscopy images (Figure 2.46A 
and B) show racemic [EuL1] and fluorescein and demonstrate that the time gating 
shown in Fig. 2.39 is also possible using optical microscopy. Figure 2.46C-F shows 
the development of the chiroptical contrast system using the two enantiomers of 
[EuL2]. In Fig. 2.46C, the time-resolved image of the Λ- (top) and Δ- (bottom) 
enantiomers of [EuL2] is revealed, demonstrating that with no chiroptical selection, 
both pieces of paper exhibit equal image contrast. Introduction of a band pass filter 
selective to the ΔJ = 1 region of the europium(III) emission (Fig. 2.46D), does not 
affect the relative contrast of the two pieces of paper. In Fig. 2.46E and F, selection 
of horizontal and vertical linearly polarised light, respectively, shows differential 
image contrast between the two pieces of paper. In image E, where horizontal 
linearly polarised light is selected, the top piece of paper (Λ-[EuL2]) appears 
brighter. Since horizontal linearly polarised light originates from the right-handed 
CPL, this corresponds to a negative CPL signal. Λ-[EuL2] has a strong negative CPL 
signal in the region of interest, consistent with the microscopy images. The reverse 
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behaviour is observed in image F, when selecting for vertical linearly polarised light 
(= left-handed CPL) as the lower piece of paper with Δ-[EuL2] appears brighter. In 
the control experiment, racemic [EuL1] gave rise to constant image brightness, 
irrespective of which chiroptical channel was selected.134  
 
Figure 2.46 Microscopy images following sample excitation using a 365 nm UV-LED (tacq. = 7.2 
ms/frame, 395 nm dichroic mirror, λem LP-420 nm) of fluorescein, Λ- and Δ- europium(III) complex 
recorded on a custom-built microscope incorporating a chiroptical selector unit. (A) Ungated image 
of (top) racemic [EuL1] (1:1) and (bottom) fluorescein, using 10 frame accumulation imaging 
sequence. (B) Time-resolved image of (top) Λ– and Δ-[EuL1] (1:1) and (bottom) fluorescein (td = 6 μs, 
λem LP-420 nm, 50 frame acc.). (C) Time-resolved image of (top) Λ-[EuL2] and (bottom) Δ- [EuL2] (td = 
6 μs, λem LP 420 nm, 70 acc.). (D) Time-resolved image of (top) Δ-[EuL2] and (bottom) Λ-[EuL2] (td = 6 
μs, λem BP 595/10 nm, 150 frame acc.). (E) Time-resolved image of (top) Λ-[EuL2] and (bottom) Δ-
[EuL2] using the RIGHT (horizontal polarisation) circularly polarised light chiroptical channel (td = 6 
μs, λem BP-589/20 nm, 370 frame acc.; contrast ratio CR Λ : Δ = 3.23 : 1) (F) Time-resolved image of 
(top) Λ-[EuL2] and (bottom) Δ-[EuL2], using the LEFT (vertical polarisation) circularly polarised light 
channel (td = 6 μs, λem BP-589/20 nm, 370 frame accumulations; contrast ratio, CR Λ : Δ = 1 : 3.64). 
Despite the relatively small gem values, the optical setup, in combination with the 
saturation limiting algorithm, provides contrast ratios in excess of 3:1 when 
observing enantiopure lanthanide complexes. Although discrimination of chiral 
molecules has been demonstrated on chiral liquid crystals using scanning tunnelling 
microscopy,155,156 and on surfaces patterned with chiral molecules by chemical 
force microscopy,157 to the best of our knowledge, this is the first time that chiral 
image contrast in optical microscopy has been experimentally validated. This 
experimental set up is unlikely to permit chiroptical discrimination of chiral organic 
molecules, where the gem values are 100 times smaller.  
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Attempts to repeat the above microscopy experiments using the doped polymer 
films were hampered by microscopic surface inhomogeneity. Very small variations 
in the thickness of the film introduced difficulty in simultaneous imaging of both 
films in the same focal plane. Due to this inhomogeneity, some regions of the film 
appeared brighter than others, making comparison of the chiral contrast 
challenging. 
2.10    Conclusions and Future Work 
Novel, highly emissive chiral europium complexes, [EuL1] and [EuL2], based on 9-N3 
macrocycles bearing pendant pyridylarylalkynyl chromophore arms have been 
synthesised and characterised. Their photophysical properties have been measured 
and were found to be consistent with related complexes previously synthesised in 
Durham. Their absorption maxima make them amenable to excitation at 355 or 365 
nm using commonly available light sources. Coupled with high quantum yields and 
molar extinction coefficients, this makes them ideal candidates for use as emissive 
security labels. 
The complexes [EuL1-4] have been successfully resolved by chiral HPLC and their CPL 
spectra were obtained. The enantiomers of each complex exhibit strong mirror 
imaged CPL spectra which correlate well in form and sequence with the parent 
complexes that do not possess the extended chromophore arm. Increased 
resolution in all transitions (ΔJ = 1, 2, 3, 4) has been observed in the CPL spectra 
when compared to total emission. Large emission dissymmetry values have been 
observed in the CPL spectra all four complexes. Additionally, the 5D0 → 7F5 
transition and various 5D1 → 7FJ transitions have been observed in both total 
emission and CPL emission in solution and doped into PMMA films. 
An alternative synthetic route to complexes with carboxylate donors was 
investigated, which would allow chiral resolution of an intermediate complex, prior 
to further functionalisation. The solubility of the intermediate complex made it 
difficult to handle, although Sonogashira couplings were achieved in DMSO 
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solution, allowing the synthesis of a novel carboxylate complex [EuL12], whose 
photophysical properties were consistent with similar carboxylate complexes.  
The racemisation kinetics of the methyl and phenyl phosphinate complexes were 
investigated, showing that in methanol solution, the half-life for racemisation of 
[EuL4] at 60 °C was 180 ± 10 h, considerably longer than for the parent system. No 
racemisation was observed for [EuL2] after 3 weeks under the same conditions. 
Repeating the experiments at 80 °C and 130 °C in ethylene glycol showed that the 
rate of racemisation is clearly solvent dependent, which is an area for future 
investigation, as it may aid in the elucidation of the racemisation mechanism. 
Further investigations need to be made into the racemisation kinetics of these 
complexes at various temperatures and in various solvents. 
Various time-gated photography experiments have been carried out, with 
combinations of europium(III) complexes and fluorescent organic molecules using 
an off-the-shelf camera system. Short-lived organic fluorescence could be 
distinguished from longer lived europium(III) emission both in solution and in the 
solid state. Multi-coloured markings comprising a mixture of emissive components 
have been used to demonstrate colour and lifetime-based discrimination using the 
camera system. 
Finally, time-gated chiral contrast microscopy has been demonstrated using a 
custom-built microscope equipped with a quarter-wave plate and linear polariser 
combination. The system was able to discriminate between regions of paper 
marked with enantiopure europium(III) complexes emitting equal and opposite CPL. 
By selecting a spectral region of interest and converting left- and right-handed CPL 
to vertical and horizontal linearly polarised light, chiral contrast images can be 
accumulated with contrast ratios in excess of 3:1. 
Further development of the deposition of complex-doped polymers is required 
before such substrates can be used successfully in chiral contrast microscopy. Spin-
coating a sol-gel containing emissive complexes onto quartz discs has been 
achieved previously in the group,158 and such a method might prove successful 
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here, allowing homogeneous films to be produced. The preliminary work described 
here has shown that the desirable photophysical properties and strong polarised 
luminescence of the complex [EuL2] are retained once immobilised in the polymer, 
suggesting that deposition of the complex in polymers warrants further 
investigation.  
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CHAPTER THREE : SOLVENT EFFECTS IN Ln(III) EMISSION  
3.1 Introduction 
Solvatochromism in internal charge transfer transitions is a much-investigated 
phenomenon. The energy of the internal charge transfer excited state is dependent 
on its environment, including factors such as temperature and solvent polarity. 
Recent work on the 9-N3 based pyridylarylalkynyl family of europium(III) complexes 
has shown that the wavelength of the absorption maximum varies with solvent 
polarity.29,137,159 In these studies, bathochromic shifts were observed for the 
internal charge transfer absorption bands as solvent polarity was increased. Such 
behaviour can be attributed to the dipole of the polar solvents coupling with the 
dipole of the extended chromophore, thereby stabilising the chromophore excited 
state. As a result, the excited state is lower in energy, causing a shift to lower 
energy (longer wavelength) in the excitation band.  
Although the absorption behaviour of these complexes has been studied in some 
detail, a thorough investigation of the emission profiles of these complexes has not 
been carried out. Recent work by the group of Faulkner has demonstrated 
solvatochromism in the emission from bimetallic Eu/Tb complexes in various 
solvents.160 On changing from acetonitrile to methanol to water, the emission from 
Eu(III) was quenched whilst the emission from Tb(III) showed little change. In this 
instance, the effect was attributed to a combination of differences in O-H oscillator 
quenching efficiency of the excited state of the two metals by the different 
solvents, and also to subtle changes in molecular conformation affecting the ability 
of the chromophore to sensitise europium(III) emission. In this case, the change in 
conformation was such that the distance between the chromophore and the metal 
centre was varied significantly. However, it might be expected that more subtle 
changes in molecular geometry would effect modulation of emission behaviour, 
especially for the hypersensitive transitions of europium(III).  
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Sensitisation of europium(III) emission by pyridylarylalkynyl chromophores is known 
to occur via an internal charge transfer transition that is solvent-dependent. 
Therefore, it is reasonable to hypothesise that in solvents of different polarity, the 
electron distribution in the chromophores is affected. Such a change will influence 
the polarisability of the pyridine nitrogen atom, and hence the strength of the Eu-
Npy bond. Additionally, interactions such as hydrogen bonding to the phosphinate 
donor groups may also contribute to small differences in complex geometry. Minor 
changes in the environment of the metal centre can result in modification of the 
fine structure of the emissive manifolds. As such, the emission behaviour of several 
compounds in various solvents has been investigated. In each case, total emission 
and CPL spectra were recorded in a variety of solvents spanning a wide range of 
polarities and viscosities. 
Solvent polarity can be classified using Reichardt’s solvent polarity parameter ET, 
based on the transition energy for the longest-wavelength solvatochromic 
absorption of a pyridinium-N-phenoxide betaine dye (see Fig. 3.1). Originally, this 
solvent polarity parameter was simply defined as the energy of the absorptive 
transition (in kcal mol-1). Subsequently, these parameters have been normalised to 
the extreme values of the reference solvents, water and tetramethylsilane, such 
that water has a value of 1.000 and tetramethylsilane has a value of 0.000 on the 
𝐸T
N scale. The Reichardt solvent polarity parameters, 𝐸T
N, for the solvents used in 
this work are shown in Table 3.1, as well as their respective viscosities at 298 K. 
 
Figure 3.1 The structure of the pyridinium-N-phenoxide betaine dye used in the calibration of 
Reichardt’s solvent polarity parameters. 
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Table 3.1 Solvent polarity parameters and viscosities for the range of solvents 
used in this work. 
Solvent Reichardt solvent 
polarity parameter,161 
𝑬𝐓
𝐍 
Viscosity at 25 °C162 / 
mPa s 
Water 1.000 0.890 
2,2,2-Trifluoroethanol (TFE) 0.898 1.84a 
Methanol (MeOH) 0.762 0.544 
Ethanol (EtOH) 0.654 1.074 
Isopropanol (IPrOH) 0.546 2.038 
Acetonitrile (MeCN) 0.460 0.369 
Dimethylsulfoxide (DMSO) 0.444 1.987 
N,N-Dimethylformamide (DMF) 0.404 0.794 
Tert-butanol (tBuOH) 0.389 4.312 
Acetone 0.355 0.306 
Dichloromethane (DCM) 0.309 0.413 
Chloroform 0.259 0.537 
a From Ref. [163]  
 
3.2 Solvent effects in the emission and CPL of [EuL2] 
3.2.1 Solvent effects in the total emission of [EuL2] 
Initially, [EuL2] was selected for study as it was the brightest of the four complexes 
[EuL1-4]. Additionally, the presence of the phenyl phosphinate donor group was 
expected to allow solubility in a greater range of solvents (notwithstanding its lack 
of solubility in water). As expected, the complex [EuL2] exhibited solvatochromism 
in absorption, with the absorption maximum varying from 322 nm in acetone to 
343 nm in 2,2,2-trifluoroethanol (TFE). No obvious trend in emission lifetime was 
observed with changing solvent polarity or viscosity.  
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In the total emission spectrum, there were significant changes in the spectral form 
(see Fig. 3.2). In the ΔJ = 2 manifold, the strongest transition around 614 nm 
(transition A, Fig. 3.3) showed little variation, but the two longer wavelength 
components (B and C) showed both changing position and intensity ratio. On 
moving from polar protic solvents (e.g. MeOH) to non-polar solvents (e.g. CHCl3), 
the two components appeared to move apart with the left-hand transition B 
moving to shorter wavelength and the right hand transition C moving to longer 
wavelengths (see Fig. 3.3). Additionally, the relative intensity of these two 
transitions varied considerably. As solvent polarity decreased, the longer 
wavelength transition C became less intense compared to transition B.  
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Figure 3.2 The total emission spectra of [EuL2] in various solvents (295 K, excitation at absorption 
maximum in each solvent). Spectra are normalised to the integrated emission intensity of the ΔJ = 1 
manifold. 
 
Figure 3.3 Expanded emission spectra of [EuL2] in various solvents in the ΔJ = 2 manifold. Transitions 
are labelled as described in the text. 
A 
B 
C 
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The variation of the intensity ratios between the major transition (A, 614 nm) and 
transition B (approx. 617 nm), and between transitions B and C (approx. 621 nm), 
with Reichardt’s normalised solvent polarity parameter, showed correlations with 
solvent polarity in each case (see Fig. 3.4). In each case, the ratios for DMF (𝐸T
N = 
0.404) appeared to be anomalous. Additionally, the ratios in chloroform (𝐸T
N = 
0.259) do not ‘fit’ the apparent trend. It is possible that these anomalies point 
towards specific solvation effects in these solvents, rather than their behaviour 
being governed simply by solvent polarity. However, the overall trends suggest that 
the energies of transitions B and C are primarily determined by solvent polarity, and 
that the intensities of transitions A and C are more susceptible to variation in 
solvent polarity than transition B. The overall integrated emission intensity ratio for 
the ΔJ = 2 vs. ΔJ = 1 manifolds exhibits a modest increase with increasing solvent 
polarity, consistent with enhanced ligand polarisability in more polar media. 
 
Figure 3.4 Ratios of the intensity of emissive transitions A vs. B (orange) and B vs. C (green) as a 
function of solvent polarity.  
Similar behaviour was observed in the behaviour of the ΔJ = 4 manifold (see Fig. 
3.5). In this case, the longest wavelength transition, F, exhibits a bathochromic shift 
as solvent polarity decreases, while transitions D and E appear to coalesce, and 
increase in intensity. The weak transitions between 702 and 715 nm were not 
investigated in detail. Whilst the ΔJ = 4 manifold is not strictly hypersensitive (it 
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does not meet the selection rule for hypersensitive transitions), the intensities of 
the transitions are still sensitive to local environment. The significant modulation in 
spectral form of the ΔJ = 4 manifold is consistent with variations in local polarity 
causing both intensity changes and changes to the energies of various crystal field 
states of the 7F4 level. Although it is unlikely that the molecular conformation is 
modified to any great extent, this behaviour could be tentatively attributed to small 
changes in metal-ligand bond distances. 
 
Figure 3.5 Expanded emission spectra of [EuL2] in various solvents in the ΔJ = 4 manifold. Transitions 
are labelled as described in the text. 
The ratio of the intensity of the major transition, E, against the lower energy 
transition F showed a non-linear decrease as solvent polarity was increased (see 
Fig. 3.6). Similarly, the intensity of the major transition, E, relative to the intensity of 
the magnetic dipole allowed transition ΔJ = 1, which is supposedly largely 
independent of the environment, exhibits the same decrease. Both relationships 
appear to level off as solvent polarity increases beyond 𝐸T
N = 0.6, suggesting that a 
limit is reached where increasing solvent polarity cannot induce further spectral 
change. Unfortunately, since the complex is not soluble in water, it was not possible 
D 
E 
F 
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to obtain further data points in more polar solvents. Common laboratory chemicals 
with 𝐸T
N values between methanol and water were either solids at room 
temperature (e.g. phenol) or had boiling points too high to allow recovery of 
material (e.g. glycerol).  
 
Figure 3.6 Ratios of the intensity of emissive transitions E vs. F (light blue) and E vs. ΔJ = 1 at 593 nm 
(purple) as a function of solvent polarity. 
Judd-Ofelt theory is commonly invoked to rationalise the intensity of various 
transitions in europium(III) emission spectra.164,165 However, these mathematical 
models of dipole strength fail to account for the hypersensitive nature of certain 
Ln(III) transitions.2 Whilst the observed hypersensitive transitions do obey the 
selection rules for electric quadrupole transitions, the magnitudes of the 
hypersensitive transitions far exceed those predicted for quadrupole transitions.166  
As such, an alternative explanation can be proposed, where the electric quadrupole 
allowed transition (5D0 → 7F2) gains dipole strength via coupling to a lanthanide 
quadrupole-induced dipole on the ligand.167 In systems which are not cylindrically 
symmetric, it is necessary to include the anisotropy of the ligands in calculated 
oscillator strengths for hypersensitive transitions.168 Therefore, the intensity of 
these hypersensitive transitions is related to the polarisability of the ligand dipole, 
and is sensitive to the anisotropy of this polarisability. Thus, small variation in 
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solvation and coupling of solvent dipoles with ligand dipoles may account, in part, 
for the change in intensity of certain transitions in manifolds that are sensitive to 
environment. 
3.2.2 Solvent effects in the CPL of [EuL2] 
In addition to the modulations of the total emission spectral profile for [EuL2] in 
different solvents, changes in the spectral form of the CPL emission have also been 
studied. As discussed previously, the CPL can often provide increased resolution of 
transitions close in energy, as they may have opposite sign. However, it must be 
noted that the factors controlling CPL signal intensity are not the same as those 
regulating the oscillator strength of total emission bands.143  
The CPL spectrum of Λ-[EuL2] was recorded in ten different solvents (Fig. 3.7). 
Several transitions appear to change sign in different solvents. In particular, the 
somewhat broad ΔJ = 1 manifold appears to resolve into two transitions of opposite 
sign in TFE (see Fig. 3.8). Had more polar solvents been available, it might be 
expected that this transition would continue to become more positive with 
increasing polarity. However, as discussed in Section 3.2.1, spectra in more polar 
solvents could not easily be obtained. It has already been noted in the methyl 
phosphinate analogues that transitions of opposite sign were observed in the ΔJ = 1 
manifold in methanol. It is possible that in more polar solvents, the phenyl 
phosphinate complexes are either conformationally or electronically more similar 
to the methyl phosphinate analogues, which could explain the emergence of similar 
spectral profiles.  
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Figure 3.7 Circularly polarised emission spectra of Λ-[EuL2] in various solvents (295 K, excitation at 
absorption maximum in each solvent). Spectra are not normalised. 
 
Figure 3.8 Expanded circularly polarised emission spectra of Λ-[EuL2] in various solvents in the ΔJ = 1 
and 2 manifolds. 
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A similar effect can be seen in the ΔJ = 2 manifold (see Fig. 3.8). As solvent polarity 
increases, the intensity of the major transition at 613 nm decreases, accompanied 
by the appearance of a negative CPL transition visible for ethanol, methanol and 
trifluoroethanol. Such behaviour is in contrast to the changes of the same transition 
in the total emission spectrum (Fig. 3.3, A), where the total intensity increased as 
solvent polarity increased. As such, the magnitude of the emission dissymmetry 
factor, gem of this transition decreases by a factor of 10, on changing from 
chloroform to TFE, which can be rationalised by considering the factors controlling 
the magnitude of gem (see Eqn. 3.1). 
𝑔em = 4
|𝐦𝒊𝒋|
|𝛍𝒊𝒋|
cos 𝜃𝛍,𝐦 (3.1) 
The oscillator strength of a transition is proportional to the square of the transition 
dipole moment, meaning an increase in the magnitude of the electric dipole 
transition moment, |μ|, leads to increased total emission intensity in response to 
varying solvent polarity. However, the magnitude of gem will reduce. It is unlikely 
that the magnitude of |m| is as dependent on solvent polarity and minor changes 
in θ would not be sufficient to change gem significantly. 
Changes can also be observed in the circularly polarised emission of the ΔJ = 4 
manifold (Fig. 3.9). However, in this case, the behaviour in response to changing 
solvent polarity appears to be reversed, compared to that seen in the ΔJ = 1 and ΔJ 
= 2 manifolds. Here, the CPL intensity decreases as solvent polarity increases. 
Whilst the two shorter wavelength transitions do not coalesce as they do in the 
total emission, it is evident that they are closer in energy in non-polar solvents, such 
as chloroform and dichloromethane, than in polar solvents, such as methanol and 
ethanol. Interestingly, in the total emission, some transitions within the manifold 
increased in intensity with changing solvent polarity, while others decreased. The 
general trend in the CPL spectra is that all components of the manifold decrease in 
intensity as solvent polarity decreases.  
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Figure 3.9 Expanded circularly polarised emission spectra of Λ-[EuL2] in various solvents in the ΔJ = 4 
manifold. 
It is evident from comparing the spectra that the ΔJ = 4 manifold responds to 
changes in solvent polarity quite differently from the ΔJ = 1 and 2 manifolds.  
A plot of the intensity ratio of the CPL at 593 nm (ΔJ = 1) to the CPL at 613 nm (ΔJ = 
2) versus the solvent polarity (Fig. 3.10, green) shows an increase which is initially 
gradual, but becomes steeper at higher solvent polarity. It is possible that the series 
of alcohols (isopropanol, ethanol, methanol and trifluoroethanol) which correspond 
to the solvents with polarities above 𝐸T
N = 0.50, display more specific hydrogen 
bonding interactions with the complexes than the less polar aprotic solvents. Such a 
difference may account for the change in gradient of the plot. When comparing the 
relative intensities of the major transitions of the ΔJ = 1 or 2 manifolds against the 
ΔJ = 4 transitions, it is clear that the ratios both decrease as solvent polarity 
increases (Fig. 3.10, purple and orange). The biggest change is observed when 
comparing ΔJ = 2 and ΔJ = 4, where in chloroform the ΔJ = 2 CPL is more than 6 
times more intense than ΔJ = 4. In trifluoroethanol, the ratio is almost reversed with 
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ΔJ = 4 approximately 5 times more intense than ΔJ = 2. Plots such as these could be 
used as calibration curves for use of these complexes as solvent polarity probes. 
 
Figure 3.10 Ratios of the intensity of various CPL transitions as a function of solvent polarity: 
593 nm / 613 nm (green); 593 nm / 690 nm (purple); and 613 nm / 690 nm (orange). 
3.2.3 Chiral additives 
Since it was evident that changing solvent polarity affected both the energy of 
some transitions, and their intensities in both CPL and total emission, it was 
hypothesised that addition of chiral solvent may induce a modulation in the 
spectral form of the CPL. Preliminary experiments had shown that addition of very 
small amounts of achiral polar solvent (e.g. MeOH) to [EuL2] dissolved in less polar 
solvent (e.g. CHCl3) led to the spectral form resembling those observed in the more 
polar solvent. Molecular structures of various parent systems obtained by X-ray 
crystallography have shown that polar protic solvents (MeOH and water) 
preferentially solvate the complexes via hydrogen bonding to the oxygen atoms in 
the phosphinate donor groups. Interactions such as these are not possible with 
aprotic solvents. Therefore, it was envisaged that addition of a chiral protic solvent 
to a complex dissolved in an aprotic solvent may induce changes in spectral form by 
differential solvation of the complex.  
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In order to test such a hypothesis, the complex [EuL2] was dissolved in a non-polar 
aprotic solvent and a polar protic chiral additive was added in small aliquots. After 
each addition, CPL and total emission spectra were recorded. Since extinction 
coefficients had not been obtained in all solvents, samples of complex were 
prepared in methanol and the absorbance of these solutions was used to calculate 
the concentration of complex.  
Initially, (R)-1-phenylethanol was added to solutions of Δ- and Λ-[EuL2] in THF. 1-
Phenylethanol was chosen as it was expected that the significant difference in the 
size of the substituents around the chiral centre would cause certain 
diastereoisomeric interactions to be favoured, leading to a change in the CPL form. 
In the total emission spectrum, no change in form was observed, but a small 
decrease in intensity was evident across all the bands after addition of 50 
equivalents of (R)-1-phenylethanol (see Fig. 3.11).  
 
Figure 3.11 Total emission spectra of Λ-[EuL2] in THF and with additions of (R)-1-phenylethanol (295 
K, λexc 340 nm). 
In the CPL spectra of both enantiomers of [EuL2] after addition of (R)-1-
phenylethanol, no change in spectral form was observed, even after the addition of 
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50 equivalents (see Fig. 3.12). Again, there was a small reduction in overall 
intensity, which could be explained by the small increase in volume caused by the 
addition of the chiral alcohol.  
 
Figure 3.12 CPL spectrum spectra of Δ- and Λ-[EuL2] in THF and with additions of (R)-1-
phenylethanol (295 K, λexc 340 nm). 
Since 1-phenylethanol did not stimulate a change in spectral form, it was decided to 
repeat the experiment with a more polar chiral additive. Again, an additive with 
large substituents on the chiral carbon was chosen to maximise the potential 
difference in diastereomeric interactions. As such, aliquots of (S)-
hexahydromandelic acid were added to solutions of both enantiomers of [EuL2]. 
Again, no change in spectral form in total emission (see Fig. 3.13) or CPL (Fig. 3.14) 
was observed for either enantiomer on addition of (S)-hexahydromandelic acid. A 
small decrease in intensity was again observed, consistent with the increased 
sample volume.  
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Figure 3.13 Total emission spectra of Λ-[EuL2] in CHCl3 and with additions of (S)-hexahydromandelic 
acid (295 K, λexc 340 nm). 
 
Figure 3.14 CPL spectra of Δ- and Λ-[EuL2] in CHCl3 and with additions of (S)-hexahydromandelic acid 
(295 K, λexc 340 nm). 
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The lack of observable change in total emission or CPL spectral form for [EuL2] on 
addition of 1-phenylethanol and hexahydromandelic acid, even in large excess, 
suggests that the complex is sufficiently rigid such that addition of chiral additives 
does not disrupt the structure of the lowest energy molecular conformation 
sufficiently to modulate the emission. Similarly, addition of polar protic solvents 
does not appear to overcome the solvation by the bulk non polar aprotic solvents. It 
is possible that this is due to the low concentrations of the chiral additives, even at 
50 equivalents. If the molecules of chiral additive preferentially interact with each 
other rather than hydrogen bonding to the complex, then the complex will remain 
effectively solvated by the bulk solvent, and so no modulation of emission would 
occur.  
3.3 Solvent effects in the total emission and CPL of [EuL6] 
Since the work on [EuL2] had provided clear evidence of solvent dependent 
emission, it was decided to investigate whether the same behaviour is observed in 
the parent system [EuL6]. Since this complex does not possess an extended 
chromophore, it does not sensitise the metal through an internal charge transfer 
transition, and excitation occurs via the traditional triplet-mediated pathway. If 
similar behaviour was observed in a system without the extended chromophore, it 
would suggest that the effect of the solvent polarity can be attributed to 
perturbations on the donor ability and/or polarisability of the pyridine nitrogen 
atoms and phosphinate oxygen atoms rather than effects associated with dipolar 
coupling involving the large extended chromophore dipole. 
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3.3.1 Solvent effects in the total emission of [EuL6] 
Unlike [EuL2], the complex [EuL6] did not display significant variation in the position 
and intensity of the absorption maximum upon changing solvent, consistent with 
the absence of an internal charge transfer transition. However, [EuL6] did display 
solvent dependent emission behaviour (Fig. 3.15). In the total emission spectra, it is 
immediately evident that variation is observed beyond the electric dipole allowed 
manifolds, ΔJ = 2 and 4. In the case of [EuL6], significant differences were observed 
in ΔJ = 1, 2 and 4. 
 
Figure 3.15 The total emission spectra of [EuL6] in various solvents (295 K, λexc 268 nm). Spectra are 
normalised to the integrated emission intensity of the ΔJ = 1 manifold. 
Inspection of the ΔJ = 1 manifold (585-600 nm) shows a consistent profile for the 
series of alcohols and acetonitrile, but broadening was evident in dichloromethane, 
separating into a major and minor peak in chloroform (see Fig. 3.16). The fine 
structure of the ΔJ = 1 manifold is controlled by the crystal field splitting in the 7F1 
level caused by the set of donor atoms in the ligand.2 As such, the structure of this 
manifold varies considerably with changing donor atoms, and in systems of 
different symmetry. Indeed, the number of expected transitions can be predicted 
from the symmetry of the complex. In C3 symmetric systems, the ΔJ = 1 manifold 
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exists as a non-degenerate singlet and a twofold degenerate pair of crystal field 
states. The order and separation of these levels is dependent on the size of the 
crystal field parameter (vide infra Section 3.4). It is likely that the crystal field 
parameter is sufficiently small in this complex that multiple bands cannot normally 
be resolved in this manifold. However, the appearance of the shoulder in the ΔJ = 1 
manifold of [EuL6] in chloroform suggests that there is a specific interaction present 
in this solvent that increases the magnitude of the crystal field splitting.  
In the ΔJ = 2 manifold, dichloromethane and chloroform also exhibit behaviour that 
cannot be accounted for simply by their solvent polarity. In the alcohol series, as 
polarity decreases, the longest wavelength transition reduced in intensity and 
became a more pronounced shoulder on the neighbouring transition. Meanwhile, 
the intensity of the shortest wavelength transition (at 613 nm) showed very little 
variation. In contrast, for dichloromethane and chloroform, the transition at 613 
nm was significantly weaker and the two transitions at longer wavelength were not 
resolved, as would be expected if the spectra followed a simple solvent polarity 
trend (i.e. the spectra for chloroform and dichloromethane might be expected to 
resemble that of tBuOH). In fact, in chloroform, the manifold appeared simply as 
two broad bands of approximately equal intensity. 
 
Figure 3.16 Expanded emission spectra of [EuL6] in various solvents in the ΔJ = 1 and 2 manifolds. 
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The ΔJ = 4 manifold also displays specific solvent effects for dichloromethane and 
chloroform (see Fig. 3.17). Ignoring these two solvents, the general behaviour is 
similar to that displayed by [EuL2] (Fig. 3.5), with the longest wavelength transition 
moving to lower energy with decreasing solvent polarity and the lower wavelength 
and central transitions coalescing. However, anomalous behaviour is clearly 
exhibited in chloroform and dichloromethane, which does not fit with the general 
trend shown in other solvents.  
 
Figure 3.17 Expanded emission spectra of [EuL6] in various solvents in the ΔJ = 4 manifold. 
 
3.3.2 Solvent effects in the CPL of [EuL6] 
Since [EuL6] is inherently less bright than [EuL2], its CPL spectra appear more noisy. 
However, they are sufficiently intense to observe some general trends (see Fig. 
3.18.). Of particular interest in the CPL spectra is the behaviour of the ΔJ = 1 and 2 
manifolds, which show significant changes as solvent is varied.  
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Figure 3.18 Circularly polarised emission spectra of Λ-[EuL6] in various solvents (295 K, λexc 268 nm). 
Spectra are not normalised. 
In the ΔJ = 1 manifold of Λ-[EuL6] in polar solvents, the CPL spectrum showed a 
transition of positive sign at 592 nm, followed by a negative transition at 594 nm 
(see Fig. 3.19). This pattern is consistent with the behaviour of other methyl 
phosphinate complexes recorded in polar solvents such as water and 
methanol.39,133,134 As solvent polarity is decreased, the positive transition appears to 
invert sign and coalesce with the negative transition, resulting in a single negative 
transition centred at 593 nm in tBuOH. In tBuOH, the pattern in the ΔJ = 1 manifold 
more closely resembles the profile of the same transition in the phenyl phosphinate 
series of complexes (see Fig. 3.8). However, in dichloromethane and to a greater 
extent chloroform, a positive and negative transition are observed, which does not 
fit the overall solvent polarity trend. Additionally, the transitions move slightly 
further apart, which may explain the appearance of the shoulder in the same 
manifold in the total emission spectrum, i.e. the transitions are sufficiently different 
in energy for two transitions to be observed in total emission.  
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Figure 3.19 Expanded circularly polarised emission spectra of Λ-[EuL6] in various solvents in the ΔJ = 
1 and 2 manifolds. 
The form of the ΔJ = 2 manifold of the CPL spectrum is also very different in 
chloroform and dichloromethane. There is a clear trend following solvent polarity, 
with the exception of dichloromethane and chloroform (Fig. 3.19). In polar solvents 
there is a positive transition followed by a negative transition around 614 nm. As 
solvent polarity is decreased, the negative transition becomes weaker and the 
positive transition increases in intensity. However, in dichloromethane, the profile 
resembles that of isopropanol in this region, and in chloroform, there is no positive 
transition, just a single broad negative transition at 614.5 nm. The two longer 
wavelength transitions also appear as a single transition in the chlorinated solvents.  
In contrast to the behaviour of [EuL2], the changes of the ΔJ = 4 manifold for [EuL6] 
were less clear (see Fig. 3.20). No coalescence of peaks in the CPL spectra was 
observed in total emission, although the transition around 690 nm does appear to 
move to slightly longer wavelength in chloroform. Neither is any significant change 
observed in the relative intensities of transitions within the manifold, as the solvent 
is varied.  
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Figure 3.20 Expanded circularly polarised emission spectra of Λ-[EuL6] in various solvents in the ΔJ = 
4 manifold. 
3.3.3 Specific solvent effect of chlorinated solvents 
The results above show a clear indication that there is a specific solvent interaction 
occurring between [EuL6] and chloroform, and to a lesser extent, dichloromethane, 
which cannot be attributed simply to modulation of solvent polarity. Chloroform 
can be considered a C-H acid, due to the electron withdrawing nature of the three 
chlorine atoms. As such it is capable of interacting with lone pairs of electrons on 
solutes. In the structure of [EuL6] obtained by X-ray crystallography,39 water 
molecules are observed to hydrogen bond to the lone pairs on the phosphinate 
oxygen atoms (see Fig. 3.21). This observation is consistent with other crystal 
structures of complexes with phosphinate donors, where polar protic solvents are 
seen to interact in the same manner.30,133 However, the appearance of the emission 
spectrum of [EuL6] in chloroform is very different to those obtained in polar protic 
solvents, suggesting that chloroform is not behaving as a hydrogen bond donor in 
an interaction with the ligand phosphinate oxygen.  
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Figure 3.21 X-ray crystal structure of [EuL6] showing a water molecule hydrogen bonded to the 
phosphinate oxygen atom; r = 1.893 Å, θ = 119.18°.39 Atom colours are as follows: grey, carbon; 
white, hydrogen; blue, nitrogen; red, oxygen; orange, phosphorus; brown, bromine; turquoise, 
europium. CCDC identifier: 948247/GINCEN. 
Alternatively, it is possible that there is a C-H···Br interaction with the bromine 
atom in the 4-position of the pyridine ring. There are several literature examples of 
chloroform interactions with aromatic bromides, including some in metal 
complexes. A selection obtained by screening the CCDC database is shown in Fig. 
3.22. Only short contact interactions with chloroform are shown. Some of the 
structures crystallise with additional chloroform molecules in the unit cell, but they 
do not exhibit short contact interactions.  
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Figure 3.22 Examples from the Crystal Structure Database of Cl3C-H···Br interactions. Top: a 
bimetallic manganese chelate,169 r = 2.815 Å, θ = 95.84°, CCDC identifier: 729555/GUXXON, [BPh4]- 
counter-ion omitted for clarity. Middle: a 1,3-alternate calixarene capped with a cobalt ion,170 r = 
2.765 Å, θ = 103.32°, CCDC identifier: 744813/PURVOO. Bottom: A triple decker dinuclear 
neodymium sandwich complex,171 r1 = 2.749 Å, θ1 = 90.62°, r2 = 2.913 Å, θ2 = 74.86°, CCDC identifier: 
91969/VILWIY. Atom colours: grey, carbon; white, hydrogen; blue, nitrogen; red, oxygen; brown, 
bromine; green, chlorine; purple, manganese; dark blue, cobalt; pale green, neodymium. 
In each case, the Cl3C-H···Br distance is less than the sum of the van der Waals radii 
of the atoms, i.e. a ‘short contact’. Additionally, the interactions are all ‘side-on’, i.e. 
the C-H bond points towards the equator of the bromine atoms, rather than along 
the C-Br bond. Such an interaction is to be expected, as electron deficient aromatic 
bromides do display anisotropic electron density, with an electron rich equator and 
an electron deficient pole (see Fig. 3.23).172 In [EuL6], the pyridine ring is electron 
deficient due to the electron withdrawing nature of the central metal ion.  
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Figure 3.23 Computed electrostatic potentials of bromobenzene (left) and 
pentafluorobromobenzene (right), showing the developing electron deficient pole and electron rich 
equator as electron withdrawing groups are added. Colour ranges in kcal mol-1 are: red, greater than 
20; yellow, between 20 and 10; green, between 10 and 0; blue, negative. Adapted from Ref. [172] 
with permission of Springer. Copyright Springer-Verlag 2011. 
It ought to be noted that this interaction is distinct from halogen bonding, where a 
halogen bond acceptor donates electron density into the electron deficient hole, 
along the axis of the C-X bond. Here, an electron deficient hydrogen atom is 
receiving electron density from the halogen.173  
If such an interaction is occurring between chloroform and [EuL6], it would be 
expected that varying the nature of the halogenated solvent might provide more 
information regarding the nature of the contact. The emission from [EuL6] in 
dichloromethane has already suggested that there is a specific solvation effect, and 
that it is weaker than in chloroform. Therefore, attempts were made to record total 
emission and CPL spectra of [EuL6] in carbon tetrachloride. If a C-H acid interaction 
was occurring in chloroform and dichloromethane, this anomalous behaviour would 
not be expected to occur in carbon tetrachloride as there is no hydrogen atom. 
Unfortunately, [EuL6] was not sufficiently soluble in carbon tetrachloride for good 
spectra to be obtained. Similar attempts were made in dibromomethane and 
bromoform which would be expected to produce weaker C-H acid interactions than 
chloroform and dichloromethane, respectively, but the complex was not soluble in 
these solvents either. As such, it has not been possible to confirm a specific C-H acid 
interaction with [EuL6] in chlorinated solvents. Very recent work in the related 
system [EuL15] has also indicated that specific solvent interactions occur with 
chlorinated solvents.148 In this example, the complex contained two extended 
chromophore arms and one 4-hydroxypyridine arm. The unusual emission 
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behaviour was attributed to chloroform acting as a C-H hydrogen bond donor to the 
oxygen lone pair of the 4-hydroxypyridine moiety. 
 
Another recent example of solvent dependent CPL emission involved mixing achiral 
Eu(hfac)3 with the enantiomers of the planar chiral paracyclophane Phanephos, 
which is used as a chiral ligand in catalysis.174 The resulting complexes exhibited CPL 
emission, in which some transitions in the ΔJ = 1 and 2 manifolds inverted sign on 
changing the solvent from acetone to chloroform. However, there appears to be 
some variation in complex speciation in the two solvents, so it is difficult to 
determine to what extent the change in solvent affects the emission, or whether it 
is due to a change in molecular structure. Additionally, no further solvents were 
investigated, so it is impossible to ascertain whether any real trend was present. 
Whilst the observations described above are not conclusive evidence of a C-H···Br 
interaction between chloroform and [EuL6], the unusual emission behaviour does 
point towards a specific interaction which differs from that observed in non-
chlorinated solvent. There is a precedent in the literature for such interactions, 
although only a few have been observed in the solid state in metal coordinated 
aromatic bromides. However, since these are X-ray crystal structure records, it is 
very likely that these interactions occur in systems which do not crystallise from 
chloroform.  
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3.4 A combined emission and NMR study into solvent effects in the 
[LnL7] series 
In parallel to the investigations into solvent dependent emission described above, 
an in-depth study of the unusual paramagnetic NMR shift behaviour of several 
series of lanthanide complexes has been carried out (Dr. Kevin Mason, Durham). Of 
particular interest has been the unexpected behaviour of the chemical shifts of the 
pyridine resonances in the [LnL7] series of complexes.175  
 
The chemical shift behaviour in paramagnetic lanthanide complexes has, for many 
years, been interpreted using Bleaney’s theory of magnetic anisotropy.176,177 Briefly, 
the observed chemical shift of a proton resonance is the sum of the diamagnetic 
shift and the paramagnetic shift. The paramagnetic contribution can be further split 
into the Fermi contact shift (a very short range, through bond transfer of spin 
polarisation) and the pseudocontact shift (a through space dipolar effect caused by 
the magnetic anisotropy of unpaired electrons). Bleaney’s theory states that for 
nuclei where the Fermi contact shift is negligible (usually considered for nuclei 
more than 4 bonds away from the paramagnetic centre), the paramagnetic 
chemical shift is dominated by the pseudocontact shift, which can simply be related 
to the complex geometry, the crystal field splitting, and a term relating to the 
nature of the lanthanide ion. In the case of [LnL7], it has been shown that the 
contact shift is negligible for the pyridine proton resonances.178 For axially 
symmetric complexes such as [LnL7], the pseudocontact shift, δpc, can be 
approximated by Eqn. 3.2. 
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𝛿𝑝𝑐 = −
𝐶𝐽𝜇𝐵
2
60(𝑘𝑇)2
[
(3 cos2 𝜃 − 1)
𝑟3
𝐵0
2] (3.2) 
where CJ is Bleaney’s constant, μB is the Bohr magneton, k is the Boltzmann 
constant, T is the temperature, r and θ are polar coordinates of the nucleus with 
respect to the principal axis of the magnetic susceptibility tensor χ, and 𝐵0
2 is the 
second rank axial crystal field parameter.** In turn, Bleaney’s constant can be 
expressed as a function of the total angular momentum quantum number, J, the 
Landé factor, gJ, and a numerical coefficient ⟨𝐽||𝑘||𝐽⟩ which is specific to a particular 
f n configuration. 
𝐶𝐽 = 𝑔
2𝐽(𝐽 + 1)(2𝐽 − 1)(2𝐽 + 3)⟨𝐽||𝑘||𝐽⟩ (3.3) 
As Bleaney’s constant is dependent only on the total angular momentum and the 
Landé factor, the electronic configuration determines Bleaney’s constant for a given 
lanthanide ion.  
There are two critical assumptions made in this theory. The first is that the total 
crystal field splitting is much less than kT (205 cm-1 at 298 K), and the second is that 
J is a good quantum number. The crystal field splitting in [LnL7] is small, so the first 
assumption is expected to hold in this example.  
As a result of this theory, in a series of lanthanide complexes of the same ligand, 
assuming that the crystal field and the complex geometry are constant across the 
series, there should be a linear relationship between the pseudocontact shift for a 
proton resonance and Bleaney’s constant for a given lanthanide ion. In recent work 
on [LnL7] (and other complexes) the experimental data do not support a linear 
relationship with Bleaney’s constants.178,179 Indeed, in some examples, even the 
ordering of the pseudocontact shift contributions cannot be predicted.  
                                                     
** There are various formalisms used to describe crystal field. In this thesis, spherical tensor 
formalism is used, in contrast to the Stevens’ operator formalism originally used by Bleaney, and 
used for calculations in Ref. [175]. Conversion between the systems can be achieved using the 
following relationship taken from Table 6 in Ref. [142]: 2𝐵2
0[Stevens′ operator]  =
 𝐵0
2[Spherical tensors]. 
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In the case of [LnL7] (where Ln = Eu, Tb, Dy, Ho, Er, Tm and Yb), the magnitude and 
order of the pseudocontact shifts of the three pyridyl proton resonances do not 
correlate with Bleaney’s constant (see Fig. 3.24). Assuming a constant crystal field 
across the series, the expected order is Dy < Tb < Ho < Eu < Yb < Er < Tm, whist the 
experimentally observed pseudocontact shifts follow the order Tb < Ho < Eu < Er < 
Yb < Dy < Tm. Of particular note here, is that [DyL1] exhibits pseudocontact shifts of 
positive sign, despite having the most negative Bleaney constant.175  
                        
 
Figure 3.24 Top: structure of [LnL7] and assignment of the three pyridyl (py) H atoms. Bottom: 
pseudo-contact shift (𝛿𝑝) as a function of the Bleaney constant, CJ for the three pyridyl H atoms 
(pyH3-5) for [LnL7] (in D2O, 298 K). Reprinted with permission from Ref. [175]. Copyright (2017) 
American Chemical Society. 
Additionally, a significant solvent dependence was observed on changing between 
D2O, MeOD and d6-DMSO, with the three pyridyl proton resonances swapping order 
with changing solvent for some metals (see Fig. 3.25). It is important to note that 
this solvent dependence cannot be attributed simply to the diamagnetic shifts 
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varying with solvent, as the solvent dependence of the chemical shifts of the 
diamagnetic complex [YL7] is negligible (<0.2 ppm variation). Indeed, in some 
examples a change in sign is observed, which cannot be accounted for by changes 
in diamagnetic shift.  
In order to rationalise these observations computational methods have been 
developed by collaborators (Prof. Eric J. L. McInnes and Dr. Nicholas F. Chilton, 
Manchester; Dr. Ilya Kuprov, Southampton).175 Whilst a detailed description of the 
computations will not be given here, a summary of the methods and results will be 
presented in order to explain the unusual NMR and emission behaviour of the 
[LnL7] series.  
     
Figure 3.25 Solvent dependence of the pseudocontact shift, 𝛿𝑝𝑐 of pyH3-5 for [DyL
7] (left) and [EuL7] 
(right) in D2O, MeOD, and d6-DMSO (solution at 298 K). Reprinted with permission from Ref. [175]. 
Copyright (2017) American Chemical Society. 
Various attempts to calculate pseudocontact shifts using existing computational 
models could not successfully predict the pseudocontact shifts in [DyL1]. In fact, the 
predictions from the different methods varied by up to 40 ppm and were of various 
signs. Comparisons of the computed optimised structures showed that the various 
methods predicted identical macrocycle structures and very minor differences in 
the pyridine orientations. Since the pseudocontact shift is dependent on both a 
structural component and on the magnetic anisotropy, this raises an important 
point. Since the structural variation in the calculated structures was minimal (<10 
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%), the large variation in the calculated pseudocontact shifts must be attributed to 
the magnetic anisotropy term. Therefore, seemingly trivial structural change must 
cause large changes in the magnetic anisotropy, which in turn result in unexpected 
experimental pseudocontact shifts. 
The tricapped trigonal prismatic donor atom set in the [LnL7] series comprises three 
axial nitrogen atoms (from the 9-N3 macrocycle), three equatorial nitrogen atoms 
(in the pyridine rings), and three axial oxygen atoms (from the carboxylate groups) 
(see Fig. 3.26). Treating the donor atoms as point charges, crystal field theory 
predicts that a donor atom switches from being axial to equatorial at an angle of 
approximately 55° (or 125°) from the C3 axis.180 As a donor atom switches from 
being axial to equatorial (or vice versa), it can be expected that the magnetic 
anisotropy will be affected. In [LnL7] both sets of nitrogen donors sit far enough 
away from the so-called ‘magic angle’ of 55°, such that small variations in their 
position do not affect the magnetic susceptibility anisotropy significantly. However, 
the three oxygen atoms sit sufficiently close to the magic angle that small variations 
in their position lead to significant variation in the calculated magnetic anisotropy. 
Indeed, a variation of just 2° in the angle of the oxygen donors is sufficient to 
change the sign of the magnetic anisotropy.175 DFT calculations show that the 
energy required for a 2° change in polar angle of the oxygen atoms is within kT at 
298 K. 
 
Figure 3.26 Top: schematic of the variation of polar angles (θ) for O, Neq, and Nax donor atoms in 
[DyL7]. The orange line represents the C3 symmetry axis. Reprinted with permission from Ref. [175]. 
Copyright (2017) American Chemical Society. 
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In the Russell-Saunders coupling scheme, Dy(III) has a 6H15/2 ground state 
comprising sixteen mJ levels which exist as eight Kramers doublets (the Dy(III) 
ground state has non-integer spin). In the optimised geometry, the two lowest-lying 
Kramers doublets are separated by only 11 cm-1 in energy. Importantly, the lowest 
energy doublet has ‘easy axis’ magnetic anisotropy while the first excited doublet is 
‘easy plane’, and a change of only 1° in the angle of the three oxygen donor atoms 
can swap the order of these doublets (see Fig. 3.27).175 The implication here is that 
very small variations in molecular geometry are sufficient to change the sense of 
the anisotropy of the magnetic susceptibility and hence the sign of the crystal field 
parameter, 𝐵0
2. Thus, the crystal field cannot be assumed to be constant across the 
series of lanthanides, which explains the apparent breakdown of Bleaney’s theory 
in predicting pseudocontact shifts in these complexes.  
 
Figure 3.27 CASSCF-SO calculated energy levels of the J = 15/2 ground state of Dy(III) in [DyL7] as a 
function of O-donor polar angle θ). The barycentre of each multiplet is set to zero. The magnetic 
anisotropy of the Kramers doublets is visualised as red for easy axis (𝑔|| > 𝑔⊥), green for isotropic 
(𝑔|| = 𝑔⊥) and blue for easy plane (𝑔|| < 𝑔⊥). Kramers doublets between perfectly easy axis and 
isotropic appear orange/yellow, and those between fully easy plane and isotropic appear light 
blue/green. Reprinted with permission from Ref. [175]. Copyright (2017) American Chemical Society. 
With a detailed understanding of the behaviour of the anisotropy of the magnetic 
susceptibility in hand, the solvent dependent behaviour in [DyL7] was assessed. The 
experimental data showed that on moving from D2O to MeOD to d6-DMSO the 
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pseudocontact shifts of the pyridyl protons in [DyL7] became more positive and 
have a larger spread. Using the model developed in D2O, it was confirmed that the 
dependence of the magnetic anisotropy on the polar angle of the oxygen donors is 
conserved on changing solvent. The position of the pyridyl protons is very similar in 
all three solvents, meaning the structural factor in the pseudocontact shift equation 
(Eqn. 3.2) does not vary significantly. Therefore, the observed solvent dependence 
must be due to changes to the magnetic anisotropy. Using the experimental results 
for pseudocontact shift in the three solvents, the polar angles of the oxygen donor 
atoms in each solvent were calculated to be 52.0, 53.3 and 53.8° for D2O, MeOD 
and d6-DMSO, respectively.175 This suggests that as the solvent becomes more polar 
and increases in hydrogen bonding ability, the oxygen donor atoms become more 
axial.  
In order to confirm this behaviour by an independent method, luminescence 
spectra were recorded for [DyL7] in H2O, MeOH and DMSO (emission profiles were 
observed to be identical in deuterated solvent). The emissive level in Dy(III) is a 4F9/2 
state and emission (see Fig. 3.28) is observed between 450 and 770 nm into the 
6H15/2, 6H13/2, 6H11/2 and 6H9/2 states. The latter transition overlaps with 4F9/2 → 6F11/2.  
 
Figure 3.28 The emission spectra of [DyL7] in H2O (blue), MeOH (green) and DMSO (red) (295 K, λexc 
272 nm). 
4F9/2 → 6H15/2 
4F9/2 → 6H13/2 
4F9/2 → 6H11/2 4F9/2 → 6H9/2, 6F11/2 
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In terms of determining the ordering of the ground state Kramers doublets, the 
highest energy transition into the ground state 6H15/2 ground state is of most 
interest. Assuming that emission occurs only from the lowest mJ level of the 4F9/2 
state, one might expect to see a maximum of eight components in this manifold, 
corresponding to transitions into each of the Kramers doublets in the 6H15/2 ground 
state. However, the crystal field splitting is not sufficiently large to resolve eight 
transitions in this manifold, and only six transitions were apparent in the emission 
spectra (see Fig. 3.29). The shoulder at 470 nm appears to become more distinct on 
moving from H2O to MeOH to DMSO, whilst the lower energy transitions exhibit a 
small bathochromic shift on reducing solvent polarity. This behaviour correlates 
with the change in the calculated structures, where the polar angle of the oxygen 
donor atoms increased with decreasing solvent polarity. As this angle increases, the 
energy levels of the 6H15/2 state become more separated (Fig. 3.27), which is 
reflected in the experimental emission data, where the components of the 4F9/2 → 
6H15/2 manifold become more separated as solvent polarity is decreased. 
Unfortunately, because the eight transitions cannot be resolved in this spectrum, it 
is impossible to assign each transition reliably.  
 
Figure 3.29 The expanded emission spectra of [DyL7] in the 4F9/2 → 6H15/2 manifold in H2O (blue), 
MeOH (green) and DMSO (red) (295 K, λexc 272 nm). 
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In an attempt to increase resolution, low temperature emission spectra were 
obtained for [DyL7]. By reducing vibrations, transitions at low temperature should 
be sharper, and appear better resolved in the spectra. Since this would involve 
cooling the sample to 80 K, a suitable solvent mixture was required that produces a 
transparent glass at room temperature. A commonly used glass is a mixture of 
methanol:ethanol (1:4 v/v).181 Comparison of the spectrum recorded at room 
temperature in methanol to that recorded in the methanol:ethanol mixture showed 
that they were very similar, meaning any assignments made at low temperature 
could be used reliably in methanol.  
As the temperature was reduced, resolution was enhanced. In fact, at 80 K it 
appears that more than eight transitions are visible. The high energy shoulder at 
470 nm that was visible at room temperature gradually disappears, suggesting that 
it might originate from a higher energy mJ level of the 4F9/2 emissive state. The 
complex appearance of the manifold still does not allow reliable assignments to be 
made, as it is impossible to rule out the contributions from higher energy crystal 
field levels of the emissive state. Indeed, literature examples of studies of Dy(III) 
emission suggest that the next mJ level of the 4F9/2 state is approximately 45 cm-1 
higher in energy than the lowest emissive level,182,183 which is within kT even at 80 K 
(kT ≈ 55 cm-1 at 80 K).  
Several examples in the literature have fitted very complex, poorly resolved 
emission manifolds with multiple Gaussian components to calculate the energies of 
the various transitions and to aid in their assignment.182–185 However, this method is 
somewhat dubious, and attempts to utilise this procedure on the emission of [DyL7] 
could not produce repeatable deconvolutions of the bands. 
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Figure 3.30 Variable temperature emission spectra of [DyL7] in the 4F9/2 → 6H15/2 manifold showing 
increased resolution as temperature is decreased (1:4 v/v methanol:ethanol, λexc 272 nm). 
The enantiomers of [DyL7] were resolved by chiral HPLC and their CPL spectra were 
recorded in D2O, CD3OD and d6-DMSO. It was hoped that the CPL spectra could 
provide increased resolution, if neighbouring transitions possessed opposite CPL 
sign. Despite the CPL signals being very weak, due to inefficient emission from 
dysprosium(III) compared to europium(III), variation in the relative intensities of 
                                                  CHAPTER THREE : SOLVENT EFFECTS IN Ln(III) EMISSION 
177 
 
some transitions was evident (see Figs. 3.31 and 3.32). Of particular note is the size 
of the CPL signal in the 4F9/2 → 6H11/2 (650-670 nm) and the overlapping 4F9/2 → 
6H9/2 and 4F9/2 → 6F11/2 manifolds (730-770 nm). However, the 4F9/2 → 6H11/2 and 4F9/2 
→ 6F11/2 are magnetic dipole allowed transitions which may account for their large 
CPL signals relative to the total emission intensity. 
 
Figure 3.31 Total emission (top) and CPL (bottom) of [DyL7] in D2O showing the 4F9/2 → 6H15/2, 4F9/2 → 
6H13/2, 4F9/2 → 6H11/2 and the overlapping 4F9/2 → 6H9/2 and 4F9/2 → 6F11/2 manifolds (Δ-(red) and Λ-
(blue), 295 K, λexc 272 nm). 
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Figure 3.32 CPL spectra of Δ- (red) and Λ- (blue) [DyL7] in CD3OD (top) and d6-DMSO (bottom) 
showing the 4F9/2 → 6H15/2, 4F9/2 → 6H13/2, 4F9/2 → 6H11/2 and the overlapping 4F9/2 → 6H9/2 and 4F9/2 → 
6F11/2 manifolds (295 K, λexc 272 nm). 
The emission from [DyL7] was too complex to assign reliably. In contrast, the 
emission spectrum of [EuL7] was much more informative. The emission spectra in 
water, methanol and DMSO are shown in Figure 3.33. It is evident that 
solvatochromic behaviour is observed in multiple manifolds, notably in water where 
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a different pattern in the ΔJ = 4 manifold was observed compared to the other 
solvents.  
However, it is the nature of the ΔJ = 1 manifold that is diagnostic here. In trigonal 
symmetry, the 7F1 state is split into a degenerate doublet (mJ = ±1) and a singlet (mJ 
= 0). The ordering and degree of separation of these levels in axially symmetric 
environments are dependent only on the axial crystal field parameter, 𝐵0
2. For 
positive values of 𝐵0
2, the singlet is higher in energy than the doublet, and vice 
versa.186 
 
Figure 3.33 The total emission spectra of [EuL7] in water (blue), methanol (green) and DMSO (red) 
(295 K, λexc 272 nm). 
It is evident that the 7F1 splitting increases on changing from water to methanol to 
DMSO, and this is observed experimentally as the resolution of two transitions in 
the ΔJ = 1 manifold (see Fig. 3.34). Fitting the emission lines with Gaussian curves 
for all three solvents results in the expected 1:2 integrated area ratio, and 
demonstrates that 𝐵0
2 is negative in all three cases. The 7F1 splitting energies, Δ, for 
water, methanol and DMSO were found to be -33, -67 and -78 cm-1, respectively. 
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The 7F1 splitting energy, Δ, can be related to 𝐵0
2 in the spherical tensor formalism as 
follows187: 
∆= 𝐸𝑠𝑖𝑛𝑔𝑙𝑒𝑡 − 𝐸𝑑𝑜𝑢𝑏𝑙𝑒𝑡 = 0.3𝐵0
2 (3.4) 
As such, the 𝐵0
2 values for [EuL7] in water, methanol and DMSO were found to 
be -110, -223 and -260 cm-1, respectively. In water, this value is approximately half 
the value of kT at 298 K, and in methanol and DMSO, the crystal field parameter is 
greater than kT. Therefore, Bleaney’s assumption that 𝐵0
2 << kT does not hold true 
in this system.  
Using the same methods employed for [DyL7], it was shown that the polar angle of 
the oxygen donor atoms in [EuL7] increases on going from water to methanol to 
DMSO, with values calculated to be 52.7, 54.1 and 54.5°, respectively.175 These 
values are slightly larger than observed for [DyL7] which can be tentatively ascribed 
to the slightly larger size of the Eu(III) ion requiring a more open molecular 
structure. 
 
Figure 3.34 Expanded emission spectra of [EuL7] in the ΔJ = 0 and 1 regions in water (blue), methanol 
(green) and DMSO (red) (295 K, λexc 272 nm); raw data is shown as open circles, fitted spectra as 
solid lines and deconvoluted Gaussians as dotted lines.  
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CPL spectra of Δ-[EuL7] were also acquired in water, methanol and DMSO (see Fig. 
3.35). Again, solvent dependent profiles were observed in the ΔJ = 1 manifold, with 
the intensity ratio of the two components varying with solvent. Unfortunately, the 
resolution of the CPL spectrometer was not sufficiently high to allow the energies of 
the transitions to be extracted accurately. 
 
Figure 3.35 Circularly polarised luminescence spectra of the ΔJ = 1 and 2 region for Δ-[EuL7] in H2O 
(blue), MeOH (green) and DMSO (red) (λexc 272 nm, 295 K). The maximum gem values in the ΔJ = 1 
manifold are +0.07 in water, and +0.18 in DMSO and MeOH. 
The difference in gem between water (+0.07), methanol and DMSO (both +0.18) is 
unlikely to be accounted for by a change in the angle between the magnetic and 
electric dipole transition moments, as a small change in angle cannot account for a 
factor of more than 2 in the gem values. It more likely that the difference is due to 
the variation in the relative magnitudes of the magnetic and electric dipole 
transition moments; variation in the latter may be more likely here. 
In summary, experimental data from two independent techniques have 
demonstrated that the crystal field in the [LnL7] series of complexes is extremely 
sensitive to geometric and electronic changes in the complex. In particular, 
calculations have shown that seemingly insignificant variations in the position of 
the three oxygen donor atoms are capable of changing the magnitude and, in some 
cases, the sign of the crystal field parameter, 𝐵0
2. Whilst the total emission and CPL 
spectra of [DyL7] obtained in water, methanol, DMSO and in a methanol:ethanol 
mixture were not sufficiently resolved to assign individual transitions, solvent 
dependence was observed. However, the emission from [EuL7] allowed the 
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energies of the 7F1 states to be measured, showing complementary solvent 
dependent behaviour to that observed in the rest of the [LnL7] series. 
3.5 Conclusions and Future Work 
In addition to the known solvatochromism in the internal charge transfer 
absorption in complexes with extended pyridylarylalkynyl chromophores, 
significant solvatochromism has been observed in the emission behaviour of [EuL2] 
in both total emission and CPL. In total emission, the most significant variations 
were observed in the ΔJ = 2 and 4 manifolds, which are known to be particularly 
sensitive to the environment. It is important to note that this behaviour is not due 
to a change in inner sphere donor atoms; there is no coordinated solvent molecule 
in these complexes. Instead, it is due to outer sphere effects, likely due to changes 
in ligand polarisability caused by the chromophore dipole coupling with the solvent 
dipole. In the CPL spectra, variation was observed in the ΔJ = 1 manifold. Since this 
manifold is generally regarded as being relatively insensitive to the environment, 
any change here is likely due to changes in the crystal field. However, the changes 
are probably too small to be observed in the total emission spectrum. Addition of 
polar chiral solvents to solutions of [EuL2] in non-polar solvents did not result in a 
change in the spectral form in either total emission or CPL. 
Similar results were observed for [EuL6], although anomalous behaviour was 
exhibited in chloroform and dichloromethane, suggesting a specific interaction in 
these solvents, possibly due to the C-H acid nature of the protons. Since the 
appearance of the spectra were considerably different to those recorded in polar 
protic solvents, it was assumed that this interaction was distinct from the hydrogen 
bonding interaction with the phosphinate oxygen observed in the X-ray crystal 
structure. A literature search for short range interactions between aromatic 
bromides and chloroform yielded several examples of ‘side-on’ C-H···Br 
interactions, where the electron rich equator of the bromine atom was interacting 
with the partial positive charge on the chloroform proton. The unusual emission 
behaviour in chloroform and dichloromethane has been tentatively attributed to 
such an interaction, although further evidence using other chlorinated solvents 
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could not be obtained due to lack of solubility. Future work should include similar 
analyses of the 4-chloro, 4-iodo and unsubstituted analogues of [EuL6] in order to 
more confidently ascertain the nature of the interaction with chloroform. 
In parallel to a wide-ranging study into the behaviour of several paramagnetic 
complexes by NMR spectroscopy, the solvent dependent emission behaviour of 
[DyL7] and [EuL7] has been investigated. Combined with extensive computational 
modelling and calculations carried out by collaborators,175 the results show that the 
crystal field in the [LnL7] series cannot be assumed to be constant, and is very 
sensitive to minor changes in electronic and geometric structure.  
It is possible that the same processes observed in the [LnL7] series are responsible 
for the variation in the ΔJ = 1 manifolds of [EuL2] and [EuL6] with changing solvent. 
However, in contrast to [LnL7], the ΔJ = 1 manifold of [EuL6] suggests that the value 
of 𝐵0
2 is positive in chloroform. Without further investigation, it is difficult to say 
whether this is indicative of a change in sign of 𝐵0
2 in chlorinated solvents, or 
whether 𝐵0
2 is positive in all solvents for this complex, because the transitions in the 
ΔJ = 1 manifold are not well resolved in other solvents.  
The outcome of these investigations has implications in the design of responsive 
probes based both on optical properties and magnetic resonance, and also 
demonstrates the scope and potential of this class of complex in environment-
dependent sensing. 
Future investigation into the solvent dependent emission behaviour of these 
complexes should include detailed studies of the changing crystal field in 
derivatives of [LnL7]. Addition of pyridyl substituents could allow solubility in a 
wider range of solvents than possible for [LnL7]. Additionally, if the substituents 
were capable of intermolecular interactions with chiral solvents, subtle changes in 
the crystal field may be observed in CPL. Varying pyridyl substituents would also 
affect the ligand polarisability which may help to elicit the relationship between 
modulation of the ligand dipole by solvent, and the corresponding total emission 
and CPL spectral form. 
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CHAPTER FOUR : CELL UPTAKE OF CHIRAL Eu(III) COMPLEXES  
4.1 Introduction 
Europium(III) complexes have been used extensively as stains for live cell 
fluorescence microscopy (Section 1.5). The development of responsive probes has 
allowed emissive europium(III) complexes to be used to measure the intracellular 
concentrations of a number of biologically relevant molecules, in addition to pH and 
pO2. Of critical importance for intracellular stains and probes, is the mechanism of 
uptake. In order for a complex to be used in cellulo, a comprehensive 
understanding of cell uptake and sub-cellular localisation is required, and can aid in 
the design of new probes to target particular organelles. Whilst the cell uptake 
mechanism of a wide range of 12-N4 based systems has been studied,22 a thorough 
investigation of the mechanism of internalisation of the EuroTracker 9-N3 based 
systems with pyridylarylalkynyl chromophores has not been undertaken. A 
preliminary investigation suggested that macropinocytosis was involved in the 
uptake of these complexes, but the presence of other competing mechanisms was 
not ruled out.100 Additionally, the complexes tested in the preliminary study either 
possessed multiple anionic groups or contained conjugated polycationic nuclear 
localisation peptides. The highly charged nature of these complexes is likely to 
affect their uptake mechanism. 
Of particular interest is the effect of probe chirality in the uptake process. Since 
biological recognition is achieved using chiral sugars and proteins, any uptake of 
chiral species might be expected to display some chiral discrimination due to 
differential diastereomeric interactions. Indeed, chiral discrimination of such 
complexes by sugars has already been demonstrated in the resolution of the 
enantiomers by chiral HPLC using sugar-based chiral stationary phases. Similarly, if 
the sub-cellular transport of the complexes is regulated by proteins, then variation 
in the localisation of the enantiomers and their rate of transfer inside the cell may 
also be affected.  
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Initially, a cell uptake study was carried out using racemic [EuL4], which has already 
been demonstrated to be taken into cells, in order to confirm that 
macropinocytosis is the mechanism by which internalisation occurs. Secondly, the 
uptake and sub-cellular localisation of [EuL3] and [EuL4] were investigated. Cell 
work was carried out by Holly Linford and Dr. Robert Pal. 
The synthesis of each complex was achieved via previously reported routes (see 
Scheme 4.1 for [EuL4]),29,188 analogous to those used for the synthesis of the 
phenylphosphinate derivatives [EuL1] and [EuL2] (see Section 2.2). Full synthetic 
details and characterisation can be found in Chapter 5. 
 
Scheme 4.1  Synthetic route to [EuL3] and [EuL4]. 
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4.2 Cell uptake mechanism of [EuL4] 
The cell uptake behaviour of [EuL4] was investigated in NIH-3T3 cells (mouse skin 
fibroblast) in the presence of various promoters and inhibitors of macropinocytosis, 
clathrin-mediated endocytosis and caveolae-mediated endocytosis (see Fig. 4.1). 
 
Figure 4.1 A schematic illustration of three possible endocytotic pathways for the uptake of 
lanthanide complexes, and the maturation of endosome to lysosomes. In red are known activators 
(denoted with a +) and inhibitors (-) of each process. Reprinted from Ref. [116] with permission 
Copyright (2009) Elsevier.  
In each case, the cells were grown on coverslips using standard methods (see 
Chapter 5). For the cell uptake experiments, the cells were incubated for 30 
minutes in growth medium containing the promoters and inhibitors shown in Figure 
4.1 (the concentrations used are reported in Chapter 5). The cells were then 
washed and incubated with growth medium containing [EuL4] (30 μM) and the 
promoters/inhibitors. After 4 hours, the coverslips were removed, washed with 
growth medium and mounted on glass slides. A control sample was produced using 
identical procedures, without the addition of promoters or inhibitors. Microscopy 
images were recorded using a Leica SP5 II laser scanning confocal microscope, with 
pulsed excitation at 355 nm. The extent of complex internalisation was measured 
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by analysis of the brightness of the acquired images. In each case, the image 
brightness in the 605-720 nm emission range of several perinuclear sample areas 
from each cell was recorded. This was repeated for multiple cells. Overall, at least 
45 sample areas from multiple cells were recorded per treatment. The mean value 
was taken for each result and compared to the image brightness recorded using the 
same method for the control sample (see Fig. 4.2). Earlier work has shown that 
comparative image brightness measurements in such experiments were similar to 
independent measurement of intracellular europium concentration by ICP-MS.189 
 
Figure 4.2 Mean relative brightness of europium(III) emission from cells incubated with [EuL4] after 
treatment with promoters and inhibitors of various cell uptake mechanisms. Inhibitors (red) and 
promoters (green) of macropinocytosis are highlighted. Results which have statistical significance 
(two-tailed student’s t-test at 95% confidence) are marked with an asterisk. Error bars represent one 
standard deviation from the mean. 
It is immediately evident that 1,2-dipalmitoyl-rac-diacylglycerol (Di-Rac), a fatty acid 
glycerol and known promoter of macropinocytosis, significantly enhances the 
uptake of [EuL4]. After treatment of the cells with amiloride and wortmannin, both 
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inhibitors of macropinocytosis, the internalisation of [EuL4] is reduced by almost 
50%. Similarly, for cells incubated at low temperature, the uptake of complexes is 
reduced, although low temperature is expected to inhibit all three endocytotic 
pathways. Such behaviour does, however, confirm that uptake is via an active 
process. The promoters and inhibitors of other pathways do not have significant 
effects on the internalisation of the complex. Such behaviour is consistent with that 
observed previously for 12-N4 based complexes.22 
The error bars for some treatments are quite large, which is to be expected when 
dealing with live cell imaging, where variation between cells is natural. However, 
variation in microscope performance can be discounted in this experiment as the 
acquisition of control samples was repeated between each measurement of treated 
cells.  
Conspicuously, on treatment of the cells with a phorbol ester (phorbol 12-myristate 
13-acetate) which is known to stimulate macropinocytosis, the brightness of the 
complex in the cells is reduced by approximately 30% relative to the control. In 
order to check whether the phorbol ester was quenching the [EuL4] emission and 
causing this anomalous result, emission spectra were recorded in cell lysate in the 
presence and absence of phorbol ester. In the presence of phorbol ester, the 
emission intensity was quenched by approximately 35% (see Fig. 4.3), without a 
significant change in emission lifetime (1.11 vs. 1.06 ms). Such behaviour is 
consistent with reduced absorption efficiency or energy transfer to the metal, 
rather than quenching of the metal excited state. Whilst a 35% quenching effect 
may initially appear to account for the 30% reduced brightness in microscopy, one 
cannot assume that the relative concentrations of the complex and the phorbol 
ester is the same in cellulo as it is in vitro. However, it does provide evidence that 
such a quenching process may account, at least in part, for the lower than expected 
emission observed for this complex by microscopy.  
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Figure 4.3 Spectral imaging of [EuL4] in cell lysate (red) and cell lysate containing phorbol 12-
myristate 13-acetate (yellow) (λexc 355 nm). 
Taking into account all the data, it seems highly likely that macropinocytosis is the 
primary route of uptake of [EuL4], although confirmation using a method 
independent of brightness would be beneficial. The use of ICP-MS would allow the 
concentration of Eu(III) in the cell to be measured, which would be independent of 
any quenching of sensitised europium(III) emission. Co-staining at early time points 
with a fluorescein isothiocyanate-dextran conjugate (which localises in 
macropinosomes),190 would also allow confirmation that [EuL4] is internalised via 
macropinocytosis. 
Since macropinocytosis is a non-selective pathway, these results combined with 
those acquired in the preliminary study for complexes with similar structures, 
suggest that macropinocytosis is the primary route of uptake for this class of 
compounds. Previous work on 12-N4 complexes concluded that simultaneous 
passive uptake was unlikely, as complexes of different hydrophilicity (by 
comparison of octanol-water partition coefficients) did not show any variation in 
cell uptake.22 Since the uptake of anionic, cationic and neutral complexes appear to 
be affected to a similar extent by promoters and inhibitors of macropinocytosis, it is 
reasonable to assume that variations in charge and hydrophilicity do not affect the 
uptake mechanism, across a series of otherwise structurally similar complexes. 
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However, it should be noted that anionic complexes bearing sulfonate groups in 
various positions on the complexes are not internalised by cells, even after long 
incubation times, and instead localise on the plasma membrane.81,191  
Unlike receptor-mediated endocytosis which is activated by binding of a specific 
substrate to a specific cell surface receptor, macropinocytosis is a non-selective 
uptake mechanism. It occurs in response to stimulation of receptor tyrosine 
kinases,192 which are trans-membrane proteins capable of up-regulating actin 
polymerisation. It is the increase of actin polymerisation that is responsible for the 
formation of membrane ruffling. Occasionally, the membrane ruffles fold back on 
themselves, forming macropinosomes. These macropinosomes are large (>0.2 μm 
diameter and up to 5 μm in some examples)111,193 compared to other endocytotic 
vesicles (e.g. clathrin-coated vesicles are approximately 100 nm in diameter),194 
meaning a large volume of extracellular fluid is internalised (see Fig. 4.4). 
It has been observed that the fate of macropinosomes varies in different cell types. 
In epithelial and fibroblast cells (such as A431 and NIH-3T3) which are growth factor 
stimulated, macropinosomes remain relatively isolated from the endolysosomal 
system and eventually fuse back with the cell membrane.193 Such an observation is 
consistent with the need for these types of cells to constantly reorganise the 
plasma membrane in response to external stimuli. In contrast, in cells where 
degradation of extracellular material is key (such as renal cells and macrophages), 
macropinosomes fuse with late endosomes and lysosomes.195  
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Figure 4.4 Schematic diagram describing the process of macropinocytosis. The plasma membrane is 
represented by a blue line, while black lines represent actin filaments. Reprinted from Ref. [196] 
with  permission from Macmillan Publishers Ltd. Copyright 2011. 
4.3 Effect of chirality on cell uptake and sub-cellular localisation 
Although macropinocytosis is a non-specific mechanism of internalisation, the 
possibility of chirality dependent cell uptake and sub-cellular localisation is not 
precluded. For instance, favourable interaction of one enantiomer of complex with 
a protein or other substrate in the extracellular environment which can stimulate 
membrane ruffling, may result in one enantiomer being internalised more than the 
other. The fate of the complex once internalised may also involve transport by 
protein. Since proteins possess chiral binding pockets, it is possible that different 
sub-cellular localisations may be observed for different enantiomers.  
An understanding of such behaviour is crucial in the use of emissive stains and 
probes in live cell imaging, both for chiral complexes and achiral complexes which 
may exhibit induced chirality on binding. Since complex [EuL4] has already been 
reported as a stain for live cell imaging,100 and it is simple to resolve the 
enantiomers by chiral HPLC (see Section 2.4), it was a logical choice for such an 
investigation. Additionally, experiments were carried out on [EuL3] to ascertain 
whether the nature of the chromophore would affect its uptake or localisation 
profile.  
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Initially, NIH-3T3 cells were treated with racemic [EuL4] and studied by microscopy. 
The complex was readily internalised by the cells and co-staining with MitoTracker 
Green confirmed a predominant mitochondrial localisation after 4 hours (see Fig. 
4.5), consistent with the behaviour observed previously for this complex.100 
Although mitochondria are often illustrated as ‘bean-shaped’ organelles (and often 
appear as such in electron micrographs where cells are fixed with heavy metals), in 
live cells they are dynamic, with the ability to change their shape as well as fuse and 
divide.197 As such, in live cell imaging they appear as a tubular network rather than 
as distinct organelles. 
 
Figure 4.5 LSCM images of NIH-3T3 cells treated with [EuL4] and MitoTracker Green showing (A) 
mitochondrial localisation of [EuL4] (4 h, 30 μM, λexc 355 nm, λem 605-720 nm); (B) MitoTracker 
Green (0.2 μM, λexc 488 nm, λem 500-530 nm); (C) RGB merged image showing co-localisation (P = 
0.92); (D) A transmission image of the cell of interest. 
A B 
C D 
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4.3.1 Cell uptake of enantiopure complexes 
Cell uptake experiments were repeated with enantiopure Δ- and Λ-[EuL4]. NIH-3T3 
cells were treated with complex (30 μM) and examined by microscopy after 24 
hours incubation. Comparison of the europium(III) emission brightness showed that 
emission from the cells treated with Λ-[EuL4] was brighter than from the cells 
treated with Δ-[EuL4] by a factor of two. In order to confirm that uptake of the two 
enantiomers was different, cells were also prepared for inductively coupled plasma 
mass spectrometry (ICP-MS) measurements. In this technique, samples are ionised 
using an argon plasma and analysed using a mass spectrometer, which can detect 
metal ions at very low concentrations (as low as 1 in 1015 in some cases). Cells 
dosed with complex were washed with phosphate buffered saline to remove any 
complex that was not internalised, before being trypsinated and harvested from the 
cover slip. Following digestion of the sample overnight in concentrated nitric acid, 
ICP-MS was used to measure the concentration of europium in the sample. This 
value can then be used to calculate the concentration of europium that was in the 
cell sample. In the case of cells treated with [EuL4], ICP-MS analysis of a number of 
cell samples showed that on average there was 1.6 times more Λ-[EuL4] than Δ-
[EuL4] internalised. Whilst the difference in uptake measured by ICP-MS is not as 
pronounced as that observed by microscopy, it is further evidence that the Λ-
enantiomer is selectively internalised by NIH-3T3 cells.  
Initial attempts to carry out the same experiments using Δ- and Λ-[EuL3] resulted in 
cell images that were significantly less bright that those observed for [EuL4], when 
cells were treated with the same concentration of complex. However, it was 
possible to estimate that the emission from the cells treated with Δ-[EuL3] was 
more intense by approximately 30%. ICP-MS analysis of these cell samples revealed 
that 1.7 times more of the Δ-enantiomer was internalised than the Λ-enantiomer  
The reduced brightness in cells can be attributed to self-aggregation leading to 
quenching of the europium(III) emission. In water, a reduction in emission lifetime 
is observed for [EuL3] at concentrations above 15 μM. Whilst ICP-MS data suggests 
that the overall concentration in the cells is not this high, it is possible that local 
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concentrations in areas where the complex localises may be similar to this. 
Additionally, both enantiomers of [EuL3] were more emissive and possessed longer-
lived excited states in cell growth medium than in water, suggesting that complex 
aggregation is suppressed in the growth medium. 
Repeating the cell experiments with a lower dosing of complex [EuL3] (3 μM) 
resulted in significantly brighter images for both enantiomers than were originally 
acquired, confirming that self-quenching was indeed occurring at higher 
concentration. In agreement with the more concentrated treatments, and the ICP-
MS data, the cells treated with Δ-[EuL3] were brighter than those treated with Λ-
[EuL3]. 
Spectral imaging of the complexes in cellulo revealed emission profiles and lifetimes 
that are consistent with those observed in vitro, confirming that the europium(III) 
ion is still held within the intact ligand framework (see Fig. 4.6). 
 
Figure 4.6 Spectral imaging of [EuL3] in cellulo showing an emission profile consistent with that 
obtained in vitro, and an emission lifetime of 0.81 ms. 
It is evident that in each case, one enantiomer is favourably internalised. Such 
behaviour might be explained if one of the enantiomers is interacting more strongly 
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with a protein and being internalised whilst bound to protein. In order to test this 
hypothesis, each enantiomer of [EuL4] was titrated with bovine serum albumin 
(BSA, the most abundant protein in the cell growth medium). The absorption and 
emission spectra, as well as emission lifetimes, were monitored as a function of 
added BSA for each enantiomer. 
In the absorption spectra, the extinction coefficient of the chromophore internal 
charge transfer band of both enantiomers increased as BSA was added, and for Λ-
[EuL4] a small hypsochromic shift (5 nm) of the absorption maximum was observed. 
Such behaviour is consistent with the chromophore experiencing a less polar 
environment.  
The total emission intensity for each enantiomer increased as a function of added 
BSA, although a more significant change was observed for the Λ-enantiomer (see 
Fig. 4.7).  
 
Figure 4.7 Total integrated emission intensity for Δ- and Λ-[EuL4] as a function of added BSA (4 μM 
complex, 0.1 M HEPES, 0.1 M NaCl, pH 7.40, 295 K, λexc 340 nm). 
The emission lifetime of Λ-[EuL4] also increased by approximately 20% as the 
protein concentration increased, while the lifetime of the Δ-enantiomer showed 
little variation. The CPL spectra of the enantiomers were also recorded as protein 
was added (Fig. 4.8). The CPL spectrum of Λ-[EuL4] increased in intensity as protein 
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was added, consistent with the increased intensity observed in total emission. The 
behaviour of Δ-[EuL4] was more complicated. In the ΔJ = 4 manifold, a small 
decrease in CPL intensity is observed, whilst a significant decrease in CPL intensity is 
evident in the ΔJ = 1 and 2 manifolds. The ΔJ = 3 manifold is largely unaffected by 
protein. If the complex was experiencing protein-catalysed racemisation, all 
manifolds would be expected to lose CPL intensity together.  
 
Figure 4.8 CPL spectra of Δ- and Λ-[EuL4] in the presence and absence of 10 equivalents of BSA 
(4 μM complex, 0.1 M HEPES, 0.1 M NaCl, pH 7.40, 295 K, λexc 340 nm). 
The increase in emission intensity and lifetime exhibited by Λ-[EuL4] with added 
protein is consistent with the complex experiencing a less polar environment, which 
reduces the extent of quenching by water, and may enhance the efficiency of 
energy transfer from the ICT excited state to the europium(III) ion, as the energy of 
the ICT state is changed. Although Δ-[EuL4] does exhibit a small increase in emission 
intensity, the effect is clearly not as significant as that observed for the Λ-
enantiomer. Such behaviour suggests that the two enantiomers do not experience 
the same interaction with BSA as each other. Given the more significant response 
displayed by Λ-[EuL4], it conceivable that it is experiencing a stronger interaction 
with BSA, which might tentatively explain why it is internalised more than Δ-[EuL4].  
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Serum albumin possesses a number of distinct binding pockets of varying 
structure,198,199 and is known to bind to a variety of endogenous and exogenous 
species, including fatty acids, metal ions, steroids, amino acids and many drugs.200–
203 It is also known to bind to a variety of chelating and macrocyclic metal 
complexes used as contrast agents.204–207 Indeed, recent work within the Parker 
group has shown that complexes bearing pyridylarylalkynyl chromophores bind to 
serum albumin, perturbing the energy of the ICT excited state, signalled by a 
switching on of europium(III) emission.208  
It has been proposed that serum albumin proteins exhibit non-specific adsorption 
to cell surface membranes, acting to protect the cell membrane from physical 
stress, although this behaviour seems to originate from physicochemical 
interactions as opposed to any biological response.209 Studies of the interaction 
between BSA and lipid bilayers suggest that BSA adsorbs to the membrane at low 
concentrations, but causes disruption and membrane leakage at higher 
concentration.210 However, serum albumins also bind to a number of cell surface 
receptors, which vary depending on cell type.211 Binding to cell membranes allows 
serum albumins to deliver their cargo directly to target cells.  
If Λ-[EuL4] interacts more strongly with serum albumin, then it may increase the 
local concentration of the complex at the cell membrane, hence increasing the 
probability of internalisation of this enantiomer over the Δ-enantiomer. 
Chiral lanthanide(III) complexes have previously been shown to exhibit differential 
binding to BSA.87 The enantiomers of complexes with tetraazatriphenylene 
chromophores were shown to have very different behaviour in the presence of BSA, 
with the Δ enantiomer binding to BSA with a 1:1 binding constant of log K= 5.1, 
while the Λ-enantiomer formed various low affinity adducts. Indeed, for the Δ-
enantiomer, there was a significant change in CPL spectral form, consistent with a 
change in complex helicity upon binding.88 Whilst such significant variation in 
behaviour is not exhibited by [EuL4], there is a precedent for enantioselective 
protein binding in emissive europium(III) complexes.  
                                          CHAPTER FOUR : CELL UPTAKE OF CHIRAL Eu(III) COMPLEXES 
198 
 
4.3.2 Sub-cellular localisation of enantiopure complexes 
In addition to studying the relative uptake of the enantiomers of [EuL3] and [EuL4], 
the sub-cellular localisation of the enantiomers was also investigated. As before, 
the cells were incubated with enantiopure complex and imaged by laser scanning 
confocal microscopy. Complex [EuL4] clearly demonstrated differential localisation 
after 24 hours, with the Λ-enantiomer predominantly exhibiting mitochondrial 
localisation (revealed by the appearance of tubular networks, Fig. 4.9) while the Δ-
enantiomer exhibited a more lysosomal profile (appearing as circular dots, 
especially in the perinuclear region, Fig. 4.10). Both enantiomers also produced 
weak emission from the cytosol. 
 
Figure 4.9 LSCM images of NIH-3T3 cells treated with Λ-[EuL4] showing a predominant mitochondrial 
localisation profile (24 h, 20 μM, λexc 355 nm, λem 605-720 nm). Scale bars denote 20 μm. 
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Figure 4.10 LSCM images of NIH-3T3 cells treated with Δ-[EuL4] showing predominant lysosomal 
localisation (24 h, 20 μM, λexc 355 nm, λem 605-720 nm). Scale bar denotes 20 μm. 
After 24 hours incubation, the cells were still alive and exhibiting normal cell cycles. 
Indeed, in Figure 4.9, it is possible to see a cell in the telophase state of mitosis 
(indicated with an arrow), where the nuclear membranes have reformed, and the 
cell is about to undergo cytokinesis, where the cell membrane separates to form 
two distinct cells. 
Similar behaviour was observed for [EuL3], with the Λ-enantiomer exhibiting 
predominantly localisation in the mitochondrial network after 24 hours, in contrast 
to the lysosomal localisation shown by the Δ-enantiomer (Figures 4.11 and 4.12, 
respectively).  
As discussed in Section 4.3.1, at the initial complex loading concentration of 30 μM, 
the images of [EuL3] were not particularly bright due to a self-quenching effect. 
Therefore, the experiments were repeated using lower concentrations of complex 
(3 μM). Additionally, co-staining with LysoTracker Green allowed comparison of the 
localisation profiles of both enantiomers of [EuL3] to a species known to localise to 
the lysosomes (see Fig. 4.13). 
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Figure 4.11 LSCM images of NIH-3T3 cells treated with Λ-[EuL3] showing mitochondrial localisation 
(24 h, 30 μM, λexc 355 nm, λem 605-720 nm). Scale bars denote 20 μm. 
 
Figure 4.12 LSCM images of NIH-3T3 cells treated with Δ-[EuL3] showing predominant lysosomal 
localisation (24 h, 30 μM, λexc 355 nm, λem 605-720 nm). Scale bars denote 20 μm. 
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Figure 4.13 LSCM images of NIH-3T3 cells treated with Λ-(left) and Δ-(right) [EuL3] (top, 24 h, 3 μM, 
λexc 355 nm, λem 605-720 nm); LysoTracker Green (0.2 μM, middle, λexc 514 nm, λem 530-550 nm); and 
RGB merged image (bottom) (PΛ = 0.65, PΔ = 0.79). Scale bars denote 20 μm. 
Λ-[EuL3] Δ-[EuL3] 
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From the images in Figure 4.13, it is evident that the localisation profiles of the 
enantiomers of [EuL3] are retained, even at much lower dosing concentrations. 
Again, the Λ-enantiomer appeared to be predominantly mitochondrial while the Δ-
enantiomer was predominantly lysosomal. These profiles were confirmed by co-
staining with LysoTracker Green. The localisation of Δ-[EuL3] very closely matched 
that of LysoTracker Green, with the RGB colour merge showing almost exact co-
localisation in spherical organelles concentrated around the nucleus. In contrast, 
the profiles for LysoTracker Green and Λ-[EuL3] show weaker correlation, with the 
complex emission appearing much more diffuse than the lysosomal localisation of 
the BODIPY-based stain. 
Given that the different enantiomers of [EuL3] and [EuL4] localise in both the 
mitochondrial network and the lysosomes, it is perhaps surprising that this cannot 
be observed in the images acquired of cells treated with racemic complex. For 
example, in Figure 4.5, the localisation of the racemic [EuL4] appears distinctly 
mitochondrial. However, it should be noted that those images were recorded after 
4 hours incubation with complex, rather than after 24 hours. It is possible, 
therefore, that both enantiomers initially localise in the mitochondria, but that the 
Δ-enantiomer moves to the lysosomes faster than the Λ-enantiomer. Such time-
dependent localisation behaviour has been observed previously for racemic 
complexes bearing both pyridylarylalkynyl chromophores and azaxanthones.22,100  
The sub-cellular localisation behaviour of the closely-related complex [EuL9] is 
consistent with this hypothesis.148 Complex [EuL9] is structurally similar to [EuL4], 
with one extended chromophore arm replaced by a 4-methoxy substituted pyridine 
moiety.  
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At early time points, Λ-[EuL9] exhibited localisation predominantly in the 
mitochondrial network, which was confirmed by co-staining with MitoTracker 
Green (Fig. 4.14). In contrast, europium(III) emission from both the tubular 
networks of the mitochondria and the circular perinuclear lysosomes was evident in 
cells treated with Δ-[EuL9], suggesting both mitochondrial and lysosomal 
localisation (Fig. 4.15).148  
 
Figure 4.14 LSCM images of NIH-3T3 cells treated with Λ-[EuL9] and MitoTracker Green showing 
predominant mitochondrial localisation of Λ-[EuL9] (left, 8 h, 26 μM, λexc 355 nm, λem 605-720 nm) 
and MitoTracker Green (right, 0.2 μM, λexc 488 nm, λem 500-530 nm). Scale bars denote 20 μm. 
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Figure 4.15 LSCM images of NIH-3T3 cells treated with Δ-[EuL9] showing both mitochondrial and 
lysosomal localisation (4 h, 26 μM, λexc 355 nm, λem 605-720 nm). Scale bars denote 20 μm. 
Such behaviour is consistent with a time-dependent process. The complexes are 
internalised in macropinosomes which, in fibroblast cells such as NIH-3T3, are 
isolated from the endosomal-lysosomal pathways.193 Therefore, direct trafficking of 
the Δ-enantiomers to the lysosomes is unlikely. A more likely hypothesis is that 
both enantiomers are transported to the mitochondria and the Δ-enantiomer is 
subsequently removed from the mitochondria and trafficked to the lysosomes, 
while the Λ-enantiomer remains in the mitochondria.  
Due to their irregular structure and lack of coating compared to endocytotic 
vesicles regulated by clathrin or caveolae, macropinosomes are more prone to 
leakage of their contents. Leakage of macropinosome content has been observed in 
A431 epithelial cells, where fluorescent dyes used to label macropinosomes were 
found to be distributed throughout the cytosol.212 The cells were confirmed to be 
viable as they excluded Trypan Blue, a dye which stains only necrotic or apoptotic 
cells.213 Indeed, the complexes described above do exhibit weak emission from the 
cytosol, suggesting that some of the complex leaks from the macropinosomes. 
Whilst extensive research into transport of biological molecules has been carried 
out, the mechanisms of intracellular transport of exogenous molecules are largely 
unknown. It is likely that trafficking of the complexes to their sub-cellular 
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destinations is via vesicular transport, but the processes that govern the 
destinations of different complexes are still unknown.  
Mitochondria are comprised of two membranes. The inner membrane is permeable 
only to small neutral molecules (oxygen, carbon dioxide and water) and contains 
sophisticated transport proteins to facilitate entry of specific molecules required for 
aerobic respiration, which occurs inside the mitochondria.214 The proteins 
responsible for ATP synthesis are embedded in the inner membrane. The outer 
membrane is similar in composition to the cell surface membrane. Between the two 
membranes is the intermembrane space which is broadly similar in composition to 
the cytosol. The outer membrane also contains porins, which are a family of barrel-
shaped proteins through which large molecules (in some cases up to 5000 Da) can 
diffuse into the intermembrane space.215 It is possible that the europium(III) 
complexes diffuse through these porins and localise in the intermembrane space, or 
that they localise to the outside of the outer mitochondrial membrane.  
From here, the observed localisation profiles suggest that the Δ-enantiomer is more 
quickly trafficked to the lysosomes than the Λ-enantiomer. Since the function of the 
lysosomes is to chemically degrade unwanted species using enzymes operating at 
acidic pH,216 it is possible that the Δ-enantiomer is less well tolerated by the cell, 
hence is removed to the lysosomes for degradation faster than the Λ-enantiomer. 
Alternatively, it is possible that the Λ-enantiomer preferentially interacts with a 
species in the mitochondria, which reduces its rate of transport to the lysosomes.  
4.4 Conclusions and Future Work 
The primary mechanism of cell uptake of [EuL4] in mouse skin fibroblast cells has 
been confirmed to be macropinocytosis, determined by measuring complex uptake 
in the presence of inhibitors and promoters of various endocytotic pathways. In 
order to confirm these findings, similar experiments on other structurally similar 
complexes should be carried out. Additionally, quantitative measurements by ICP-
MS could be used to confirm the observations made by LSCM.  
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Using both microscopy and ICP-MS, differential uptake of the enantiomers of [EuL3] 
and [EuL4] has been observed. In the case of [EuL3], the Δ-enantiomer is 
internalised to a greater extent than the Λ-enantiomer, whilst for [EuL4] the reverse 
behaviour was observed. Titrations of the enantiomers of [EuL4] with BSA showed 
varied interactions, with the Λ-enantiomer appearing to interact more strongly with 
BSA. This behaviour might explain why this enantiomer is internalised to a greater 
extent.  
The self-quenching behaviour of [EuL3] has been explored, both in vitro and in 
cellulo. In cells dosed with 30 μM solutions of complex, emission was significantly 
quenched. Cells dosed with diluted solutions appeared much brighter, suggesting 
that at high concentration, the [EuL3] complex aggregates, resulting in a quenching 
of europium(III) emission.  
Comparison of the sub-cellular localisation profiles of enantiopure complexes 
shows that for both [EuL3] and [EuL4], the Λ-enantiomer predominantly localises in 
the mitochondrial network, while the Δ-enantiomer exhibits a predominantly 
lysosomal localisation after 24 hours. Similar behaviour has also been reported for 
the related complex [EuL9]. The Δ-enantiomer exhibits both mitochondrial and 
lysosomal localisation at early time points, consistent with a time-dependent 
localisation process. 
A proposed pathway involves leakage of the complexes from the macropinosomes 
into the cytosol, followed by trafficking to the mitochondria. Subsequent removal 
to the lysosomes for degradation may occur more quickly for the Δ-enantiomer. 
Whilst the mechanisms by which the complexes are trafficked between various sub-
cellular locations remain unknown, it is evident that there is chiral selectivity in the 
process.  
Whilst it has long been known that different enantiomers of drugs can exhibit 
different biological activity, to the best of our knowledge, there has been only one 
other report of enantioselective localisation of emissive metal complexes. The two 
enantiomers of a chiral ruthenium(II) complex exhibited slightly different 
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localisation patterns with the Δ-enantiomer appearing in the cytosol, while the Λ-
enantiomer seemed to concentrate around the nucleus of HepG2 cells (human liver 
cancer cells).217 The difference in localisation behaviour was ascribed to each 
enantiomer having a different mechanism of internalisation, although no attempt 
to identify the uptake mechanisms was reported.  
Further work regarding the cell uptake mechanism of complexes such as [EuL3] and 
[EuL4] might include confirming macropinocytosis as the primary mechanism in 
alternative cell types. Since the fate of macropinosomes varies between different 
types of cell, it is possible that the fate of the complexes internalised in them may 
also be affected.  
In order to elucidate the sub-cellular trafficking mechanisms of complexes such as 
[EuL3] and [EuL4], a detailed understanding of the transport of exogenous 
molecules would be required. Genetic modifications of cells to ‘knock out’ proteins 
known to be involved in trafficking might allow certain routes to be identified, 
although this is likely to affect normal cell function. 
An understanding of the sub-cellular localisation mechanisms of these complexes is 
key to fully understanding their biological behaviour. Their time-dependent 
localisation means that their use as organelle stains (especially in the racemic form) 
requires very careful consideration. Similarly, responsive probes designed to 
measure the concentration of various analytes in cellulo may also exhibit time-
dependent localisation. Since the concentration of the target analytes may vary 
between organelles, judicious interpretation of the results is required. 
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CHAPTER FIVE : EXPERIMENTAL METHODS 
5.1 General Procedures 
Commercially available reagents were used as received. Solvents were laboratory 
grade and were dried over appropriate drying agents when required. Where 
appropriate, solvents were degassed using freeze-pump-thaw cycles. 
Thin layer chromatography (TLC) was carried out on aluminium-backed silica gel 
plates with 0.2 mm thick silica gel 60 F254 (Merck), and visualised by UV irradiation 
at 254 nm or 366 nm. Preparative flash column chromatography was performed 
using flash silica gel 60 (230-400 mesh) from Merck or Fluorochem.  
1H, 13C and 31P NMR spectra were recorded in commercially available deuterated 
solvents on a Bruker Avance-400 (1H at 400.06 MHz, 13C at 100.61 MHz and 31P at 
161.95 MHz), a Mercury 400 (1H at 399.95 MHz), a Varian VNMRS-600 (1H at 599.67 
MHz, 13C at 150.79 MHz and 31P at 242.75 MHz), or a Varian VNMRS-700 (1H at 
699.73 MHz, 13C at 175.95 MHz and 31P at 283.26 MHz). All chemical shifts are in 
ppm and coupling constants are in Hz.  
Electrospray mass spectra were obtained on a TQD mass spectrometer equipped 
with an Acquity UPLC system, an electrospray ion source and an Acquity 
photodiode array detector (Waters Ltd., UK). Accurate masses were recorded on an 
LCT Premier XE mass spectrometer or a QToF Premier Mass spectrometer, both 
equipped with an Acquity UPLC, a lock-mass electrospray ion source and an Acquity 
photodiode array detector (Waters Ltd., UK). Methanol or acetonitrile were used as 
the carrier solvents.  
Gas chromatography mass spectra were obtained using a Shimadzu QP2010-Ultra 
spectrometer equipped with an Rxi-5Sil-MS column, operating in EI mode at 70 eV 
using helium as the carrier gas (0.41 mL/min). 
Melting points were determined using a Sanyo Gallenkamp Melting Point Apparatus 
at atmospheric pressure and are uncorrected. 
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X-ray crystal structure images were produced using Mercury CSD 3.7 software using 
data from the Cambridge Structural Database. Original publications of the crystal 
structures, along with their CCDC identifiers, are cited in the text. 
5.2 HPLC analysis 
Reverse phase HPLC was performed at 295 K using a Shimadzu system comprising a 
Degassing Unit (DGU-20A5R), a Prominence Preparative Liquid Chromatography 
pump (LC-20AP), a Prominence UV-Vis Detector (SPD-20A) and Communications 
Bus Module (CBM-20A). For preparative HPLC an XBridge C18 OBD column was 
used (19 x 100 mm, 5 µm) with a flow rate of 17 mL/min. For analytical HPLC a 
Shimadzu Shim-Pack VP-ODS column was used (4.6 x 150 mm, 5 µm) with a flow 
rate of 2.0 mL/min. Fraction collection was performed manually. A solvent system 
of H2O / CH3OH (Methods A-C and E) or H2O / CH3CN (Method D) was used with 
gradient elution as follows: 
Method A 
 
 
 
 
Method B 
 
 
 
 
 
Step Time / min % H2O % CH3OH 
0 0 90 10 
1 3 90 10 
2 13 0 100 
3 17 0 100 
4 18 90 10 
Step Time / min % H2O % CH3OH 
0 0 90 10 
1 10 90 10 
2 25 0 100 
3 30 0 100 
4 31 90 10 
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Method C 
 
 
 
 
 
Method D 
 
 
 
 
 
Method E 
 
 
 
 
 
 
Step Time / min % H2O % CH3OH 
0 0 90 10 
1 7 90 10 
2 22 0 100 
3 27 0 100 
4 28 90 10 
Step Time / min % H2O % CH3CN 
0 0 90 10 
1 7 90 10 
2 22 0 100 
3 27 0 100 
4 28 90 10 
Step Time / min % H2O % CH3OH 
0 0 90 10 
1 3 90 10 
2 23 0 100 
3 26 0 100 
4 27 90 10 
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Chiral HPLC analysis was carried out on a Perkin Elmer Series 200 system comprising 
a Perkin Elmer Series 200 pump, autosampler, and UV/Vis detector, using either 
Daicel CHIRALPAK-IC or ID columns (4.6 x 250 mm for analytical with a flow rate of 
1.0 mL/min, 10 x 250 mm for preparative with a flow rate of 4.4 mL/min, all 5 µm 
particle size). Isocratic methanol was used as the mobile phase. Fraction collection 
was performed manually. Data was analysed using TotalChrom 6.3.1 software. 
5.3 Optical measurements 
All solution state optical analyses were carried out in quartz cuvettes with a path 
length of 1 cm. UV/Vis absorbance spectra were measured on an ATI Unicam 
UV/Vis spectrometer (Model UV2) using Vision software (version 3.33). Emission 
spectra were recorded using either an ISA Jobin-Yvon Spex Fluorolog-3 
luminescence spectrometer using DataMax software (version 2.2.10) or a HORIBA 
Jobin-Yvon Fluorolog-3 luminescence spectrometer equipped with an iHR320 
module, which selects either a HORIBA FL-1073 (Hammatsu R928P) photomultiplier 
tube or a HORIBA Synapse BIDD CCD for detection of emitted light, using 
FluorEssence software (based on Origin® software). Quantum yields were recorded 
using a HORIBA Quanta-Φ integrating sphere. Lifetime measurements were carried 
out using a Perkin Elmer LS55 spectrometer using FL Winlab software. Low 
temperature emission spectra were recorded in the above instruments using a Janis 
VNF-100 cryostat coupled to a LakeShore 332 temperature controller, and cooled 
with liquid nitrogen.  
CPL spectra were recorded on a custom-built spectrometer consisting of a laser 
driven light source (Energetiq EQ-99 LDLS, spectral range 170 – 2100 nm) coupled 
to an Acton SP2150 monochromator (600 g/nm, 300 nm Blaze) that allows 
excitation wavelengths to be selected with a 6 nm FWHM band-pass. The collection 
of the emitted light was facilitated (90° angle setup) by a Lock-In Amplifier (Hinds 
Instruments Signaloc 2100) and Photoelastic Modulator (Hinds Instruments Series 
II/FS2AA). The differentiated light was focused onto an Acton SP2150 
monochromator (1200 g/nm, 500 nm Blaze) equipped with a high sensitivity cooled 
Photo Multiplier Tube (Hamamatsu H10723-20 PhotoSensor). Red correction is 
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embedded in the detection algorithm and was constructed using a calibrated Ocean 
Optics lamp. Spectra were recorded with 0.5 nm spectral intervals and 500 µs 
integration time, using a 5 spectral average sequence for europium(III) complexes 
and between 10 and 12 spectral averages for dysprosium(III) complexes. The 
monochromators, PEM control unit and lock-in amplifier were interfaced with a 
desktop PC and controlled by LabView code.  
5.4 Time-gated photography 
Time-gated photography was achieved using an off-the-shelf DSLR camera (Nikon 
D5300) equipped with an i-TTL flash unit (Nikon SB910) paired with a wireless flash 
trigger and receiver (YN-622N). Test samples were prepared using Canson Infinity 
Rag Photographique 2010 g/m2 paper. Emissive species were deposited as solutions 
in methanol using a small volume pipette (Gilson, Inc.) and allowed to dry in air. 
Time-gating was introduced by placing the camera and sample 1.8 m apart, giving a 
6 ns delay (light travels at 0.3 m ns-1).  
5.5 Circularly polarised microscopy 
Chiroptical contrast based imaging was facilitated via modification of a time-
resolved Zeiss Axiovert 200M epifluorescence microscope set-up.218 Areas of the 
two enantiopure [EuL2] spots with similar brightness were selected (contrast 
values: Λ-[EuL2] 222/255 and Δ-[EuL2] 231/255) and using a dye punch (0.3 x 150 
mm), two well-defined line-shaped blotted pieces of paper were mounted parallel 
to each other on a SuperFrost microscope slide capped with a 170 μm coverslip for 
imaging. The microscope is equipped with a variable pulse sequence generator, 
allowing both CW and time-resolved operation. Images were acquired using an 
EO-M (monochrome, Thor Labs.) 0.7 megapixel rolling shutter camera with an 
acquisition time set at 7.2 ms per frame. A typical value for time gating was 6-10 μs, 
after pulsed excitation with a 365 nm UV LED (Nichia, 24 V, 1.2 W, collimated and 
scrambled to 1” diameter, focused to the back focal plane of a Zeiss x10/0.25NA A-
Plan air objective). Chiroptical selection was achieved by converting right- and left-
handed CPL into vertical and horizontal linearly polarised light, respectively, using a 
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10 mm aperture quarter-wave plate (400-800 nm, Thor Labs.). Light of the correct 
linear polarisation was selected using a pair of linear polarisers (1”; 40000:1 
extinction ratio, Thor Labs.) orientated at 90° to each other. This light was focused 
onto a CCD detector (EO-1312M, Edmund Optics). The imaging sequence can be 
programmed for any number of frame averages or in the case of low light 
collection, an accumulation sequence, controlled manually or by an average FOV 
pixel contrast saturation-limiting algorithm. The image is accumulated until the 
maximum contrast value of 255 is achieved in a 20 pixel cluster, at which point any 
further acquisition saturates the image; in digital image acquisition there are 254 
possible shades of grey, in addition to black and white. The accumulations are 
averaged until the difference in contrast between the two regions is 5x the signal to 
noise ratio.  
5.6 Preparation of PMMA films 
A 100 μL aliquot of a 1 mg mL-1 solution of europium(III) complex in DMF was added 
to 1 mL of a 10 mg mL-1 solution of PMMA (average Mw ≈ 15 000) in DMF. The 
resulting solution was stirred at room temperature for approximately 30 min, after 
which the solution was drop-cast in 20 μL portions using a Gilson pipette onto a 
quartz disc (20 × 1 mm, UQG Optics, UK) and dried in air. After the final deposition, 
the disc was heated to 35 °C overnight before photophysical properties were 
measured.  
5.7 Cell culture protocols 
Cells used for simple microscopy studies were cultured as follows. Cells were grown 
in a 12-well plate on a sterilised (autoclaved at 121 °C for 45 min) glass coverslip in 
phenol red 3-containing DMEM/F12 cell growth medium (pH 7.6) supplemented 
with sodium pyruvate, glucose, 0.25 mM HEPES buffer and 10% fetal bovine serum. 
The cells were allowed to grow to 70-80% confluence at which point the medium 
was removed and replaced with medium containing complex. The cells were 
incubated at 37 °C at 5% CO2 and 10% humidity. For co-staining experiments, 
MitoTracker Green (0.2 μM) was added to the medium 30 min before imaging, 
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while LysoTracker Green (0.2 μM) was added 5 min before imaging. Prior to 
imaging, the coverslips were washed with fresh medium three times and fixed to 
glass slides for imaging. 
Cell uptake mechanism experiments using promoters and inhibitors of various 
uptake pathways were carried out as follows. Cells were pre-incubated with 
medium containing the treatment (concentrations below) for 30 min, before being 
incubated at 37 °C for a further 4 h in complex-containing medium (30 μM). In the 
case of the low temperature samples, the cells were incubated at 4 °C. The control 
samples were prepared in an identical fashion without promoter/inhibitor 
treatment. Prior to imaging, the coverslips were removed, washed with fresh 
medium four times and fixed to glass slides.  
Treatment Dose 
Phorbol 12-myristate-13-acetate 8 nM 
Amiloride 30 μM 
Wortmannin 3 nM 
1,2,-Dipalmitoyl-rac-diacylglycerol 90 nM 
Monensin 0.2 nM 
Chloroquine 1 μM 
Sucrose 0.5 mM 
Poly-L-lysine 0.001% w/v 
Filipin 1.5 μM 
Chlorpromazine 5 μM 
 
In all cases, the following experimental parameters were used for imaging. For 
europium complexes: λexc = 355 nm, λem 605-720 nm; for MitoTracker Green: λexc = 
488 nm, λem 500-530 nm; for LysoTracker Green: λexc = 514 nm, λem 530-550 nm. 
Cells used for ICP-MS studies were prepared as follows. Cells were cultured in a 6-
well plate to 90% confluence. Cells were then counted (107 cells based on a cell 
volume of 4000 µm3) and incubated with medium containing the complex before 
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being washed three times with phosphate-buffered saline (PBS). The cells were 
then trypsinated and harvested and diluted to 1 mL with PBS. Concentrated nitric 
acid (0.6 mL) was added and the samples were digested for 24 h at 37 °C. These 
digested samples were submitted for ICP-MS measurements (Dr. Chris Ottley, 
Department of Earth Sciences, Durham University). The samples were run against a 
series of Eu standards, and the measured concentration was back calculated to find 
the total Eu concentration present in the original counted cells. 
5.8 Confocal microscopy and cell imaging 
Cell images and co-localisation experiments were obtained using a Leica SP5 II 
microscope equipped with PhMoNa.219 In order to achieve excitation with maximal 
probe emission, the microscope was coupled by an optical fibre to a coherent 355 
nm CW (Nd:YAG) laser (3rd harmonic), operating at 8 mW power. A HeNe or Ar ion 
laser was used when commercially available organelle-specific stains (e.g. 
MitoTracker Green and LysoTracker Green) were used to corroborate cellular 
compartmentalisation. The microscope was equipped with a triple channel imaging 
detector, comprising two conventional PMT systems and a HyD hybrid avalanche 
photodiode detector. The latter part of the detection system, when operated in the 
BrightRed mode, is capable of improving imaging sensitivity above 550 nm by 25%, 
reducing signal to noise by a factor of 5. The pinhole was determined by the Airy 
disc size, calculated from the objective in use (HCX PL APO 63x/1.40 NA Lbd Blue), 
using the lowest excitation wavelength (355 nm) and was set to 0.6 Airy unit. 
Scanning speed was adjusted to 200 Hz in a unidirectional mode, to ensure both 
sufficient light exposure and enough time to collect the emitted light from the 
lanthanide based optical probes (1024 x 1024 frame size, a pixel size of 120 x 120 
nm and depth of 0.772 μm) but sufficiently fast to prevent movement of cellular 
compartments due to natural homeostasis. Spectral imaging in cells was achieved 
using a custom built microscope (modified Zeiss Axiovert 200M), using a Zeiss 
APOCHROMAT  63x/1.40 NA objective combined with a low voltage (24 V) 365 nm 
pulsed UV LED focused, collimated excitation source (1.2 W). For rapid spectral 
acquisition the microscope was equipped at the X1 port with a Peltier cooled 2D-
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CCD detector (Maya Pro, Ocean Optics) used in an inverse 100 Hz time gated 
sequence. Spectra were recorded from 400-800 nm with a resolution of 0.24 nm 
and averaged using a 10,000 scan duty cycle. Probe lifetimes were measured on the 
same microscope platform using a novel cooled PMT detector (Hamamatsu H7155) 
interchangeable on the X1 port, with the application of pre-selected interference 
filters. Both the control and detection algorithm were written in LabView2014, 
where probe lifetime was determined by using a single exponential fitting algorithm 
to the monitored signal intensity decay.   
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5.9 Synthetic procedures 
 2-(2,2-Dibromovinyl)-1,3,5-trimethoxybenzene,220 2 
 
2,4,6-Trimethoxybenzaldehyde 1 (0.50 g, 2.5 mmol) and triphenylphosphine 
(1.34 g, 5.10 mmol) were dissolved in anhydrous dichloromethane (2 mL) and the 
solution was cooled in ice. A solution of tetrabromomethane (1.69 g, 5.10 mmol) in 
anhydrous dichloromethane (3 mL) was added dropwise. The reaction was allowed 
to warm to room temperature and was stirred for 22 h, at which time further 
triphenylphosphine (1.34 g, 5.10 mmol) was added. The reaction was stirred for a 
further 6 h, before the solvent was removed under reduced pressure. The residue 
was purified by silica gel column chromatography (neat hexane to 7:3 v/v 
hexane:ethyl acetate) to give a white solid (0.205 g, 23%); m.p. 126-129 °C (lit.220 
128-130 °C); 1H NMR (700 MHz, CDCl3) δ 7.19 (1 H, s, H2), 6.11 (2 H, s, H5), 3.82 (3 H, 
s, H8), 3.81 (6 H, s, H7); 13C NMR (176 MHz, CDCl3) δ 161.9 (C6), 158.2 (C4), 131.1 (C2), 
107.0 (C3), 92.9 (C1), 90.6 (C5), 55.8 (C7), 55.5 (C8); LCMS (ESI+) m/z 353 [M+H]+; 
HRMS (ESI+)  m/z 350.9220 [M+H]+ (C11H13O379Br2 requires 350.9231).  
2-Ethynyl-1,3,5-trimethoxybenzene,220 3 
 
2-(2,2-Dibromovinyl)-1,3,5-trimethoxybenzene 2 (0.300 g, 0.85 mmol) was 
dissolved in anhydrous tetrahydrofuran (8 mL) and the solution was cooled 
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to -78 °C. n-Butyllithium (1.13 mL of a 1.6 M solution in hexane) was added 
dropwise and the pale yellow solution was stirred for 20 min. Water (3 mL) was 
added slowly and the solution was stirred for 30 min. The organic solvents were 
removed under reduced pressure and the remaining aqueous solution was 
extracted with ethyl acetate (2 x 10 mL). The organic layers were combined and 
washed with brine (20 mL), then dried with MgSO4 , filtered and concentrated 
under reduced pressure to yield a yellow solid (0.162 g, 99%) which was used 
without further purification; m.p. 120-123 °C (lit.220 119-122 °C); 1H NMR (700 MHz, 
CDCl3) δ 6.11 (2 H, s, H5), 3.88 (6 H, s, H7), 3.83 (3 H, s, H8), 3.49 (1 H, s, H1); 13C NMR 
(176 MHz, CDCl3) δ 163.2 (C4), 162.1 (C6), 93.2 (C3), 90.5 (C5), 83.9 (C1), 76.7 (C2), 
56.2 (C7), 55.6 (C8). LCMS (ESI+) m/z 192 [M+H]+; HRMS (ESI+)  m/z 193.0853 [M+H]+ 
(C11H13O3 requires 193.0865). 
2-Bromo-6-methylpyridine-1-oxide,30 6 
 
2-Bromo-6-methylpyridine (4.95 mL, 7.48 g, 43.5 mmol) and m-chloroperbenzoic 
acid (15 g, 86.9 mmol) were dissolved in chloroform (110 mL). The resulting 
colourless solution was stirred at 65 °C under argon for 17 h, at which time TLC 
showed complete consumption of starting material. The solution was cooled and 
the solvent was removed under reduced pressure. The resulting residue was 
dissolved in dichloromethane (50 mL) and washed with saturated aqueous sodium 
bicarbonate (3 x 50 mL). The aqueous solution was extracted with dichloromethane 
(3 x 50 mL). The organic layers were combined, dried over MgSO4, filtered and 
concentrated to yield a yellow oil (7.69 g, 94%); 1H NMR (400 MHz, CDCl3) δ 7.55 (1 
H, d, 3JH-H 7.5, H3), 7.22 (1 H, d, 3JH-H 7.5, H5), 7.00 (1 H, t, 3JH-H 7.5, H4), 2.57 (3 H, s, 
H7); 13C NMR (101 MHz, CDCl3) δ 150.7 (C6), 133.1 (C2), 128.4 (C3), 125.0 (C5), 124.8 
(C4), 18.9 (C7); LCMS (ESI+) m/z 188 [M+H]+; HRMS (ESI+)  m/z 187.9702 [M+H]+ 
(C6H7O79Br requires 187.9711). 
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2-Bromo-6-methyl-4-nitropyridine-1-oxide,30 7 
 
2-Bromo-6-methylpyridine-1-oxide 6 (19.65 g, 0.101 mol) was dissolved in 
concentrated sulfuric acid (98%, 37 mL) and the resulting solution was cooled in an 
ice bath. Concentrated nitric acid (70%, 34 mL) was added dropwise, and the 
resulting brown solution was stirred at 100 °C for 19 h. The solution was poured 
cautiously onto 200 mL of ice water, with immediate precipitation of a pale yellow 
solid. This solid was collected by filtration and dissolved in dichloromethane 
(100 mL). The solution was dried over MgSO4, filtered and concentrated to yield the 
product as a pale yellow solid (16.00 g, 66%); m.p. 138-141 °C (lit.30 138-139 °C); 1H 
NMR (600 MHz, CDCl3) δ 8.42 (1 H, d, 4JH-H 3.0, H3), 8.10 (1 H, d, 4JH-H 3.0, H5), 2.63 (3 
H, s, H7); 13C NMR (151 MHz, CDCl3) δ 151.7 (C6), 140.6 (C4), 133.9 (C2), 122.8 (C3), 
118.8 (C5), 19.5 (C7); LCMS (ESI+) m/z 233 [M+H]+; HRMS (ESI+) m/z 232.9564 [M+H]+ 
(C6H6N2O379Br requires 232.9562). 
2-Bromo-6-methyl-4-nitropyridine,30 8 
 
2-Bromo-6-methyl-4-nitropyridine-1-oxide 7 (3.94 g, 16.91 mmol) was dissolved in 
chloroform (150 mL). Phosphorus tribromide (4.8 mL, 51 mmol) was added 
dropwise and the resulting yellow solution was stirred at 60 °C for 17 h. The 
solution was cooled and the solvent removed under reduced pressure. The residue 
was dissolved in dichloromethane (100 mL) and washed with saturated aqueous 
sodium bicarbonate (2 x 50 mL). The aqueous layer was extracted with 
dichloromethane (3 x 100 mL). The organic extracts were combined, dried over 
MgSO4, filtered and concentrated to give a bright yellow oil which solidified on 
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standing (2.72 g, 74%); m.p. 56-58 °C (lit.221 51-52 °C); 1H NMR (400 MHz, CDCl3) δ 
8.03 (1 H, d, 4JH-H 1.5, H3), 7.84 (1 H, d, 4JH-H 1.5, H5), 2.71 (3 H, s, H7); 13C NMR (101 
MHz, CDCl3) δ 163.1 (C6), 155.0 (C4), 142.5 (C2), 118.6 (C3), 115.2 (C5), 24.7 (C7); 
GCMS-EI m/z 217 [M(79Br)]+. 
Ethyl (6-methyl-4-nitropyridin-2-yl)(phenyl)phosphinate,30 9 
 
2-Bromo-6-methyl-4-nitropyridine, 8 (1.00 g, 4.61 mmol) was dissolved in 
anhydrous toluene (10 mL) and the solution was degassed (freeze-pump-thaw x 3). 
Ethyl phenylphosphinate (830 µL, 5.53 mmol) and trimethylamine (2.25 mL, 
16.1 mmol) were added. Argon was bubbled through the solution for 45 min. [1,1’-
Bis(diphenylphosphino)ferrocene]dichloropalladium (II) (188 mg, 0.231 mmol) was 
added and the resulting red solution was stirred at 120 °C under argon for 16 h. The 
solvent was removed under reduced pressure and the resulting black residue was 
purified by column chromatography (silica, 3:1 hexane:ethyl acetate to 1:2 
hexane:ethyl acetate) to yield the desired product as a yellow oil (380 mg, 27%); 1H 
NMR (600 MHz, CDCl3) δ 8.56 (1 H, dd, 3JH-P 6.5, 4JH-H 2.5, H3), 7.98 (2 H, ddd, 3JH-P 
12.5, 3JH-H 8.0, 4JH-H 1.5, H9), 7.91 (1 H, br s, H5), 7.56 (1 H, tq, 3JH-H 7.0, 4JH-H, 1.5, 5JH-P 
1.5, H11), 7.47 (2 H, td, 3JH-H 8.0, 4JH-P 3.5, H10), 4.19-4.15 (2 H, m, H12), 2.73 (3 H, s, 
H7), 1.39 (3 H, t, 3JH-H 7.0, H13); 13C NMR (151 MHz, CDCl3) δ 163.2 (d, 3JC-P 21, C6), 
158.3 (d, 1JC-P 168, C2), 154.2 (d, 3JC-P 14, C4), 133.0 (d, 4JC-P 3, C11), 132.6 (d, 2JC-P 10, 
C9), 129.2 (d, 1JC-P 141, C8), 128.6 (d, 3JC-P 13, C10), 117.6 (d, 2JC-P 24, C3), 117.5 (d, 4JC-P 
3, C5), 62.3 (d, 2JC-P 6, C12), 25.0 (C7), 16.6 (d, 3JC-P 6, C13); 31P NMR (162 MHz, CDCl3) δ 
+23.6; LCMS (ESI+) m/z 307 [M+H]+; HRMS (ESI+) m/z 307.0850 [M+H]+ (C14H16NO4P 
requires 307.0848). 
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(6-Methyl-4-nitropyridin-2-yl)(phenyl)phosphinic acid30  
 
 
Ethyl (6-methyl-4-nitropyridin-2-yl)(phenyl)phosphinate 9 (380 mg, 1.24 mmol) was 
dissolved in acetyl bromide (2.75 mL, 37.2 mmol) and the solution as stirred at 
70 °C for 16 h. The solution was cooled and added dropwise to ice cold stirring 
methanol (20 mL). This solution was stirred at room temperature for 1 h, after 
which time the solvent was removed under reduced pressure to yield a dark red oil 
(348 mg, 90%) which was used without further purification; 1H NMR (600 MHz, 
CD3OD) δ 8.39 (1 H, dd, 3JH-P 7.0, 4JH-H 2.5, H3), 8.30 (1 H, d, 4JH-H 2.5, H5), 7.97 (2 H, 
dd, 3JH-P 11.5, 3JH-H 7.0, H9), 7.67 (1 H, t, 3JH-H 7.0, H11), 7.58 (2 H, t, 3JH-H 7.0, H10), 2.79 
(3 H, s, H7); 13C NMR (151 MHz, CD3OD) δ 159.5 (d, 3JC-P 8, C6), 152.8 (d, 1JC-P 132, C2), 
144.6 (d, 3JC-P 11, C4), 134.7 (d, 4JC-P 1, C11), 134.5 (s, C5), 133.3 (d, 2JC-P 11, C9), 132.4 
(d, 2JC-P 12, C3), 131.8 (d, 1JC-P 147, C8), 130.2 (d, 3JC-P 14, C10), 20.3 (C7); 31P NMR (162 
MHz, CD3OD) δ +13.6; LCMS (ESI+) m/z 312 [M+H]+; HRMS (ESI+) m/z 311.9794 
[M+H]+ (C12H1279BrNO2P requires 311.9789). 
Ethyl (6-methyl-4-nitropyridin-2-yl)(phenyl)phosphinate,30 10 
 
(6-Methyl-4-nitropyridin-2-yl)(phenyl)phosphinic acid (348 mg, 1.12 mmol) was 
dissolved in triethyl orthoformate (11 mL, 66.1 mmol) and the solution was stirred 
140 °C for 65 h under argon. The solvent was removed under reduced pressure to 
give a brown oil. The crude product was purified by column chromatography (silica, 
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CH2Cl2 to 1% CH3OH in CH2Cl2) yielding a pale yellow oil (282 mg, 75%); 1H NMR 
(600 MHz, CDCl3) δ 8.06 (1 H, dd, 3JH-P 6.5, 4JH-H 2.0, H3), 7.97 (2 H, ddd, 3JH-P 12.0, 
3JH-H 7.0, 2JH-H 1.5, H9), 7.53 (1 H, td, 3JH-H 7.0, 4JH-P  1.5, H11), 7.45 (2 H, td, 3JH-H 7.0, 
4JH-P 3.5, H10), 7.40 (1 H, br s, H5), 4.18-4.08 (2 H, m, H12), 2.54 (3 H, s, H7), 1.36 (3 H, 
t, 3JH-H 7.0, H13); 13C NMR (151 MHz, CHCl3) δ 161.1 (d, 3JC-P 21, C6), 155.5 (d, 1JC-P 
166, C2), 133.5 (d, 3JC-P 15, C4), 132.6 (d, 4JC-P 3, C11), 132.5 (d, 2JC-P 10, C9), 129.9 (d, 
1JC-P 140, C8), 128.7 (d, 4JC-P, 3, C5), 128.6 (d, 2JC-P 24, C3), 128.5 (d, 3JC-P 13, C10), 62.0 
(d, 2JC-P 6, C12), 24.5 (s, C7), 16.6 (d, 3JC-P 6, C13); 31P NMR (162 MHz, CHCl3) δ +24.3; 
LCMS (ESI+) m/z 340 [M+H]+; HRMS (ESI+) m/z 340.0114 [M+H]+ (C14H1679BrNO2P 
requires 340.0102). 
Ethyl (4-nitro-6-methyl-1-oxo-yridin-2-yl)(phenyl)phosphinate,30 11 
 
 
Ethyl (6-methyl-4-nitropyridin-2-yl)(phenyl)phosphinate 10 (282 mg, 0.829 mmol) 
and m-chloroperbenzoic acid (300 mg, 1.74 mmol) were dissolved in anhydrous 
CHCl3 (5 mL) and the solution was heated at 65 °C for 42 h, after which time the 
solvent was removed under reduced pressure. The pale yellow residue was 
dissolved in CH2Cl2 (15 mL) and washed with 0.5 M NaHCO3 solution (15 mL). The 
aqueous layer was extracted with CH2Cl2 (3 x 15 mL). The organic layers were 
combined, dried over MgSO4, filtered and concentrated. The crude product was 
purified by column chromatography (silica, CH2Cl2 to 3% CH3OH in CH2Cl2) to yield a 
pale yellow oil (224 mg, 76%); 1H NMR (700 MHz, CDCl3) δ 8.04 (1 H, dd, 3JH-P 8.0, 
4JH-H 2.5, H3), 7.98 (2 H, dd, 3JH-P 12.5, 3JH-H 7.5, H9), 7.51 (1 H, td, 3JH-H 7.5, 4JH-H 1.5, 
H11), 7.46 (1 H, d, 4JH-H 2.5, H5), 7.42 (2 H, td, 3JH-H 7.5, 4JH-P 3.5, H10), 2.45 (3 H, s, H7), 
4.16-4.08 (2 H, m, H12), 1.34 (3 H, t, 3JH-H 6.5, H13); 13C NMR (176 MHz, CDCl3) δ 
151.0 (d, 3JC-P 3, C6), 144.3 (d, 1JC-P 146, C2), 133.3 (d, 2JC-P 10, C9), 133.1 (d, 4JC-P 4, 
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C11), 133.0 (d, 2JC-P 11, C3), 132.2 (d, 4JC-P 3, C5), 129.1 (d, 1JC-P 148, C8), 128.4 (d, 3JC-P 
14, C10), 117.6 (d, 3JC-P, 12, C4), 62.3 (d, 2JC-P 5, C12), 17.5 (d, 4JC-P 2, C7), 16.6 (d, 3JC-P 7, 
C13); 31P NMR (283 MHz, CDCl3) δ +21.4; LCMS (ESI+) m/z 356 [M+H]+; HRMS (ESI+) 
356.0064 [M+H]+ (C14H16NO3P79Br requires 356.0051). 
Ethyl [4-bromo-6-(hydroxymethyl)pyridine-2-yl](phenyl) phosphinate,188 4 
 
Ethyl (4-bromo-6-methylpyridin-1-oxide-2-yl)phenylphosphinate 11 (224 mg, 
0.63 mmol) was dissolved in anhydrous acetonitrile (5 mL). Trifluoroacetic 
anhydride (1.77 mL, 2.64 g, 12.6 mmol) was added and the resulting green solution 
was heated to 60 °C under argon. After 3 h, the formation of the trifluoroacetate 
ester was complete (confirmed by 1H NMR). The solvent was removed under 
reduced pressure, and the residue dissolved in a 1:1 mixture of ethanol:water 
(10 mL). This solution was stirred at room temperature for 21 h, at which time the 
organic solvent was removed under reduced pressure and the aqueous solution 
was extracted with dichloromethane (3 x 20 mL). The organic layers were 
combined, dried over MgSO4, filtered and concentrated to give a brown oil which 
was purified by silica gel column chromatography (CH2Cl2 to 3% CH3OH in CH2Cl2) to 
yield a yellow oil (164 mg, 73%); 1H NMR (700 MHz, CDCl3) δ 8.14 (1 H, d, 3JH-P 6.5, 
H3), 7.93 (2 H, dd, 3JH-P 12.0, 3JH-H 7.5, H9), 7.58 (1 H, s, H5), 7.55 (1 H, t, 3JH-H 7.5, H11), 
7.47 (2 H, td, 3JH-H 7.5, 4JH-P 3.5, H10), 4.75 (2 H, s, H7), 4.19-4.09 (2 H, m, H12), 1.37 (3 
H, t, 3JH-H 7.0, H13); 13C NMR (176 MHz, CDCl3) δ 162.2 (d, 3JC-P 20, C6), 155.0 (d, 1JC-P 
165, C2), 134.3 (d, 3JC-P 14, C4), 133.0 (d, 4JC-P 3, C11), 132.4 (d, 2JC-P 10, H9), 130.0 (d, 
3JC-P 23, C3), 129.4 (d, 1JC-P 141, C8), 128.7 (d, 3JC-P 13, C10), 126.0 (d, 4JC-P 3, C5), 64.0 
(s, C7), 62.2 (d, 2JC-P 6, C12), 16.7 (d, 3JC-P 6, C13); 31P NMR (283 MHz, CDCl3) δ +24.4; 
LCMS (ESI+) m/z  356 [M(79Br)+H]+; HRMS (ESI+) m/z 356.0047 [M+H]+ 
(C14H16NO3P79Br requires 356.0051). 
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Ethyl [6-(hydroxymethyl)-4-[2-(2,4,6-trimethoxyphenyl)ethynyl] pyridin-2-
yl](phenyl)phosphinate, 13 
 
2-Ethynyl-1,3,5-trimethoxybenzene 3 (30 mg, 0.15 mmol) and ethyl [4-bromo-6-
(hydroxymethyl)pyridine-2-yl](phenyl) phosphinate 4 (50 mg, 0.14 mmol) were 
dissolved in anhydrous tetrahydrofuran (1 mL) and the solution was degassed 
(freeze-pump-thaw cycle x 3). Triethylamine (96 µL, 70 mg, 0.7 mmol) was added 
and the solution degassed again (freeze-pump-thaw x 1). [1,1’-
Bis(diphenylphosphino)ferrocene]dichloropalladium(II) (11.4 mg, 0.0140 mmol) and 
CuI (5.3 mg, 0.0280 mmol) were added and the solution stirred at 65 °C under 
argon for 4 h. The solvent was removed under reduced pressure and the residue 
was purified by silica gel column chromatography (neat CH2Cl2 to 3% CH3OH in 
CH2Cl2). The product was still contaminated with catalyst residue so the mixture 
was subjected to a second purification by silica gel column chromatography (1:1 to 
4:1 v/v ethyl acetate:hexane) which gave a yellow oil (41 mg, 62%); 1H NMR 
(700 MHz, CDCl3) δ 8.12 (1 H, d, 3JH-P 6.5, H3), 7.95 (2 H, dd, 3JH-P 12.0, 3JH-H 7.0, H9), 
7.53 (1 H, t, 3JH-H 7.0, H11), 7.45 (2 H, dt, 3JH-H 7.0, 4JH-P 3.5, H10), 7.41 (1 H, s, H5), 6.10 
(2 H, s, H18), 4.73 (2 H, d, 5JH-P 5.0, H7), 4.19-4.08 (2 H, m, H12), 3.88 (6 H, s, H20), 3.84 
(3 H, s, H21), 1.36 (3 H, t, 3JH-H 7.0, H13); 13C NMR (176 MHz, CDCl3) δ 163.0 (C19), 
162.9 (C17), 160.0 (d, 3JC-P 19, C6), 152.8 (d, 1JC-P 167, C2), 133.9 (d, 3JC-P 12, C4), 132.7 
(d, 4JC-P 3, C11), 132.4 (d, 2JC-P 10, C9), 129.9 (d, 1JC-P 140, C8), 128.8 (d, 2JC-P 23, C3), 
128.5 (d, 3JC-P 13, C10), 123.9 (d, 4JC-P 3, C5), 93.5 (d, 4JC-P 2, C14), 93.2 (C16), 90.6 (C18), 
89.9 (C15), 63.9 (C7), 62.0 (d, 2JC-P 6, C12), 56.2 (C20), 55.6 (C21), 16.6 (d, 3JC-P 6, C13); 31P 
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NMR (162 MHz, CDCl3) δ +25.8; LCMS (ESI+) m/z 468 [M+H]+; HRMS (ESI+)  m/z 
468.1568 [M+H]+ (C25H27NO6P requires 468.1576).  
{4-[2-(2,4,6-Trimethoxyphenyl)ethynyl]-6-[ethoxy(phenyl)phosphoryl]pyridin-2-
yl}methyl methanesulfonate, 14 
 
Ethyl [6-(hydroxymethyl)-4-[2-(2,4,6-trimethoxyphenyl)ethynyl] pyridin-2-
yl](phenyl)phosphinate 13 (41 mg, 0.088 mmol) was dissolved in anhydrous 
tetrahydrofuran (2 mL) and the solution was cooled in an ice bath. Triethylamine 
(25 µL, 0.18 mmol) was added followed by dropwise addition of methanesulfonyl 
chloride (10 µL, 0.13 mmol), which resulted in the formation of a precipitate. The 
reaction was stirred under argon for 45 min and the solvent was removed under 
reduced pressure. The residue was redissolved in dichloromethane (20 mL) and 
washed with saturated brine solution (20 mL). The aqueous solution was re-
extracted with dichloromethane (3 x 20 mL) and the organic layers combined, dried 
with MgSO4, filtered and concentrated under reduced pressure to give a pale yellow 
oil (48 mg, quant.) which was used without further purification; 1H NMR (400 MHz, 
CDCl3) δ 8.14 (1 H, d, 3JH-P 6.0, H3), 7.98-7.89 (2 H, m, H9), 7.55 (1 H, s, H11), 7.45 (2 
H, d, 4JH-P 4.0, H10), 7.43 (1 H, s, H5), 6.08 (2 H, s, H18), 5.28 (2 H, s, H7), 4.11 (2 H, q, 
3JH-H 7.0, H12), 3.87 (6 H, s, H20), 3.82 (3 H, s, H21), 2.94 (3 H, s, H22), 1.36 (3 H, t, 3JH-H 
7.0, H13); LCMS (ESI+) m/z 546 [M+H]+; HRMS (ESI+) m/z 546.1345 [M+H]+ 
(C26H29NO8PS requires 546.1352). 
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1,4,7-Tris({4-[2-(2,4,6-trimethoxyphenyl)ethynyl]-6-
[ethoxy(phenyl)phosphoryl]pyridin-2-yl}methyl)-1,4,7-triazacyclononane (tri-ethyl 
ester of L1) 
 
1,4,7-Triazacyclononane trihydrochloride (6.5 mg, 0.027 mmol) and potassium 
carbonate (15.0 mg, 0.109 mmol) were dissolved in anhydrous acetonitrile (1 mL). 
{4-[2-(2,4,6-Trimethoxyphenyl)ethynyl]-6-[ethoxy(phenyl)phosphoryl]pyridin-2-yl} 
methyl methanesulfonate (6) (48 mg, 0.088 mmol) was added as a solution in 
anhydrous acetonitrile (1 mL). The solution was stirred at 65 °C under argon for 
16 h, at which time the solution was cooled to room temperature, and the solution 
decanted from excess potassium salts and concentrated under reduced pressure. 
The residue was purified by silica gel column chromatography (neat CH2Cl2 to 10% 
CH3OH in CH2Cl2) to give a yellow film (7.1 mg, 18%); 1H NMR (600 MHz, CDCl3) δ 
8.12 (3 H, d, 3JH-P 6.5, H3), 7.85 (6 H, dd, 3JH-P 12.0, 3JH-H 7.0, H9), 7.50 (3 H, t, 3JH-H 7.0, 
H11), 7.44-7.40 (9 H , m, H5 + H10, peaks overlap), 6.11 (6 H, s, H18), 4.14-4.09 (6 H, 
m, H12), 3.90-3.89 (24 H, two overlapping singlets, H7 + H20), 3.85 (9 H, s, H21), 3.03-
2.65 (12 H, m, ring CH2), 1.34 (9 H, t, 3JH-H 7.0, H13); 13C NMR (151 MHz, CDCl3) δ 
163.2 (C19), 163.1 (C17), 159.9 (C6), 154.4 (d, 1JC-P 168, C2), 134.2 (d, 3JC-P 15, C4), 
132.8 (C11), 132.4 (d, 2JC-P 10, C9), 130.5 (C8), 129.5 (C10), 128.6 (d, 2JC-P 12, C3), 127.3 
(C5), 93.3 (C14), 93.2 (C16), 90.7 (C15), 90.6 (C18), 61.9 (d, 2JC-P 6, C12), 59.6 (C7), 56.2 
(C20), 55.7 (C21), 51.5-45.4 (ring CH2), 16.7 (d, 3JC-P 6, C13); 31P NMR (243 MHz, CDCl3) 
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δ +25.7; LCMS (ESI+) m/z 1478 [M+H]+; HRMS (ESI+) m/z 1477.551 [M+H]+ 
(C81H88N6O15P3 requires 1477.552). 
[EuL1] 
 
1,4,7-Tris({4-[2-(2,4,6-trimethoxyphenyl)ethynyl]-6-
[ethoxy(phenyl)phosphoryl]pyridin-2-yl}methyl)-1,4,7-triazacyclononane (7 mg, 
4.8 µmol) was dissolved in CD3OD (0.5 mL) and a solution (0.3 mL) of 0.05 M 
potassium hydroxide in D2O was added. The solution was stirred at 60 °C under 
argon for 4 days at which point further potassium hydroxide (1 mg) was added. The 
solution was stirred for a further 4 days. Hydrolysis of the phosphinate esters was 
monitored by 31P NMR (starting material: +25.7 ppm, product: +16.5 ppm). After 
hydrolysis was complete, EuCl3·6H2O (1.8 mg, 4.9 µmol) was added and the reaction 
stirred at 60 °C for 18 h. The solution was then neutralised with dilute HCl and the 
solvent removed under reduced pressure. The crude product was purified by RP-
HPLC (Method A, tR = 13.5 min) to give the product (2.3 mg, 30%); LCMS (ESI+) m/z 
1548 [M(2H5)+H]+; λmax (MeOH) = 356 nm; τEu (MeOH) = 1.18 ms; Φ𝑀𝑒𝑂𝐻
𝑒𝑚  = 39 (±5)%. 
Accurate mass analysis could not be obtained due to multiple deuteration of the 
complex during phosphinate ester hydrolysis. This resulted in many overlapping 
signals which obscured the monoisotopic mass. A base-catalysed mechanism for 
H/D exchange has been proposed for the acidic protons in the pyridyl-CH2 linker: 
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Because Eu3+ is relatively easy to reduce compared to other Ln3+ ions (forms a 
favourable 4f7 configuration), it can act as a charge sink to favour the reaction, via 
stabilisation of the non-aromatic vinylidene structure. 
[2-(4-Methoxyphenyl)ethynyl]trimethylsilane,80 16 
 
4-Bromo-3-methylanisole 15 (0.500 g, 2.49 mmol) was dissolved in anhydrous 
tetrahydrofuran (18 mL) and the solution was degassed (freeze-pump-thaw cycle x 
3). Triethylamine (1.73 mL, 12.5 mmol) and ethynyltrimethylsilane (1.05 mL, 
7.47 mmol) were added and the solution was degassed again (freeze-pump-thaw x 
3). [1,1’-Bis(diphenylphosphino)ferrocene] dichloropalladium(II) (108 mg, 
0.25 mmol) and copper (I) iodide (48 mg, 0.25 mmol) were added and the solution 
was stirred at 65 °C under argon for 90 h. The solvent was removed under reduced 
pressure and the brown residue was purified by silica gel column chromatography 
(neat hexane to 12% dichloromethane in hexane) to yield the desired product as a 
yellow oil (0.54 g, quant.); 1H NMR (700 MHz, CDCl3) δ 7.36 (1 H, d, 3JH-H 8.5, H5), 
6.72 (1 H, d, 4JH-H 2.0, H8), 6.65 (1 H, dd, 3JH-H 8.5, 4JH-H 2.0, H6), 3.79 (3 H, s, H11), 2.41 
(3 H, s, H10), 0.25 (9 H, s, H1); 13C NMR (176 MHz, CDCl3) δ 159.8 (C7), 142.6 (C9), 
133.6 (C5), 115.4 (C4), 115.1 (C8), 111.2 (C6), 104.3 (C3), 96.5 (C2), 55.3 (C11), 21.1 
(C10), 0.3 (C1); GCMS-EI m/z 218 [M]+. 
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1-Ethynyl-4-methoxy-2-methylbenzene,80 17  
 
[2-(4-Methoxyphenyl)ethynyl]trimethylsilane 16 (0.542 g, 2.49 mmol) was dissolved 
in anhydrous tetrahydrofuran (9 mL) and triethylamine trihydrofluoride (4.1 mL, 
25 mmol) was added. The resulting orange solution was stirred at 35 °C for 140 h 
after which the solvent was removed under reduced pressure. The residue was 
redissolved in water (20 mL) and this solution was extracted with toluene (3 x 
20 mL). The organic layers were combined, dried with MgSO4, filtered, combined 
and concentrated to give the product as a red oil (0.260 g, 71%); 1H NMR (700 MHz, 
CDCl3) δ 7.39 (1 H, d, 3JH-H 8.5, H4), 6.74 (1 H, d, 4JH-H 3.0, H7), 6.68 (1 H, dd, 3JH-H 8.5, 
4JH-H 3.0, H5), 3.80 (3 H, s, H10), 3.19 (1 H, s, H1), 2.43 (3 H, s, H9); 13C NMR (176 MHz, 
CDCl3) δ 160.0 (C6), 142.7 (C8), 134.0 (C4), 115.2 (C7), 114.3 (C3), 111.4 (C5), 82.7 (C2), 
79.6 (C1), 53.4 (C10), 21.0 (C9); GCMS-EI m/z 146 [M]+. 
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Ethyl [6-(hydroxymethyl)-4-[2-(4-methoxy-2-methylphenyl)ethynyl] pyridin-2-
yl](phenyl)phosphinate, 18 
 
1-Ethynyl-4-methoxy-2-methylbenzene 17 (100 mg, 0.684 mmol) and ethyl [4-
bromo-6-(hydroxymethyl)] pyridin-2-yl](phenyl)phosphinate (221 mg, 0.622 mmol) 
were dissolved in anhydrous tetrahydrofuran (4.5 mL) and the solution was 
degassed (freeze-pump-thaw cycle x 3). Triethylamine (435 µL, 316 mg, 3.12 mmol) 
was added and the solution was further degassed (freeze-pump-thaw x 3). [1,1’-
Bis(diphenylphosphino)ferrocene]dichloropalladium(II) (51 mg, 0.062 mmol) and 
copper (I) iodide (24 mg, 0.12 mmol) were added and the solution was stirred at 
65 °C under argon for 24 h. The solvent was removed under reduced pressure and 
the brown residue was purified by silica gel column chromatography (neat CH2Cl2 to 
3% CH3OH in CH2Cl2) to yield a brown oil. This was further purified by silica gel 
column chromatography (50:50 ethyl acetate:hexane to 80:20 ethyl 
acetate:hexane) to yield the desired product as a yellow oil (192 mg, 73%); 1H NMR 
(600 MHz, CDCl3) δ 8.07 (1 H, br s, H3), 7.97 (2 H, dd, 3JH-P 11.5, 3JH-H 8.5, H9), 7.54 (1 
H, t, 3JH-H 7.0, H11), 7.45-7.48 (2 H, m, H10), 7.42 (1 H, d, 3JH-H 8.5, H17), 7.40 (1 H, s, 
H5), 6.77 (1 H, d, 4JH-H 2.5, H20), 6.73 (1 H, dd, 3JH-H 8.5, 4JH-H 2.5, H18), 4.76 (2 H, s, 
H7), 4.09-4.19 (2 H, m, H12), 3.81 (3 H, s, H23), 2.47 (3 H, s, H22), 1.38 (3 H, t, 3JH-H 7.0, 
H13); 13C NMR (151 MHz, CDCl3) δ 160.7 (C19), 160.4 (d, 3JC-P 19, C6), 153.3 (d, 1JC-P 
165, C2), 143.0 (C21), 134.1 (C17), 133.3 (d, 3JC-P 12, C4), 132.7 (C11), 132.4 (d, 2JC-P 10, 
C9), 129.8 (d, 1JC-P 141, C8), 128.7 (C3), 128.6 (d, 3JC-P 13, C10), 123.9 (C5), 115.4 (C20), 
113.8 (C16), 111.7 (C16), 95.3 (C15), 89.1 (C14), 64.0 (C7), 62.0 (C12), 55.4 (C23), 21.1 
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(C22), 16.7 (C13); 31P (243 MHz, CDCl3) δ +25.5; LCMS (ESI+) m/z 422 [M+H]+; HRMS 
(ESI+) m/z 422.1528 [M+H]+ (C24H25NO4P requires 422.1521). 
 
{4-[2-(4-Methoxy-2-methylphenyl)ethynyl]-6-[ethoxy(phenyl)phosphoryl]pyridin-
2-yl}methyl methanesulfonate, 19 
 
Ethyl [6-(hydroxymethyl)-4-[2-(4-methoxy-2-methylphenyl)ethynyl] pyridin-2-
yl](phenyl)phosphinate 18 (96 mg, 0.23 mmol) was dissolved in anhydrous 
tetrahydrofuran (3 mL) and the solution was cooled in an ice bath. Triethylamine 
(64 µL, 0.46 mmol) was added followed by dropwise addition of methanesulfonyl 
chloride (27 µL, 0.34 mmol), which resulted in the formation of a precipitate. The 
reaction was stirred under argon for 45 min and the solvent was removed under 
reduced pressure. The residue was redissolved in dichloromethane (20 mL) and 
washed with saturated brine solution (30 mL). The aqueous solution was re-
extracted with dichloromethane (3 x 20 mL) and the organic layers combined, dried 
with MgSO4, filtered and concentrated under reduced pressure to give the product 
as a pale yellow oil (115 mg, quant.) which was used without further purification; 1H 
NMR (400 MHz, CDCl3) δ 8.13 (1 H, d, 3JH-P 6.0, H3), 7.96 (2 H, dd, 3JH-P 12.0, 3JH-H 7.0, 
H9), 7.54 (1 H, br s, H11), 7.49-7.46 (2 H, m, H10), 7.45 (1 H, br s, H17), 7.42 (1 H, s, 
H5), 6.77 (1 H, d, 4JH-H 2.0, H20), 6.73 (1 H, dd, 3JH-H 8.5, 4JH-H 2.0, H18), 5.32 (2 H, s, 
H7), 4.14 (2 H, q, 3JC-P 7.0, H12), 3.81 (3 H, s, H23), 2.99 (3 H, s, H24), 2.48 (3 H, s, H22), 
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1.37 (3 H, t, 3JH-H 7.0, H13); 31P NMR (162 MHz, CDCl3) δ +24.9; LCMS (ESI+) m/z 
500[M+H]+; HRMS (ESI+) m/z 500.1286 [M+H]+ (C25H27NO6PS requires 500.1297). 
 
1,4,7-Tris({4-[2-(4-methoxy-2-methylphenyl)ethynyl]-6-
[ethoxy(phenyl)phosphoryl]pyridin-2-yl}methyl)-1,4,7-triazacyclononane (tri-ethyl 
ester of L2) 
 
{4-[2-(4-Methoxy-2-methylphenyl)ethynyl]-6-[ethoxy(phenyl)phosphoryl]pyridin-2-
yl}methyl methanesulfonate (114 mg, 0.228 mmol), 1,4,7-triazacyclononane 
trihydrochloride (16.5 mg, 0.0691 mmol) and potassium carbonate (189 mg, 
1.37 mmol) were dissolved in anhydrous acetonitrile (5 mL). The solution was 
stirred at 65 °C under argon for 66 h, at which time the solution was cooled to room 
temperature, and the solution decanted from excess potassium salts and 
concentrated under reduced pressure. Attempts to find a suitable solvent system 
for column chromatography were unsuccessful so the crude product (66 mg) was 
taken on without further purification; 1H NMR (700 MHz, CDCl3) δ 8.03 (3 H, d, 3JH-P 
5.5, H3), 7.95 (6 H, dd, 3JH-P 12.0, 3JH-H 7.5, H9), 7.56 (3 H, s, H5), 7.44-7.41 (3 H, m, 
H11), 7.39 (3 H, d, 3JH-H 7.5, H17), 7.37-7.36 (6 H, m, H10), 6.74 (3 H, d, 4JH-H 2.0, H20), 
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6.70 (3 H, dd, 3JH-H 7.5, 4JH-H 2.0, H18), 4.13-4.06 (6 H, m, H12), 3.83 (6 H, s, H7), 3.79 
(9 H, s, H23), 2.75 (12 H, br s, ring CH2), 2.43 (9 H, s, H22), 1.32 (9 H, t, 3JH-H 7.0, H13); 
13C NMR (176 MHz, CDCl3) δ 161.5 (d, 3JC-P 20, C6), 160.4 (C19), 153.8 (d, 1JC-P 167, 
C2), 142.8 (C21), 133.8 (C17), 132.5 (d, 3JC-P 12, C4), 132.4 (d, 2JC-P 10, C9), 132.3 (d, 4JC-P 
2, C11), 130.1 (d, 1JC-P 139, C8), 128.2 (d, 3JC-P 13, C10), 127.9 (d, 2JC-P 24, C3), 126.3 
(C5), 115.2 (C20), 114.0 (C16), 111.5 (C18), 94.5 (C15), 89.5 (C14), 63.7 (C7), 61.6 (d, 2JC-P 
6, C12), 55.6 (br s, ring CH2), 55.3 (C23), 21.0 (C22), 16.5 (d, 3JC-P 6, C13);  31P NMR (283 
MHz, CDCl3) δ +25.5; LCMS (ESI+) m/z 1340 [M+H]+; HRMS (ESI+) m/z 1339.538 
[M+H]+ (C78H82N6O9P3 requires 1339.536). 
The 1H NMR spectrum (700 MHz, CDCl3) of the crude mixture is shown to establish 
the extent of purity of the ligand used in the next step. 
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[EuL2] 
 
1,4,7-Tris({4-[2-(4-methoxy-2-methylphenyl)ethynyl]-6-
[ethoxy(phenyl)phosphoryl]pyridin-2-yl}methyl)-1,4,7-triazacyclononane (18.4 mg, 
0.0137 mmol) and potassium hydroxide (6 mg, 0.1 mmol) were dissolved in a 
H2O/CH3OH mixture (2 mL, v/v 3:1) and stirred at 60 °C under argon for 20 days. 
Phosphinate ester hydrolysis was confirmed by 31P NMR (starting material: 
+25.5 ppm, product: +15.5 ppm). EuCl3·6H2O (6 mg, 0.0164 mmol) was added and 
the reaction stirred at 60 °C for 19 h. The solution was neutralised with dilute HCl 
and the solvent removed under reduced pressure. The crude product was purified 
by RP-HPLC (Method A, tR  = 14.5 min) to give the product as a white solid (5.2 mg, 
29%); LCMS (ESI+) m/z 1403 [M+H]+; HRMS (ESI+) m/z 1403.341 [M(151Eu)+H]+ 
(C72H67N6O9P3151Eu requires 1403.338); λmax (MeOH) = 343 nm; τEu (MeOH) = 
1.22 ms; Φ𝑀𝑒𝑂𝐻
𝑒𝑚  = 50 (±5)%. 
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Dimethyl 4-chloropyridine-2,6-dicarboxylate,150 21 
 
Chelidamic acid 20 (949 mg, 5.18 mmol) was dissolved in thionyl chloride (6 mL) 
and 5 drops of dimethylformamide were added to aid solubility. The mixture was 
stirred at 100 °C for 48 h, after which the solvent was removed by vacuum 
distillation. The residue was redissolved in anhydrous dichloromethane (5 mL) and 
cooled to 0 °C. Anhydrous methanol (5 mL) was added dropwise over 10 min the 
solution was allowed to warm to room temperature. The solvent was removed 
under reduced pressure. The residue was washed with a saturated sodium 
bicarbonate solution (10 mL) and extracted into dichloromethane (3 x 40 mL). The 
organic layers were combined and washed successively with water (40 mL) and 
brine (40 mL), dried over MgSO4, filtered and the solvent removed under reduced 
pressure to yield the title product as an orange solid (855 mg, 72%) which was used 
without further purification; m.p. 139-141 °C (lit.222 139-140 °C); 1H NMR (400 MHz; 
CDCl3) δ 8.29 (2 H, s, H3), 4.03 (6 H, s, H6); 13C NMR (101 MHz, CDCl3) δ 163.7 (C5), 
149.1 (C2), 146.3(C4), 127.9 (C3), 53.1 (C6); LCMS (ESI+) m/z 230 [M(35Cl)+H]+; HRMS 
(ESI+) m/z 230.0222 [M(35Cl)+H]+ (C9H9NO4Cl requires 230.0220). 
 
Dimethyl 4-iodopyridine-2,6-dicarboxylate,150 22 
 
Dimethyl 4-chloropyridine-2,6-dicarboxylate 21 (353 mg, 1.54 mmol) and sodium 
iodide (2.30 g, 15.4 mmol) were dissolved in anhydrous acetonitrile (20 mL) and the 
solution was sonicated (in a bath sonicator) for 30 min under argon. Acetyl chloride 
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(0.33 mL, 4.62 mmol) was added resulting in an orange suspension, which was 
sonicated for a further 1 h. The solvent was removed under reduced pressure and 
the residue was redissolved in dichloromethane (40 mL), washed with sat. sodium 
carbonate solution (25 mL). The aqueous layer was then extracted into 
dichloromethane (3 x 20 mL). The organic layers were then combined, washed 
successively with sat. sodium thiosulfate solution (30 mL) and water (30 mL), dried 
over MgSO4, filtered and concentrated. The crude mixture was purified by silica gel 
column chromatography (neat CH2Cl2 to 1% CH3OH in CH2Cl2) to yield the title 
product as an off-white solid (352 mg, 72%); m.p. 180-182 °C (lit.223 179-180 °C); 1H 
NMR (400 MHz, CDCl3) δ 8.63 (2 H, s, H3), 4.00 (6 H, s, H6); 13C NMR (101 MHz, 
CDCl3) δ 163.9 (C5), 148.4 (C2), 137.2 (C3), 107.1 (C4), 53.5 (C6); LCMS (ESI+) m/z 322 
[M+H]+; HRMS (ESI+) m/z 321.9584 [M+H]+ (C9H9NO4I requires 321.9576). 
 
Methyl 6-(hydroxymethyl)-4-iodopicolinate,150 23 
 
Dimethyl 4-iodopyridine-2,6-dicarboxlyate 22 (353 mg, 1.10 mmol) was dissolved in 
a mixture of anhydrous dichloromethane (3 mL) and anhydrous methanol (2 mL) 
and cooled in ice under argon. Sodium borohydride (46 mg, 1.21 mmol) was added 
and the reaction was stirred at 0 °C and monitored by TLC. After 30 min, 1 M HCl 
(2 mL) was added. The volatile solvents were removed under reduced pressure and 
the aqueous solution was extracted with ethyl acetate (3 x 25 mL). The organic 
layers were combined, dried over MgSO4, filtered and concentrated. The crude 
mixture was purified by silica gel column chromatography (neat CH2Cl2 to 1.5% 
CH3OH in CH2Cl2) to yield the title product as a white solid (212 mg, 66%); m.p. 138-
139 °C (lit.223 140-141 °C); 1H NMR (700 MHz, CDCl3) δ 8.36 (1 H, s, H3), 7.98 (1 H, s, 
H5), 4.81 (2 H, s, H7), 3.97 (3 H, s, H9); 13C NMR (176 MHz, CDCl3) δ 164.4 (C8), 161.4 
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(C6), 147.3 (C2), 133.4 (C5), 133.1 (C3), 107.1 (C4), 64.3 (C7), 53.3 (C9); LCMS (ESI+) m/z 
294 [M+H]+; HRMS (ESI+) m/z 293.9633 [M+H]+ (C8H9NO3I requires 293.9627). 
Methyl 4-iodo-6-[(methanesulfonyloxy)methyl]pyridine-2-carboxylate, 24 
 
Methyl 6-(hydroxymethyl)-4-iodopicolinate 23 (212 mg, 0.72 mmol) was dissolved 
in anhydrous tetrahydrofuran (8 mL) and cooled to 0 °C under argon. Triethylamine 
(84 μL, 124 mg, 1.09 mmol) was added, followed by dropwise addition of 
methanesulfonyl chloride (200 μL, 146 mg, 1.44 mmol). The mixture was stirred 
under argon for 30 min at which point TLC showed all starting material had been 
consumed. The solvent was removed under reduced pressure and residue 
redissolved in dichloromethane (60 mL), washed with water (50 mL) and the 
aqueous layer was extracted with dichloromethane (3 x 50 mL). The organic layers 
were combined, dried over MgSO4, filtered and concentrated to give a pale yellow 
solid (268 mg, 97%) which was used immediately without further purification; 1H 
NMR (400 MHz, CDCl3) δ 8.46 (1 H, s, H3), 8.04 (1 H, s, H5), 5.36 (2 H, s, H7), 4.00 (3 
H, s, H8), 3.16 (3 H, s, H9); LCMS (ESI+) m/z 372 [M+H]+; HRMS (ESI+) m/z 371.9396 
[M+H]+ (C9H11NO5SI requires 371.9403). 
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1,4,7-Tris({4-iodo-6-[methoxycarbonyl]-pyridin-2-yl}methyl)-1,4,7-
triazacyclononane (trimethyl ester of L11) 
 
Methyl 4-iodo-6-[(methanesulfonyloxy)methyl]pyridine-2-carboxylate 24 (260 mg, 
0.70 mmol) and 1,4,7-triazacyclononane trihydrochloride (54 mg, 0.23 mmol) and 
potassium carbonate (194 mg, 1.40 mmol) were dissolved in anhydrous acetonitrile 
(15 mL) and stirred under argon at 60 °C for 19 h, at which point the mixture was 
allowed to cool to room temperature. The yellow solution was decanted from 
insoluble salts and concentrated to yield a yellow oil (202 mg, 94%); 1H NMR 
(700 MHz, CDCl3) δ 8.31 (3 H, s, H3), 8.18 (3 H, s, H5), 3.94 (9 H, s, H9), 3.91 (6 H, s, 
H7), 2.88 (12 H, br s, ring CH2); 13C NMR (176 MHz, CDCl3) δ 164.6 (C8), 161.9 (C6), 
147.6 (C2), 135.6 (C5), 132.8 (C3), 106.7 (C4), 63.9 (br, C7), 56.0 (br, ring CH2), 53.2 
(C9); LCMS (ESI+) m/z 955 [M+H]+; HRMS (ESI+) 954.9659 [M+H]+ (C30H34N6O6I3 
requires 954.9674). 
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[EuL11] 
 
The trimethyl ester of L11 (55 mg, 0.058 mmol) was suspended in 0.1 M aqueous 
sodium hydroxide and acetonitrile was added dropwise until the solid dissolved. 
The solution was stirred at room temperature for 19 h until complete ester 
hydrolysis was observed by mass spectrometry. The solution was neutralised using 
dilute hydrochloric acid and the solvent was removed under reduced pressure. The 
resulting solid was redissolved in water (3 mL) and EuCl3.6H2O (24 mg, 0.064 mmol) 
was added. The pH was adjusted to 6 with dilute HCl and the solution was stirred at 
70 °C for 20 h during which time a white precipitate formed. The solution was 
cooled and the solid was isolated by centrifugation. The solution that was removed 
showed no evidence of containing europium complex by either mass spectrometry 
or photophysical analysis. The solid could not be dissolved in any common 
laboratory solvents. The solid was suspended in DMSO and stirred at 70 °C for 48 h 
after which time enough solid had dissolved for crude photophysical 
characterisation that established that a Eu(III) complex had been formed; λmax 
(DMSO) = 277 nm; τEu (DMSO) = 1.18 ms.  
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[EuL12] and [EuL13] 
 
Complex [EuL11] (50 mg, 0.047 mmol) and 2-ethynyl-1,3,5-trimethoxybenzene 
(29 mg, 0.15 mmol) were suspended in dimethylsulfoxide (5 mL). The suspension 
was degassed using freeze-pump-thaw cycles (x 3). Triethylamine (80 µL, 58 mg, 
0.57 mmol) was added and the suspension was degassed again (freeze-pump-thaw 
x 1). [1,1’-Bis(diphenylphosphino)ferrocene]dichloropalladium(II) (14 mg, 
0.017 mmol) and copper (I) iodide (7 mg, 0.034 mmol) were added and the solution 
was stirred at 65 °C under argon for 19 h. The reaction was cooled to room 
temperature and added dropwise to 400 mL of ice cold stirring diethyl ether. The 
solution was decanted and the brown precipitate collected. This crude product was 
subjected to column chromatography (alumina, CH2Cl2 to 2% CH3OH in CH2Cl2) to 
remove the catalysts. Mass spectrometry revealed the presence of a second species 
in the product-containing fractions. This mixture was further purified by RP-HPLC 
(Method B) to give [EuL12] as a white solid (tR = 22.1 min, 4.3 mg) and [EuL13] as a 
white solid (tR = 21.0, 1.3 mg); [EuL12]: HRMS (ESI+) m/z 1253.315 [M(151Eu)+H]+ 
(C60H58N6O15151Eu requires 1253.316); λmax (MeOH) = 363 nm; τEu (MeOH) = 0.55 ms; 
Φ𝑀𝑒𝑂𝐻
𝑒𝑚  = 24 (±5)%; [EuL13]: HRMS (ESI+) m/z 1097.213 [M(151Eu)+H]+ 
(C49H47N6O12Cl151Eu requires 1097.214); λmax (MeOH) = 362 nm; τEu (MeOH) = 0.58 
ms; Φ𝑀𝑒𝑂𝐻
𝑒𝑚  = 20 (±5)%. 
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The chlorine substitution to form [EuL13] could have occurred in a number of steps. 
No trace of the chlorine substituted species was observed in the alkylation reaction 
to form the trimethyl ester of L10. However, the complexation reaction is carried 
out with europium(III) chloride so it is possible that a chloride ion displaces an 
iodide during the reaction which is carried out at increased temperature. 
Additionally, the Sonogashira coupling reaction to form [EuL12] uses a precatalyst 
with coordinated chlorides which could displace the iodide in this step. The 4-
chloropyridine will not participate in a Sonogashira reaction under the conditions 
used above, hence a chloropyridine arm is preserved in the by-product [EuL13].  
Dimethyl 4-bromopyridine-2,6-dicarboxylate,191 25 
 
Chelidamic acid 20 (1.00 g, 5.48 mmol) and phosphorus pentabromide (7.31 g, 
16.9 mmol) were heated to 90 °C and stirred for 3 h (CAUTION: HBr produced). The 
reaction mixture was cooled and the residue dissolved in anhydrous chloroform (30 
mL). The resulting deep red solution was cooled in an ice bath and anhydrous 
methanol (20 mL) was added dropwise with stirring. The solvents were removed 
under reduced pressure. Cold water (100 mL) was added and the suspension left to 
stand in an ice bath for 1 h. The precipitate was isolated and dried under vacuum, 
to yield an orange solid (1.05 g, 70%); m.p. 164-166 °C (lit.224 166-167 °C); 1H NMR 
(700 MHz, CDCl3) δ 8.40 (2 H, s, H3), 3.98 (6 H, s, H6); 13C NMR (176 MHz, CDCl3) δ 
164.0 (C5), 149.1 (C2), 135.1 (C4), 131.3 (C3), 53.5 (C6); LCMS (ESI+) m/z 274 
[M(79Br)+H]+; HRMS (ESI+) 273.9713 [M(79Br)+H]+ (C9H9NO479Br requires 273.9715).  
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Methyl 6-(hydroxymethyl)-4-bromopicolinate,191 26  
 
Dimethyl 4-bromopyridine-2,6-dicarboxylate 25 (1.05 g, 3.83 mmol) was dissolved 
in a mixture of anhydrous dichloromethane and anhydrous methanol (15 mL, 3:2). 
The solution was cooled in ice. Sodium borohydride (160 mg, 4.22 mmol) was 
added and the reaction was stirred and monitored by thin layer chromatography 
(silica, CH2Cl2:MeOH, 95:5, Rf (starting material) 0.81, Rf (product) 0.31, Rf (diol) 0.1). 
After 30 min 1 M aqueous HCl (10 mL) was added and the mixture stirred for 
30 min. The organic solvents were removed under reduced pressure and the 
aqueous solution was extracted with ethyl acetate (3 x 100 mL). The organic layers 
were combined, dried over MgSO4, filtered and concentrated to give a pale yellow 
oil, which was purified by silica gel column chromatography (neat CH2Cl2 to 3% 
CH3OH in CH2Cl2) to yield the product as a white solid (652 mg, 69%); m.p. 128-
130 °C (lit.191 131-132 °C); 1H NMR (600 MHz, CDCl3) δ 8.20 (1 H, d, 4JH-H 1.0, H3), 
7.78 (1 H, d, 4JH-H 1.0, H5), 4.86 (2 H, s, H7), 4.01 (3 H, s, H9); 13C NMR (151 MHz, 
CDCl3) δ 164.3 (C8), 161.8 (C6), 147.9 (C2),135.1 (C4), 127.5 (C3), 127.4 (C5), 64.4 (C7), 
53.4 (C9); LCMS (ESI+) m/z 246 [M(79Br)+H]+; HRMS (ESI+) 245.9785 [M(79Br)+H]+ 
(C8H9NO379Br requires 245.9766). 
Methyl 4-bromo-6-[(methanesulfonyloxy)methyl]pyridine-2-carboxylate, 27 
 
Methyl 6-(hydroxymethyl)-4-bromopicolinate 26 (100 mg, 0.407 mmol) was 
dissolved in anhydrous tetrahydrofuran (4 mL). Triethylamine (110 µL, 0.814 mmol) 
was added and the solution was cooled in ice. Methanesulfonyl chloride (50 µL, 
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0.61 mmol) was added dropwise and the resulting suspension stirred in an ice bath 
under argon. Monitoring by TLC (silica, 5% CH3OH in CH2Cl2) showed complete 
consumption of starting material after 30 min. The solvents were removed under 
reduced pressure and the residue dissolved in dichloromethane (30 mL). This 
solution was washed with water (20 mL) and the aqueous solution was extracted 
with dichloromethane (3 x 20 mL). The organic extracts were combined, dried over 
MgSO4, filtered and concentrated to yield a pale yellow solid (130 mg, 99%) which 
was used immediately without further purification; 1H NMR (400 MHz, CDCl3) δ 8.24 
(1 H, d, 4JH-H 1.5, H3), 7.84 (1 H, d, 4JH-H 1.5, H5), 5.38 (2 H, s, H7), 3.99 (3 H, s, H10), 
3.16 (3 H, s, H8); LCMS (ESI+) m/z 324 [M+H]+; HRMS 323.9547 [M+H]+ 
(C9H11NO5S79Br requires 323.9541). 
1,4,7-Tris({4-bromo-6-[methoxycarbonyl]-pyridin-2-yl}methyl)-1,4,7-
triazacyclononane (trimethyl ester of L14) 
 
Methyl 4-bromo-6-[(methanesulfonyloxy)methyl]pyridine-2-carboxylate 27 
(131 mg, 0.407 mmol) and 1,4,7-triazacyclononane trihydrochloride (31 mg, 
0.13 mmol) and potassium carbonate (110 mg, 0.800 mmol) were dissolved in 
anhydrous acetonitrile (7 mL) and stirred under argon at 60 °C for 24 h, at which 
point the mixture was allowed to cool to room temperature. The yellow solution 
was decanted from insoluble salts and concentrated. The crude residue was 
purified by column chromatography (alumina, neat CH2Cl2 to 1% CH3OH in CH2Cl2) 
to yield a yellow oil (61 mg, 58%) ; 1H NMR (700 MHz, CDCl3) δ 8.12 (3 H, dd, 4JH-H 
2.0, H3), 7.97 (3 H, dd, 4JH-H 2.0, H5), 4.07 (6 H, br s, H7), 3.93 (9 H, s, H9), 3.03 (12 H, 
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br s, ring CH2); 13C NMR (176 MHz, CDCl3) δ 164.6 (C8), 160.8 (C6), 148.4 (C2), 134.5 
(C4), 129.8 (C5), 127.4 (C3), 63.0 (br, C7), 55.1 (br, ring CH2), 53.2 (C9); LCMS (ESI+) 
m/z 811 [M+H]+; HRMS (ESI+) 811.0101 [M+H]+ (C33H34N6O679Br3 requires 811.0090). 
[EuL13] 
 
The trimethyl ester of L14 (61 mg, 0.066 mmol) was dissolved in methanol (3 mL) 
and sodium hydroxide (0.1 M, 3 mL) was added. The resulting solution was stirred 
at 50 °C for 3 days after which the organic solvent was removed under reduced 
pressure. The remaining aqueous solution was neutralised using dilute HCl and 
EuCl3.6H2O (30 mg, 0.082 mmol) was added. This solution was stirred at 50 °C for 
48 h during which time a precipitate formed. The solid was isolated from the 
solution by centrifugation, but could not be dissolved in any common laboratory 
solvents for analysis. 
Ethyl methylphosphinate,188 29 
 
Water (0.2 mL, 11.1 mmol) was added to neat diethyl methylphosphonite 28 (1.66 
mL, 1.51 g, 11.1 mmol) and the mixture was stirred under argon at room 
temperature for 18 h. Conversion to ethyl methylphosphinate was confirmed by 1H 
and 31P NMR and the product was used directly without further purification, 
containing one equivalent of ethanol; 1H NMR (400 MHz, CDCl3) δ 7.14 (1 H, d, 1JH-P 
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78539, H1), 4.05 (2 H, dq, 3JH-P 41, 3JH-H 7.0, H3), 1.47 (3 H, d, 2JH-P 15.0, H2), 1.29 (3 H, 
78t, 3JH-H 7.0, H4); 31P NMR (162 MHz, CDCl3) δ +33.7. 
Ethyl (6-methyl-4-nitropyridin-2-yl)methylphosphinate,188 30 
 
2-Bromo-6-methyl-4-nitropyridine 8 (2.0 g, 9.2 mmol), ethyl methylphosphinate 29 
(containing 1 equivalent of ethanol) (1.2 g, 11.1 mmol) and triethylamine (4.5 mL, 
3.3 g, 32.3 mmol), were added to degassed (3 x freeze-pump-thaw) anhydrous 
toluene (20 mL). Argon was bubbled through the solution for 45 min. Under 
positive flow of argon, [1,1’-bis(diphenylphosphino)ferrocene]dichloropalladium(II) 
(0.380 g, 0.47 mmol) was added. The resulting red solution was stirred at 80 °C 
under argon for 20 h. The solvent was removed under reduced pressure and the 
resulting black oil was purified by silica gel column chromatography (1:1 
hexane:ethyl acetate to 1:3 hexane:ethyl acetate) to yield an off-white solid (1.75 g, 
78%); m.p. 78-80 °C; 1H NMR (600 MHz, CDCl3) δ 8.49 (1 H, dd, 3JH-P 6.0, 4JH-H 1.5, 
H3), 7.94 (1 H, d, 3JH-H 1.5, H5), 4.15-3.84 (2 H, m, H9), 2.75 (3 H, s, H7), 1.78 (3 H, d, 
2JH-P 15.0, H8), 1.25 (3 H, t, 3JH-H 7.0, H10); 13C NMR (151 MHz, CDCl3) δ 163.1 (d, 3JC-P 
21, C6), 158.0 (d, 1JC-P 157, C2), 154.2 (d, 3JC-P 12, C4), 117.8 (d, 4JC-P 3, C5), 117.1 (d, 
2JC-P 23, C3), 61.5 (d, 2JC-P 6, C9), 24.9 (s, C7), 16.5 (d, 3JC-P 6, C10), 13.5 (d, 1JC-P 106, C8); 
31P NMR (243 MHz, CDCl3) δ +38.0; LCMS (ESI+) m/z 245 [M+H]+; HRMS (ESI+) 
245.0703 [M+H]+ (C9H14N2O4P requires 245.0691). 
 (4-Bromo-6-methylpyridin-2-yl)methylphosphinic acid,188 
 
Ethyl (6-methyl-4-nitropyridin-2-yl)methylphosphinate 30 (1.38 g, 5.65 mmol) was 
dissolved in acetyl bromide (21 mL, 170 mmol) and the mixture was stirred at 70 °C. 
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The reaction was monitored by LCMS and after 48 h all starting material had been 
consumed. The solution was cooled in an ice bath and methanol (60 mL) was added 
dropwise with stirring [CAUTION: HBr fumes produced]. The solvent was removed 
under reduced pressure and the resulting thick brown oil was used in the next step 
without further purification, assuming complete conversion to the 
bromophosphinic acid; 31P NMR (162 MHz, CD3OD) δ +27.6; LCMS (ESI+) m/z 250 
[M+H]+; HRMS (ESI+) 249.9646 [M+H]+ (C7H10NO2P79Br requires 249.9633); 1H NMR 
spectra showed extremely broad peaks that were impossible to assign. This could 
be attributed to the presence of radical species formed from the reaction being 
present in the crude product. 
Ethyl (4-bromo-6-methylpyridin-2-yl)methylphosphinate,188 31 
 
(4-Bromo-6-methylpyridin-2-yl)methylphosphinic acid (1.41 g, 5.65 mmol, assuming 
complete conversion in previous step) was dissolved in triethyl orthoformate 
(50 mL) and the solution was stirred at 140 °C under argon for 3 days. The solution 
was cooled to room temperature and solvent was removed under reduced pressure 
to yield a brown solid. This was purified by silica gel column chromatography 
(CH2Cl2 to 2% CH3OH in CH2Cl2) to yield a white solid (1.21 g, 77% over two steps); 
m.p. 69-71 °C; Elem. Anal. Found: C, 38.7; H, 4.7; N, 5.1. C9H13NO2BrP requires C, 
38.9; H, 4.7; N, 5.0%; 1H NMR (700 MHz, CDCl3) δ 8.01 (1 H, dd, 3JH-P 6.0, 4JH-H 1.5, 
H3), 7.43 (1 H, t, 3JH-H 1.5, H5), 4.11-3.81 (2 H, m, H9), 2.56 (3 H, s, H7), 1.74 (3 H, d, 
2JH-P 15.0, H8), 1.25 (3 H, t, 3JH-H 7.0, H10); 13C NMR (176 MHz, CDCl3) δ 161.0 (d, 3JC-P, 
21, C6), 155.4 (d, 1JC-P 155, C2), 133.6 (d, 3JC-P 14, C4), 128.9 (d, 4JC-P 4, C5), 128.1 (d, 
2JC-P 21, C3), 61.3 (d, 2JC-P 7, C9), 24.4 (C7), 16.5 (d, 3JC-P 5, C10), 13.5 (d, 1JC-P 106, C8) ; 
31P NMR (283 MHz, CDCl3) δ +38.9; LCMS (ESI+) m/z 278 [M+H]+; HRMS (ESI+) 
277.9945 [M+H]+ (C9H14NO2P79Br requires 277.9946). 
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Ethyl (4-bromo-6-methylpyridin-1-oxide-2-yl)methylphosphinate,188 32 
 
Ethyl (4-bromo-6-methylpyridin-2-yl)methylphosphinate 31 (100 mg, 0.36 mmol) 
was dissolved in anhydrous acetonitrile (2 mL). m-Chloroperbenzoic acid (190 mg, 
1.10 mmol) was added and the solution stirred at 65 °C for 21 h. The solvent was 
removed under reduced pressure and the resulting oil was redissolved in 
dichloromethane (5 mL). This solution was washed with aqueous NaHCO3 (0.5 M, 
5 mL), and the aqueous layer was re-extracted with dichloromethane (3 x 5 mL). 
The organic extracts were combined, dried over MgSO4, filtered and concentrated 
to yield a pale yellow oil, that was purified by silica gel column chromatography 
(CH2Cl2 to 3% CH3OH in CH2Cl2) to afford a colourless oil (75 mg, 71%); 1H NMR 
(700 MHz, CDCl3) δ 8.02 (1 H, dd, 3JH-P 8.0, 4JH-H 3.0, H3), 7.54 (1 H, d, 4JH-H 3.0, H5), 
4.19-3.91 (2 H, m, H9), 2.47 (3 H, s, H7), 1.95 (3 H, d, 2JH-P 16.0, H8), 1.30 (3 H, t, 3JH-H 
7.0, H10); 13C NMR (176 MHz, CDCl3) δ 151.1 (d, 3JC-P 3, C6), 143.8 (d, 1JC-P 136, C2), 
133.3 (d, 2JC-P 11, C3), 132.2 (d, 4JC-P 2, C5), 117.9 (d, 3JC-P, 12, C4), 62.1 (d, 2JC-P 5, C9), 
17.5 (d, 4JC-P 2, C7), 16.5 (d, 3JC-P 7, C10), 14.5 (d, 1JC-P 111, C8); 31P NMR (283 MHz, 
CDCl3) δ +32.9; LCMS (ESI+) m/z 294 [M+]+; HRMS (ESI+) 293.9902 [M+H]+ 
(C9H14NO3P79Br requires 293.9895).  
Ethyl (4-bromo-6-hydroxymethylpyridin-2-yl)methylphosphinate,188 33 
 
Ethyl (4-bromo-6-methylpyridin-1-oxide-2-yl)methylphosphinate 32 (781 mg, 
2.66 mmol) was dissolved in anhydrous acetonitrile (20 mL). Trifluoroacetic 
anhydride (7.4 mL, 11.2 g, 53.1 mmol) was added and the resulting green solution 
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was heated to 60 °C under argon. After 3 h, the formation of the trifluoroacetate 
ester was complete (monitored by 1H NMR). The solvent was removed under 
reduced pressure, and the residue dissolved in a 1:1 mixture of ethanol:water 
(50 mL). This solution was stirred at room temperature for 18 h, at which time the 
organic solvent was removed under reduced pressure and the aqueous solution 
was extracted with dichloromethane (3 x 100 mL). The organic layers were 
combined, dried over MgSO4, filtered and concentrated to give a brown oil which 
was purified by silica gel column chromatography (CH2Cl2 to 5% CH3OH in CH2Cl2) to 
yield a yellow oil (540 mg, 69%); 1H NMR (700 MHz, CDCl3) δ 8.05 (1 H, d, 3JH-P 5.5, 
H3), 7.72 (1 H, s, H5), 4.79 (2 H, s, H7), 4.36 (1 H, br s, -OH), 4.11-3.82 (2 H, m, H9), 
1.74 (3 H, s, 2JH-P 15.5, H8), 1.25 (3 H, t, 3JH-H 7.0, H10); 13C NMR (176 MHz, CDCl3) δ 
163.1 (d, 3JC-P 20, C6), 154.7 (d, 1JC-P 155, C2), 134.4 (d, 3JC-P 13, C4), 129.4 (d, 3JC-P 22, 
C3), 126.3 (d, 4JC-P 3, C5), 64.2 (C7), 61.5 (d, 2JC-P 7, C9), 16.5 (d, 3JC-P 6, C10), 13.5 (d, 
1JC-P 105, C8); 31P NMR (162 MHz, CDCl3) δ +38.9; LCMS (ESI+) m/z 294 [M(79Br)+H]+; 
HRMS (ESI+) m/z 293.9896 [M+H]+ (C9H14NO3P79Br requires 293.9895). 
Ethyl [6-(hydroxymethyl)-4-[2-(2,4,6-trimethoxyphenyl)ethynyl]pyridine-2-
yl](methyl)phosphinate,29 34 
 
Ethyl (4-bromo-6-hydroxymethylpyridin-2-yl)methylphosphinate 33 (169 mg, 
0.58 mmol) and 2-ethynyl-1,3,5-trimethoxybenzene 3 (124 mg, 0.64 mmol) were 
dissolved in anhydrous tetrahydrofuran (4 mL) and the solution was degassed 
(freeze-pump-thaw cycle x 3). Triethylamine (404 μL, 293 mg, 2.9 mmol) was added 
and the solution was further degassed (freeze-pump-thaw x 1). [1,1’-
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Bis(diphenylphosphino)ferrocene]dichloropalladium (II) (47 mg, 0.058 mmol) and 
copper (I) iodide (11 mg, 0.058 mmol) were added and the solution was stirred at 
65 °C under argon for 26 h. The solvent was removed under reduced pressure and 
the brown residue was taken into dichloromethane. This solution was washed with 
water (5 mL) and brine (5 mL). The organic layer was dried over MgSO4, filtered and 
concentrated. The crude product was purified by silica gel column chromatography 
(CH2Cl2 to 5% CH3OH in CH2Cl2) to yield a brown oil (123 mg, 53%); 1H NMR (700 
MHz, CDCl3) δ 8.08 (1 H, br s, H3), 7.48 (1 H, br s, H5), 6.10 (2 H, s, H15), 4.79 (2 H, br 
s, H7), 4.10-3.92 (2 H, m, H9), 3.88 (6 H, s, H17), 3.84 (3 H, s, H18), 1.77 (3 H, d, 2JH-P 
12.0, H8), 1.26 (3 H, t, 3JH-H 6.5, H10); 13C NMR (176 MHz, CDCl3) δ 162.9 (C16), 162.8 
(C14), 160.8 (d, 3JC-P 20, C6), 152.7 (d, 1JC-P 156, C2), 133.7 (C4), 127.9 (d, 2JC-P 24, C3), 
124.1 (C5), 93.4 (C11), 93.1 (C13), 90.5 (C15), 89.8 (C12), 64.2 (C7), 61.2 (C9), 56.0 (C17), 
55.5 (C18), 16.4 (s, C10), 13.5 (d, 1JC-P 103, C8); 31P NMR (162 MHz, CDCl3) δ +39.6; 
LCMS (ESI+) m/z 406 [M+H]+; HRMS (ESI+) m/z 406.1411 [M+H]+ (C20H25NO6P 
requires 406.1420). 
{4-[2-(2,4,6-Trimethoxyphenyl)ethynyl]-6-[ethoxy(methyl)phosphoryl]pyridin-2-
yl}methyl methanesulfonate,29 35 
 
Ethyl [6-(hydroxymethyl)-4-[2-(2,4,6-trimethoxyphenyl)ethynyl]pyridine-2-
yl](methyl)phosphinate 34 (123 mg, 0.304 mmol) was dissolved in anhydrous 
tetrahydrofuran (4 mL) and the solution was cooled in an ice bath. Triethylamine 
(85 µL, 0.608 mmol) was added, followed by dropwise addition of methanesulfonyl 
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chloride (35 µL, 0.456 mmol), which resulted in the formation of a precipitate. The 
reaction was stirred under argon for 90 min after which the solvent was removed 
under reduced pressure. The residue was redissolved in dichloromethane (20 mL) 
and washed with water (10 mL). The aqueous solution was re-extracted with 
dichloromethane (3 x 20 mL) and the organic layers combined, dried with MgSO4, 
filtered and concentrated under reduced pressure to give a brown oil (112 mg, 
76%) which was used without further purification; 1H NMR (400 MHz, CDCl3) δ 8.15 
(1 H, br s, H3), 7.57 (1 H, br s, H5), 6.11 (2 H, s, H15), 5.35 (2 H, s, H7), 4.16-3.94 (2 H, 
m, H9), 3.90 (6 H, s, H17), 3.85 (3 H, s, H18), 3.12 (3 H, s, H19), 1.77 (3 H, d, 2JH-P 15.0, 
H8), 1.27 (3 H, t, 3JH-H 7.0, H10); 31P NMR (162 MHz, CDCl3) δ +39.4; LCMS (ESI+) m/z 
484 [M+H]+; HRMS (ESI+) m/z 484.1198 [M+H]+ (C21H27NO8PS requires 484.1195). 
1,4,7-Tris({4-[2-(2,4,6-trimethoxyphenyl)ethynyl]-6-
[ethoxy(methyl)phosphoryl]pyridin-2-yl}methyl)-1,4,7-triazacyclononane (triethyl 
ester of L3)29 
 
{4-[2-(2,4,6-Trimethoxyphenyl)ethynyl]-6-[ethoxy(methyl)phosphoryl]pyridin-2-
yl}methyl methanesulfonate 35 (112 mg, 0.232 mmol), 1,4,7-triazacyclononane 
trihydrochloride (17 mg, 0.070 mmol) and potassium carbonate (58 mg, 
0.422 mmol) were dissolved in anhydrous acetonitrile (5 mL) and stirred under 
argon at 80 °C for 40 h, at which point the mixture was allowed to cool to room 
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temperature. The brown solution was isolated from insoluble salts by 
centrifugation and concentrated. The crude residue was purified by column 
chromatography (alumina, neat CH2Cl2 to 8% CH3OH in CH2Cl2) to yield a pale yellow 
oil (67 mg, 22%); 1H NMR (600 MHz, CDCl3) δ 8.04 (3 H, br s, H3), 7.44 (3 H, br s, H5), 
6.09 (6 H, s, H15), 4.12-3.96 (6 H, m, H9), 3.90 (6 H, s, H7), 3.85 (18 H, s, H17), 3.81 (9 
H, s, H18), 3.00-2.76 (12 H, m, ring CH2), 1.75 (9 H, d, 2JH-P 14.0, H8), 1.28 (9 H, t, 3JH-H 
7.0, H10); 13C NMR (151 MHz, CDCl3) δ 162.9 (C16), 162.8 (C14), 161.2 (d, 3JC-P 21, C6), 
153.4 (d, 1JC-P 159, C2), 133.7 (C4), 127.7 (d, 2JC-P 20, C3), 126.9 (C5), 93.6 (C11), 93.2 
(C13), 89.7 (C12), 90.5 (C15), 64.0 (C7), 61.1 (C9), 56.2 (C17), 55.6 (C18), 55.2 (ring CH2), 
16.4 (s, C10), 13.5 (d, 1JC-P 106, C8); 31P NMR (162 MHz, CDCl3) δ +40.1; LCMS (ESI+) 
m/z 1291 [M+H]+; HRMS (ESI+) m/z 1291.504 [M+H]+ (C66H82N6O15P3 requires 
1291.505). 
[EuL3]29 
 
The triethyl ester of L3 (67 mg, 0.052 mmol) was dissolved in a mixture of 0.1 M 
NaOH (2.5 mL) and methanol (2.5 mL). The cloudy solution was stirred at 60 °C for 
72 h at which point 31P NMR showed that no phosphinate ester was present. The 
solution was cooled and the organic solvent removed under reduced pressure. The 
remaining aqueous solution was adjusted to pH 7 with dilute HCl. EuCl3.6H2O 
(24 mg, 0.066 mmol) was added and the solution was heated at 60 °C for 24 h. The 
solution was cooled to room temperature and concentrated. The crude product 
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was purified by reverse phase HPLC (Method E, tR= 19.0 min) to give [EuL3] as an 
off-white solid (12.4 mg, 18%); LCMS (ESI+) m/z 1355 [M(151Eu)+H]+; HRMS (ESI+) 
m/z 1355.310 [M+H]+ (C60H67N6O15P3151Eu requires 1355.308). λmax (MeOH) = 
355 nm; τEu (MeOH) = 1.10 ms; Φ𝑀𝑒𝑂𝐻
𝑒𝑚  = 28 (±5)%. 
Ethyl [6-(hydroxymethyl)-4-[2-(4-methoxy-2-methylphenyl)ethynyl]pyridine-2-
yl](methyl)phosphinate,29 36 
 
Ethyl (4-bromo-6-hydroxymethylpyridin-2-yl)methylphosphinate 33 (169 mg, 
0.58 mmol) and 1-ethynyl-4-methoxy-2-methylbenzene 17 (93 mg, 0.64 mmol) 
were dissolved in anhydrous tetrahydrofuran (4 mL) and the solution was degassed 
(freeze-pump-thaw cycle x 3). Triethylamine (404 μL, 293 mg, 2.9 mmol) was added 
and the solution was further degassed (freeze-pump-thaw x 1). [1,1’-
Bis(diphenylphosphino)ferrocene]dichloropalladium (II) (47 mg, 0.058 mmol) and 
copper (I) iodide (11 mg, 0.058 mmol) were added and the solution was stirred at 
65 °C under argon for 20 h. The solvent was removed under reduced pressure and 
the brown residue was purified by silica gel column chromatography (CH2Cl2 to 10% 
CH3OH in CH2Cl2) to yield a brown oil (141 mg, 68%); 1H NMR (600 MHz, CDCl3) δ 
8.04 (1 H, br s, H3), 7.45 (1 H, s, H5), 7.43 (1 H, d, 3JH-H 8.5, H14), 6.79 (1 H, d, 3JH-H 2.0, 
H17), 6.74 (1 H, dd, 3JH-H 8.5, 4JH-H 2.0, H15), 4.82 (2 H, s, H7), 4.17-4.09 (1 H, m, H9), 
3.92-3.85 (1 H, m, H9), 3.83 (3 H, s, H20), 3.56 (1 H, br s, CH2OH), 2.49 (3 H, s, H19), 
1.80 (3 H, d, 2JH-P 14.5, H8), 1.29 (3 H, t, 3JH-H 6.5, H10); 13C NMR (176 MHz, CDCl3) δ 
161.3 (C6), 160.8 (C16), 153.0 (d, 1JC-P 153, C2), 142.8 (C18), 133.9 (C14), 133.3 (C4), 
127.8 (C3), 124.2 (C5), 115.3 (C17), 113.7 (C13), 111.6 (C15), 95.2 (C12), 89.1 (C11), 64.1 
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(C7), 61.3 (C9), 55.3 (C20), 21.0 (C19), 16.5 (d, 3JC-P 3, C10), 13.5 (d, 1JC-P 107, C8); 31P 
NMR (162 MHz, CDCl3) δ +39.4; LCMS (ESI+) m/z 360 [M+H]+; HRMS (ESI+) m/z 
360.1372 [M+H]+ (C19H23NO4P requires 360.1365). 
{4-[2-(4-Methoxy-2-methylphenyl)ethynyl]-6-[ethoxy(methyl)phosphoryl]pyridin-
2-yl}methyl methanesulfonate,29 37 
 
Ethyl [6-(hydroxymethyl)-4-[2-(4-methoxy-2-methylphenyl)ethynyl] pyridin-2-
yl](methyl)phosphinate 36 (71 mg, 0.19 mmol) was dissolved in anhydrous 
tetrahydrofuran (2 mL) and the solution was cooled in an ice bath. Triethylamine 
(54 µL, 0.40 mmol) was added followed by dropwise addition of methanesulfonyl 
chloride (22 µL, 0.29 mmol), which resulted in the formation of a precipitate. The 
reaction was stirred under argon for 30 min and the solvent was then removed 
under reduced pressure. The residue was redissolved in dichloromethane (20 mL) 
and washed with water (10 mL). The aqueous solution was re-extracted with 
dichloromethane (3 x 20 mL) and the organic layers were combined, dried with 
MgSO4, filtered and concentrated under reduced pressure to give the product as a 
yellow oil (83 mg, 98%) which was used immediately without further purification; 
1H NMR (400 MHz, CDCl3) δ 8.08 (1 H, br s, H3), 7.62 (1 H, br s, H5), 7.45 (1 H, d, 3JH-H 
8.5, H14), 6.78 (1 H, s, H17), 6.74 (1 H, d, 3JH-H 8.5, H15), 5.36 (2 H, s, H7), 4.14-4.10 (1 
H, m, H9), 3.91-3.85 (1 H, m, H9), 3.82 (3 H, s, H20), 3.14 (3 H, s, H21), 2.49 (3 H, s, 
H19), 1.78 (3 H, d, 2JH-P 15.0, H8), 1.28 (3 H, t, 3JH-H 7.0, H10); 31P NMR (162 MHz, 
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CDCl3) δ +39.2; LCMS (ESI+) m/z 438 [M+H]+; HRMS (ESI+) m/z 438.1143 [M+H]+ 
(C20H25NO6PS requires 438.1140). 
1,4,7-Tris({4-[2-(4-Methoxy-2-methylphenyl)ethynyl]-6-
[ethoxy(methyl)phosphoryl]pyridin-2-yl}methyl)-1,4,7-triazacyclononane (triethyl 
ester of L4)29  
 
{4-[2-(4-Methoxy-2-methylphenyl)ethynyl]-6-[ethoxy(methyl)phosphoryl]pyridin-2-
yl}methyl methanesulfonate 37 (85 mg, 0.195 mmol), 1,4,7-triazacyclononane 
trihydrochloride (14 mg, 0.059 mmol) and potassium carbonate (49 mg, 
0.353 mmol) were dissolved in anhydrous acetonitrile (4 mL) and stirred under 
argon at 80 °C for 21 h, at which point the mixture was allowed to cool to room 
temperature. The yellow solution was decanted from insoluble salts and 
concentrated. The crude residue was purified by column chromatography (alumina, 
neat CH2Cl2 to 1% CH3OH in CH2Cl2) to yield a yellow oil (18 mg, 26%); 1H NMR (700 
MHz, CDCl3) δ 7.98 (3 H, d, 3JH-P 5.5, H3), 7.68 (3 H, s, H5), 7.41 (3 H, d, 3JH-H 8.5, H14), 
6.76 (3 H, d, 4JH-H 2.0, H17), 6.72 (3 H, dd, 3JH-H 8.5, 4JH-H 2.0, H15), 4.12-4.07 (3 H, m, 
H9), 3.89-3.84 (3 H, m, H9), 3.82 (6 H, s, H7), 3.81 (9 H, s, H19), 3.03 (12 H, br s, ring 
CH2), 2.46 (9 H, s, H19), 1.75 (9 H, d, 2JH-P 15.5, H8), 1.25 (9 H, t, 3JH-H 7.0, H10); 13C 
NMR (176 MHz, CDCl3) δ 161.1 (d, 3JC-P 18, C6), 160.7 (C16), 153.9 (d, 1JC-P 164, C2), 
142.9 (C18), 134.0 (C14), 133.1 (C4), 127.7 (d, 2JC-P 23, C3), 126.9 (C5), 115.4 (C17), 
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113.8 (C13), 111.7 (C15) 97.2 (C12), 89.3 (C11), 61.2 (d, 2JC-P 6, C9), 55.4 (C20), 54.4 (ring 
CH2), 21.1 (C19), 16.6 (d, 3JC-P 6, C10), 13.5 (d, 1JC-P 105, C8); 31P NMR (283 MHz, CDCl3) 
δ +39.9; LCMS (ESI+) m/z 1153 [M+H]+; HRMS (ESI+) m/z 1153.490 [M+H]+ 
(C63H76N6O9P3 requires 1153.489). 
[EuL4]29  
 
The triethyl ester of L4 (18 mg, 0.016 mmol) and potassium hydroxide (3 mg, 
0.053 mmol) was dissolved in a mixture of water (1 mL) and methanol (1 mL). The 
cloudy solution was stirred at 60 °C under argon for 18 h, at which point 31P NMR 
showed no phosphinate ester was present. The solution was cooled and the organic 
solvent removed under reduced pressure. The remaining aqueous solution was 
adjusted to pH 7 with dilute HCl. EuCl3.6H2O (7 mg, 0.019 mmol) was added and the 
solution was heated at 60 °C for 48 hours. The solution was cooled to room 
temperature and concentrated. The crude product was purified by reverse phase 
HPLC (Method C, tR= 21.9 min; or Method D, tR = 16.4 min) to give [EuL4] as an off-
white solid (4.9 mg, 25%); LCMS (ESI+) m/z 1217 [M[151Eu+H]+; HRMS (ESI+) m/z 
1217.295 [M+H]+ (C57H61N6O9P3151Eu requires 1217.291). λmax (MeOH) = 342 nm; τEu 
(MeOH) = 1.14 ms; Φ𝑀𝑒𝑂𝐻
𝑒𝑚  = 42 (±5)%. 
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